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ABSTRACT 
  Epigenetics is a group of mechanisms associated with gene expression control. One of these 
mechanisms is methylation of cytosines which are part of a cytosine-guanine (CpG) dinucleotide. 
When this happens in the promoter region of a gene, it will control unwanted expression. For this 
process to take place, a methyl group donor is needed. One of the principal nutritional compounds that 
fit this role is folic acid (FA).  
  Our aim in this research was to examine whether exposure to FA would change the methylation 
profile and expression of toll like receptor (TLR) 2, immunoglobulin (Ig) β and major 
histocompatibility class (MHC) II β chain in chicken B cells.  
  The initial experiment used the chicken B cell derived DT-40 cell line. Cell cultures were incubated 
with 0, 1.72 or 3.96 mM of FA for 4 or 8 hours, with the 8 hour group treated with 0, 1 or 10 µg/ml of 
Lipopolysaccharide (LPS). A positive association was found between FA concentration and percent 
of Igβ promoter methylation and a negative association between FA concentration and percent of 
MHCII β chain promoter methylation after 4 hours of incubation. The expression of those two genes 
was affected as well. Both were downregulated after 8 hours compared to the 4 hours group. Incubation 
with 1.72 mM FA for 4 hours upregulated TLR2b and 3.96 mM FA for 4 hours upregulated MHCII β 
chain expression. FA at 3.96 mM for 8 hours downregulated TLR2b and upregulated Igβ expression. 
Treatment with LPS downregulated TLR2b expression. We concluded that FA indeed has an 
immunomodulatory effect on chicken B cells in a way that may possibly affect their ability to both 
recognize antigen through the TLR and B cell receptor (BCR) pathways and their ability to present 
antigen in an MHCII context. 
  A second series of experiments examined the effect of FA on embryonic B cells extracted from the 
bursa of Fabricius (BoF) at days (ED) 15, 18 and 21 of embryonic development. A novel protocol was 
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developed to obtain optimal growth and survival of the cells. The amount of chicken serum in the 
growth media was doubled and time of ex vivo culture was determined to ensure that the cells survive 
for the duration of the experiment. We found that our modified growth media maintained cells for the 
4 hour duration of the experiment. When compared to cells that were not incubated (0 hours), cells 
harvested at ED15 and incubated for 4 hours had a lower population of IgMlow/med cells, increased 
population of IgMhigh cells and upregulated Igβ expression. When the cells were harvested at ED21 
and incubated for 4 hours TLR2b, MHCII β chain as well as the expression of the reduced folate carrier 
(RFC), a FA transporter were downregulated compared to 0 hours. Exposure to FA did not have an 
effect on cell viability. For cells harvested at ED15 both 1.72 and 3.96 mM FA for 4 hours caused a 
downregulation of Igβ and the 3.96 mM treatment reduced the population of IgMmed cells when 
compared to these values after 4 hour incubation with no FA (0 mM FA). At ED18 both FA treatments 
reduced the IgMmed population and the 1.72 mM FA treatment reduced RFC expression compared to 
the 0 mM FA group. At ED21, 3.96 mM FA increased the IgMhigh population. The methylation status 
of the promoter region of all examined genes was not affected by either removal of the cells from the 
BoF or treatment with FA.  In this experiment, we demonstrated the immune modulating capabilities 
of FA in the developing B cell, and provided a protocol for maintaining the viability of these cells ex 
vivo for longer periods then previously published. 
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1. General Introduction 
1.1 The avian primary lymphoid tissue  
  The chicken as an immune system model was instrumental in important findings in 
immunological research. The discovery of vaccines by attenuating Pasteurella multocida by Louis 
Pasteur (Plotkin, S.A. 2003), in ovo vaccinations (Sharma, J.M. and Burmester, B.R. 1982) and 
allograft rejection (Simonsen, M. 1957), are examples which improved countless human and 
animal lives. Throughout  
  As chickens and mammals evolved from the same reptilian ancestor (Seto, F. 1981), there are 
similarities in lymphocyte development between the mammalian and avian immune systems, such 
as the T cell development process (Chen, C.H. et al. 1994). Hematopoietic stem cells, originating 
in the chicken from the para-aortic foci and the bone marrow (Dunon, D. et al. 1999) colonize the 
thymus in three waves. The cells then go through receptor rearrangement (Pickel, J.M. et al. 1993), 
after which the T cells emigrate from the thymus and populate the periphery and the spleen 
(Dunon, D. et al. 1997). Conversely, the development and maturation process of chicken B cells 
is different from the one described in mammals. While in mammals this process takes place in the 
fetal liver and then in the bone marrow (Melchers, F. 2015), the chicken has a different specialized 
organ for that purpose named the bursa of Fabricius (BoF) (Ciriaco, E. et al. 2003).  
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1.1.1 BoF development 
  The BoF is located between the cloaca and the sacrum and is attached to the gastrointestinal (GI) 
tract by the bursal duct (Casteleyn, C. et al. 2010). It was found to be an exclusive site for B cell 
maturation (these cells were in fact named B cells after this organ) in the chicken (Cooper, M.D. 
et al. 1965), and was the basis for the discovery of the role of the bone marrow in mammals in B 
cell maturation (Abdou, N.I. and Abdou, N.L. 1972).  
  During embryonic development the BoF is formed by interaction with the epithelium and 
mesenchyme (much like the thymus) (Olah, I. et al. 1986). The sac like formation is visible as 
early as embryonic development day (ED) 5 (Olah, I. et al. 1986). Over the next two days a lumen 
is formed, which is then connected to the proctodeum by the bursal duct (Nagy, N. and Olah, I. 
2010). Further proliferation of epithelium and mesenchymal cells cause the formation of folds, 
usually around 12 of them, each with its own artery and vein. It is during this time, between ED10 
and ED15, when the BoF is colonized by precursors of B cells (Nagy, N. et al. 2004). Each follicle 
is initially colonized by 2-3 B cell precursors, which continue to proliferate (Pink, J.R. et al. 1985). 
  By hatch, 90% of cells found in the BoF are immunoglobulin (Ig)M positive (McCormack, W.T. 
et al. 1991). B cells migrate from the follicles to an area where the bursal cortex is developed 
(Sayegh, C.E. et al. 2000), and from there they migrate to the periphery and secondary lymphoid 
tissues (Paramithiotis, E. and Ratcliffe, M.J. 1994a). The BoF, like the thymus, (Ciriaco, E. et al. 
2003) goes through a process of involution, beginning at 3 months post hatch up until 7 months 
post hatch (Naukkarinen, A. and Sorvari, T.E. 1984). This site, whose sole purpose is B cell 
maturation and development, makes the chicken a prime candidate for the study of these cells. 
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1.2 B cell 
  Classically, B cells fill a crucial role in the adaptive immune system. B cells recognize antigens 
through their B cell receptor (BCR) (Paus, D. et al. 2006). This type of recognition leads to 
presentation of the processed antigen on major histocompatibility complex (MHC) proteins 
(Avalos, A.M. and Ploegh, H.L. 2014). Surrounding the germinal centers are T cell zones, where 
antigen presenting cells activate cluster of differentiation (CD) 4 positive naïve T cells (Zynda, 
E.R. et al. 2015). T cell receptors (TCR) are designed to recognize antigen presentation only in 
MHCII proteins (Banchereau, J. and Steinman, R.M. 1998). If they are activated and come into 
contact with B cells presenting the same antigen through the MHCII complex. B cell will go 
through several changes which would enhance the antibody mediated response against that antigen 
(Lanzavecchia, A. 1985). This interaction does not involve the MHCII and TCR alone, but also 
the CD4 co-receptor, which is needed for intercellular signaling (Abraham, R.T. and Weiss, A. 
2004).  
  Another pair of receptors integral for the activity of the B cell are the CD40 ligand on the T cell, 
and its corresponding CD40 receptor on the B cell (Senhaji, N. et al. 2015), and finally lymphocyte 
function-associated antigen 1 (LFA-1) on the T cell which binds to intercellular adhesion molecule 
1 (ICAM-1) on the B cell, and helps anchor these two cell types together (Shekhar, S. and Yang, 
X. 2012). The interaction between T and B cells, as well as the cytokine profile secreted by the T 
cell, induces somatic hypermutation which utilizes point mutations to increase the affinity of the 
B cell receptor to the antigen (Li, Z. et al. 2004). The interaction between the cells also induces 
class switching which changes the type of the antibody heavy chain produced by the B cells, 
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dictated by the nature of the insult (Hu, J. et al. 2013). The above mentioned interaction also 
induces proliferation of the B cells and differentiation into plasma cells, which secrete the high 
affinity, class switched antibody (Hu, Y. et al. 2013), and memory B cells, which do not secrete 
antibodies. However, if there is a second interaction with the same antigen, memory B cells will 
produce affinity matured, class switched antibodies (Ettinger, R. et al. 2005).  
  Through the interactions described above, the B cell develops all the traits of the adaptive immune 
system including highly specific (Weng, N.P. 2006), memory inducing response. This response 
will be faster and more potent following a second insult (Weng, N.P. 2006). For this type of 
response antigen is recognized by the BCR and presented in an MHCII context. Recognizing a 
specific antigen through the BCR, processing it and presenting it to an effector T cell in an MHCII 
context (a T dependent B cell activation) is only one way in which the B cell can be activated (Hu, 
J. et al. 2013). Alternatively, B cells can also respond in a relatively fast, low specificity manner 
with no change from first to second antigen interaction (Kelly-Scumpia, K.M. et al. 2011). Those 
are all traits of the innate immune response, which does not require interaction with a T cell – T 
independent B cell activation (Liu, Y.J. et al. 1991). T independent antigens, such as 
lipopolysaccharides (LPS), do not have to be processed and presented to T cells to elicit antibody 
production (Mamchak, A.A. and Hodgkin, P.D. 2000). These microbial associated molecular 
patterns (MAMP) can be recognized by toll like receptors (TLRs) on B cells without involving the 
BCR or the MHC II system. This recognition will result in the production of low affinity antibodies 
(Pone, E.J. et al. 2015). Furthermore, recognition of MAMPs by TLRs can be followed by a cross 
linking and engagement between the TLRs and BCR, which can lead to antibody class switching 
and DNA recombination in both T cell independent (Macpherson, A.J. et al. 2000) and dependent 
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(Matter, M.S. and Ochsenbein, A.F. 2008) manners. Herein lays the elegance and importance of 
the B cell in defending the organism. The different receptors expressed by the B cell can work, 
alone or together, to allow a full response spectrum in terms of specificity, speed and cell 
differentiation, from a rapid, low specificity response, a trademark of the innate immune system, 
to a relatively slow, highly specific response which is associated with the adaptive immune system. 
1.2.1 Avian B cell development  
  As the BoF of Fabricius is the main organ for avian B cell development, the development of B 
cells can be divided into prebursal (Lebacq, A.M. and Ritter, M.A. 1979), bursal (Funk, P.E. and 
Palmer, J.L. 2003) and post bursal stages (Paramithiotis, E. and Ratcliffe, M.J. 1994b). Pre B cells 
originate from the dorsal aorta and yolk sac (Reynaud, C.A. et al. 1992). These cells are committed 
to the B cells lineage, as they express the B cell specific surface antigen chicken B6 (also known 
as Bu-1) (Houssaint, E. et al. 1991). The first heavy chain rearrangements can be detected as early 
as ED5 (Reynaud, C.A. et al. 1992). In chickens, this process is not a major contributor for Ig 
diversification (Ratcliffe, M.J. and Jacobsen, K.A. 1994). Light chain rearrangements coincide 
with those of the heavy chain (as opposed to mammals, where these are two separate events) 
(Ratcliffe, M.J. 2006). By ED15 all the gene rearrangements are complete and cells with fully 
rearranged genes can be found in the BoF, blood, spleen and thymus (Arakawa, H. and Buerstedde, 
J.M. 2004). However, continued B cell development is detectable only in the BoF, and the 
populations in other organs decrease (Arakawa, H. and Buerstedde, J.M. 2004). By ED10 the BoF 
contains roughly 10,000 follicles which are seeded by pre B cells between that time point and 
ED15 (Pink, J.R. et al. 1985).  
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  The migration to the BoF is thought to be dependent upon the expression of CXC motif 
chemokine receptor 4 (CXCR4) by the prebursal B cells, while the BoF expresses CXC motif 
ligand 2 (CXCL2) as its counterpart (Meyer, R.K. et al. 1959). Another molecule that is expressed 
by the prebursal B cells is sialyl Lewis x (Masteller, E.L. et al. 1995b) which has a role in the cells 
populating the BoF. While committed B cells migrate to the BoF, only those with a functional B 
cell receptor which includes surface Ig (sIg)M as well as the signal transduction peptides Igα and 
Igβ will continue to proliferate in the follicles (Pike, K.A. et al. 2004). In fact, it was discovered 
that the signal transduction capabilities are necessary and sufficient in order for the cell to 
proliferate (Pike, K.A. and Ratcliffe, M.J. 2005).  
  Repeated rounds of gene conversion (Arakawa, H. et al. 2002), the main mechanism in chickens 
for Ig diversification, begins to occur (Mansikka, A. et al. 1990). From this moment and until 
ED19, B cells begin to colonize and exponentially proliferate in the bursal buds (Lydyard, P.M. et 
al. 1976). By ED19, 90% of bursal cells express sIg (Lydyard, P.M. et al. 1976). The end of this 
stage is marked by a shift in expression from sialyl Lewis x to Lewis x on the B cell surface; this 
shift is dependent on the bursal environment (Masteller, E.L. et al. 1995a). Post hatch, there is a 
redistribution of the bursal B cells between the medulla and the newly formed cortex, and while 
the B cells that remain in the medulla slow their proliferation rate, the B cells in the cortex of the 
follicles continue to divide rapidly (Reynolds, J.D. 1987). Post hatch, roughly 95% of the cells in 
the BoF lose their surface IgM expression and undergo apoptosis (Paramithiotis, E. et al. 1995). 
While it is unclear why this happens, as all B cells proliferating in the BoF have a functionally 
rearranged light and heavy chains, it is possible that the combination of the two is not always 
functional, which may lead to these low survival rates (Motyka, B. and Reynolds, J.D. 1991). 
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Around hatching, surface IgM positive cells begin to leave the bursal area and enter peripheral 
blood and then migrate into B cell areas of spleen, thymus and cecal tonsils, where they can take 
part in the immune response (Cooper, M.D. et al. 1969). 
1.2.2 B cells in the periphery 
  After they acquire the ability to emigrate from BoF, 1% of the B cells destined for the periphery 
leaves the BoF every hour (Lassila, O. 1989). Most, but not all of these cells originate from the 
bursal follicular cortex. It has been demonstrated that B cells originating from the cortex and those 
originating from the bursal medulla have different life spans, and it is possible that these constitute 
functionally distinct B cell populations (Paramithiotis, E. and Ratcliffe, M.J. 1996). Like in 
mammals, where B cells initially emigrate from the bone marrow to the spleen, the chicken B cells 
also emigrate to the spleen and are situated in B cell specific areas called periellipsoidal lymphoid 
sheaths situated around capillaries as well as in germinal centers (Paramithiotis, E. and Ratcliffe, 
M.J. 1993). These areas are anatomically less defined than in mammals (Yasuda, M. et al. 1998). 
B cells also emigrate to secondary lymphoid tissues such as the gut associated lymphoid tissue, 
Peyer’s patches and the cecal tonsils (Hegde, S.N. et al. 1982) and the bronchus associated 
lymphoid tissue (Fagerland, J.A. and Arp, L.H. 1993). While the formation of these areas is not 
antigen dependent, their subsequent development is (Hegde, S.N. et al. 1982). Similar to the 
spleen, these areas contain a mix of T and B cells which are not as clearly defined as they are in 
mammals (Jeurissen, S.H. 1993). In these areas the B cells are activated in either a T dependent or 
independent manner. 
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1.3 Programmed cell death 
  Throughout its life, every multicellular organism is presented with instances in which it has to 
rid itself of specific cells. These situations present themselves not only when the cells are infected 
or damaged, but in general, when these cells interfere with the homeostasis of the organism (Labbe, 
K. and Saleh, M. 2008). There are several tightly maintained “Programmed cell death” (PCD) 
pathways that the organism or the cell itself can activate in order to induce cellular death. These 
pathways are heavily controlled, as spontaneous cell death with no control over the process can be 
catastrophic.  
  There are at least three PCD pathways (Portt, L. et al. 2011). Type II PCD, also called autophagy, 
is a catabolic pathway that allows the cell to sequester various cellular organelles and proteins in 
specialized double membrane vesicles with lysosomal activities, break them down and recycle 
them (Gozuacik, D. and Kimchi, A. 2007). Although mostly used for intracellular homeostasis, 
extensive autophagy may lead to cell death (Duprez, L. et al. 2009). Type III PCD, necrosis or 
oncotic cell death (Majno, G. and Joris, I. 1995), was considered up until recently to be an 
uncontrolled form of cellular death. However, evidence was found that this form of PCD is indeed 
regulated, and is even used in a developmental context (Chautan, M. et al. 1999). Type I PCD is 
also known as apoptosis. 
1.4 Apoptosis and B cell selection process 
  B cells with the potential to activate a potent immune response in both an innate and adaptive 
manner, need to be under strict control. In order to achieve this, the cells go through a rigorous 
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selection process that ensures that the cells leaving the BoF are functional (Thompson, C.B. 1992) 
as well as not strongly responsive to the organism itself (Funk, P.E. and Palmer, J.L. 2003), a trait 
that could cause a severe autoimmune disease (Grimaldi, C.M. et al. 2005). The selection process 
has two “checkpoints” that the maturing B cell has to pass in order to leave the BoF and migrate 
to the periphery. The first one is a positive selection process where the cells are tested for 
expression of a functional pre BCR complex (van der Burg, M. et al. 2002). Pre B cells that fail 
this selection step go into programmed cell death (Cheng, S. et al. 2009). It is unclear which of the 
apoptotic pathways is utilized. Some implications were made as to the role of the first apoptotic 
signal receptor (FAS) and its ligand in the process, pointing at the extrinsic pathway, but this 
subject needs to be investigated further (Opferman, J.T. 2008). The second process is negative 
selection. i.e., deletion of self-reactive B cell populations (Luning Prak, E.T. et al. 2011). Both 
selection processes are dependent on the integrity of the B cell receptor. The selection process in 
the BoF is extremely rigorous. Only 5% of B cells express a functional BCR complex and are not 
self-reactive, where as 95% of cells go through apoptosis if they fail these checkpoints (Sayegh, 
C.E. et al. 1999).  
1.5 The B cell receptor  
  The BCR, in addition to its role in B cell selection, is the link between B cells and humoral 
immune system. The receptor complex includes a sIg as an antigen capture moiety, and a signal 
transduction moiety (Chu, P.G. and Arber, D.A. 2001). The latter is made up of two non-covalently 
bound proteins (Igα and Igβ), which are involved in the activation of the cell once the antigen is 
recognized (Lee, W.Y. and Tolar, P. 2013). These two proteins both have immunoreceptor tyrosine 
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based activation motifs (ITAMs) able of activating a signaling cascade which will result in cell 
activation, proliferation and antibody secretion (Cambier, J.C. et al. 2007). It is this signaling 
ability (as opposed to the BCR ability to bind the antigen) that allows the cell to pass the first 
selection process (Wienands, J. and Engels, N. 2001). 
1.6 Pattern recognition receptors 
  One of the ways in which the innate immune system recognizes microbial elements is a family 
of receptors generally called the pattern recognition receptors (PRRs) (Takeuchi, O. and Akira, S. 
2001, Akira, S. 2006). There are several types of PRRs, such as C-type lectins (CTLs), which 
recognize carbohydrates in a calcium dependent manner (Graversen, J.H. et al. 1998). Membrane 
bound CTLs, like dectin, recognize their ligands which will lead to activation of innate immune 
cells such as dendritic cells (DCs) (Ariizumi, K. et al. 2000) and macrophages (Taylor, P.R. et al. 
2002). These cells will phagocytize the bound material and/or secrete cytokines to further advance 
the immune reaction against the intruder (Mezger, M. et al. 2008). The mannose binding lectin, 
which is a secreted type of CTL, can interact with the complement system to further amplify the 
innate immune response (Jack, D.L. et al. 2001). Other PRRs like nucleotide-binding 
oligomerization domain (NOD) like receptors and retinoic acid-inducible gene like receptors 
(RIG) are intracellular in nature, reacting with intracellular MAMPs (Kanneganti, T.D. et al. 2007). 
However, the largest and most well researched family of PRRs is the TLRs. The members of this 
family are highly conserved receptors, which can be found either in endosomes or membrane 
bound (Mogensen, T.H. 2009). Thirteen TLRs were found in humans (Zarember, K.A. and 
Godowski, P.J. 2002), with most of them having a homolog receptor in chickens (TLRs 9, 11, 12 
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and 13 are absent from the chicken TLR repertoire) (Keestra, A.M. et al. 2013). Different TLRs 
are defined by their location and ligand. For example, TLR5, which recognizes flagellin, is a 
membrane bound TLR, while TLR7, a single strand RNA recognizing receptor, is found in 
endosomes in the cytoplasm (Jimenez-Dalmaroni, M.J. et al. 2016). TLRs are expressed on several 
types of immune cells such as macrophages, DCs, B cells, and specific types of T cells. 
Furthermore, they are also expressed on nonimmune cells such as fibroblasts and epithelial cells 
(Akira, S. 2006). As with other PRRs, ligand recognition by the TLR will, in most cases, lead to 
an innate proinflammatory response (Aderem, A. and Ulevitch, R.J. 2000).  
1.6.1 Chicken TLR2 
  While most TLRs function as homodimeric complexes, TLR2 functions as part of a heterodimer 
with other TLRs (Farhat, K. et al. 2008). Each of the combinations is more sensitive to different 
types of TLR2 ligands. A TLR1-TLR2 combination can recognize triacetylated lipoproteins found 
in Gram-positive bacteria such as Clostridium spp., Staphylococcus aureus and Mycoplasma spp., 
while a TLR6-TLR2 combination recognizes diacetylated lipoproteins (a Gram-positive bacteria 
component) and zymosan (a fungal component) (Farhat, K. et al. 2008). TLR2 had also been 
known to recognize LPS in the presence of another protein, lymphocyte antigen 96 (MD2) 
(Matsuguchi, T. et al. 2000, Yitbarek, A. et al. 2012) and several protozoan (Wong-Baeza, I. et al. 
2010) and viral (Klein Klouwenberg, P. et al. 2009) ligands. Recognition of these ligands by TLR2 
will activate a Myeloid differentiation factor 88 (MyD88) mediated cascade. This activation will 
result in the activation of the transcription factor nuclear factor kappa B (NF-κB) (Arbibe, L. et al. 
2000) and the expression of several pro inflammatory cytokines such as Interleukin (IL)-1β 
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(Cogswell, J.P. et al. 1994) and IL-6 (Parikh, A.A. et al. 1997), which will, in turn, cause fever, 
acute phase protein production (Akira, S. and Kishimoto, T. 1992), macrophage activation 
(Chomarat, P. et al. 2000), endothelial expression of cell adhesion molecules and lymphocyte 
proliferation and differentiation. It has been shown that using TLR2 ligands induces both type 1 
(Th1) and type 2 (Th2) helper T cell-like responses (St Paul, M. et al. 2012b), induces anti-viral 
responses in chickens (Barjesteh, N. et al. 2015a), and that one of the responses to Salmonella 
pullorum. infections in chickens is upregulated TLR2 expression (Ramasamy, K.T. et al. 2014). 
This versatility of TLR2 based responses is the reason its ligands are used in adjuvants for vaccines 
such as the one against avian influenza, where adding them protected the chickens from challenge 
as well reduced the amount of viral shedding (Barjesteh, N. et al. 2015b). This effect was seen in 
ovo as well, where administration of TLR2 ligands conveyed protection against avian influenza 
(Barjesteh, N. et al. 2015a) as well as against infectious laryngotracheitis virus, a protection that 
was detectable post hatch as well (Thapa, S. et al. 2015). While the role of TLR2 is similar in 
chickens and mammals, chickens have two functional genes encoding for TLR2 – TLR2a, 
expressed in the cecal tonsils, liver and spleen; and TLR2b, which is more broadly distributed 
(Fukui, A. et al. 2001).  
1.7 Major histocompatibility complex class II  
  The MHC II is a crucial factor in presenting antigens to T cells (van den Elsen, P.J. et al. 2003). 
Under normal conditions, only antigen presenting cells (APCs) express MHC class II. Those cells 
include DCs, macrophages and B cells. Other cells, such as thymic epithelial cells and T cells (post 
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activation) may also express MHCII, and expression in other cells can be induced by interferon-γ 
(IFN-γ) (Boss, J.M. and Jensen, P.E. 2003, van den Elsen, P.J. et al. 2003).   
  Expression of MHCII by APCs and presentation through this complex serves different functions. 
DCs take up antigen through macropinocytosis and phagocytosis and present the processed antigen 
to naïve CD4+ T cells (ten Broeke, T. et al. 2013). As long as the proper costimulatory signals are 
presented as well, the T cell will differentiate into one of several types of T effector cells, 
determined by the cytokine profile secreted by the APC (Bailey, S.R. et al. 2014). Macrophages 
present antigen through the MHCII receptor to effector T cells found on site; in a manner similar 
to that of DCs (van den Elsen, P.J. et al. 2003). Interaction between macrophages and effector T 
cells will result in the activation of the macrophage to produce pro inflammatory cytokines and 
produce nitric oxide (Bingaman, A.W. et al. 2000). B cells also present antigen to already activated 
T cells, however, the antigen is first recognized by the antigen specific B cell receptor and only 
then it is internalized and processed (Roche, P.A. and Furuta, K. 2015). Recognition of the 
complex by the T cell will cause that cell to produce and secrete a cytokine profile that will activate 
several processes in the B cell. These include antibody class change, which will match the antibody 
produced to the nature of immune response needed (Hu, J. et al. 2013) as well as somatic 
hypermutation, which will increase the specificity of the produced antibody to the antigen (Li, Z. 
et al. 2004). Furthermore, these cytokines will induce B cell differentiation into memory cells and 
plasma cells (Ettinger, R. et al. 2005, Hu, J. et al. 2013).  
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1.8 Nutritional intervention 
  There is a clear link between nutrition and immune capabilities. It is easiest to observe while 
discussing malnutrition, the damage it causes to the organism in general and to the immune system 
specifically. However, a positive link exists between specific nutrients and immune capabilities 
(Fox, C.J. et al. 2005, Zhao, R. et al. 2016). Food components such as iron and vitamin D have 
considerable potential to reduce susceptibility to infectious diseases (Katona, P. and Katona-Apte, 
J. 2008). Examples in poultry include amino acids such as arginine or threonine (Kidd, M.T. et al. 
2001), β-glucans (Lowry, V.K. et al. 2005) and zinc and selenium as minerals which have a wide 
spectrum of effects on the immune system (Stahl, J.L. et al. 1989).  
  The race to improve the immune capabilities of production animal such as the chicken through 
nutritional intervention is crucial, especially since a growing number of countries ban the use of 
antibiotic growth promoters, as these might have adverse effects on the animals gut microbiota 
(Yitbarek, A. et al. 2013), may affect nutrient absorption (Knarreborg, A. et al. 2004) and could 
contribute to microbial resistance to antibiotics (Dibner, J.J. and Richards, J.D. 2005). Another 
reason the chicken industry may benefit from immunological nutritional intervention is that the 
selection for rapid growth and egg production has dampened the immune response (Leshchinsky, 
T.V. and Klasing, K.C. 2001).  
  Nutritional intervention can be achieved with three main strategies: Probiotics, prebiotics and 
synbiotics. Probiotics are live microbes which confer health benefit to the host (Sanders, M.E. 
2008) and compete with pathogens for nutrient absorption and colonization space (Deriu, E. et al. 
2013). The use of these beneficial bacteria has been shown to have a direct effect on the immune 
15 
 
 
 
capabilities of the host (Malin, M. et al. 1996, Isolauri, E. et al. 2001). The use of Lactobacillus 
fermentum and Saccharomyces cerevisiae, for example, has been shown to effect TLR expression 
and the T cell population in the chicken intestine (Bai, S.P. et al. 2013), and Clostridium butyricum 
has an effect on cytokine production (Zhang, L. et al. 2016). Commensal bacteria can also produce 
nutrients that are utilized by the host such as short chain fatty acids (Topping, D.L. 1996) and 
vitamins such as vitamin K, and those in vitamin B family (Resta, S.C. 2009) such as B9 (Rossi, 
M. et al. 2011), also known as folic acid (FA). Another strategy is the use of prebiotics, materials 
that either benefit the commensal bacteria population of the gut or the host directly (Roberfroid, 
M.B. 2000). Yeast derived nucleotides (Yitbarek, A. et al. 2013) have been shown to have an effect 
on TLR2b expression and cytokine production. The combined administration of probiotics and 
prebiotics is called synbiotics, and there has been extensive research done on the subject in humans 
(Chang, Y.S. et al. 2016), mice (Simeoli, R. et al. 2015) and poultry (Rodriguez-Lecompte, J.C. et 
al. 2012, Madej, J.P. and Bednarczyk, M. 2016). 
1.9 FA in nutritional intervention 
  FA has been investigated thoroughly as a nutritional immune modulator for several reasons. First, 
it is a substance that can be obtained both nutritionally as well as a metabolite of commensal 
bacteria such as Bifidobacterium adolescentis (Strozzi, G.P. and Mogna, L. 2008). Secondly, it is 
part of several integral pathways including DNA synthesis and methylation. It was found to be 
extremely important in human nutrition, especially in expecting mothers, where FA deficiency 
may cause neural tube defects (Grosse, S.D. and Collins, J.S. 2007) as well as problems in 
embryonic production of normal erythrocytes (Carmel, R. 2008) and leukocytes (Kaplan, S.S. and 
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Basford, R.E. 1976) in the developing embryos. FA supplementation is considered so beneficial, 
that Canadian and US lawmakers mandated the FA fortification of cereal grain products (Tactacan, 
G.B. et al. 2010). This led to the exploration of egg enrichment with FA through the hen’s diet 
(Seyoum, E. and Selhub, J. 1998). Egg enrichment with FA lead to increased egg folate 
concentrations, with an enriched egg containing approximately 10% of the recommended dietary 
allowance for adults (Tactacan, G.B. et al. 2010). However, beyond a certain point FA addition to 
the hens diet leads to saturation. Addition of more than 3.6 μg/kg FA to the diet does not result in 
higher concentrations of FA in the egg, (House, J.D. et al. 2002). There are other factors found to 
be altered through FA addition to poultry diet, including immunological factors such as alterations 
to the T cell population (Wintergerst, E.S. et al. 2007) and expression of the proinflammatory 
cytokine IL-1β (Munyaka, P.M. et al. 2012).  
1.10 FA transport 
  There are two major folate transporters. The proton coupled folate carrier (PCFT) mediates 
intestinal absorption of FA. Its optimal activity is at low pH values found in the upper part of the 
intestinal tract (Visentin, M. et al. 2014). The reduced folate carrier (RFC) is a neutral pH 
membrane transporter of FA (Sierra, E.E. et al. 1997). It is ubiquitously expressed throughout the 
body (Whetstine, J.R. et al. 2002) including in B cells (Baslund, B. et al. 2008) and the BoF (Jing, 
M. et al. 2009). It is crucial for proper embryonic development (Zhao, R. et al. 2001), and is 
considered to be the major folate transport system in mammals (Matherly, L.H. et al. 2007). The 
RFC has a much higher affinity for 5-methyltetrahydrofolate, the major form of reduced FA in the 
blood, than to unreduced FA by several orders of magnitude (Zhao, R. et al. 2001). Interestingly, 
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the expression of both receptors is downregulated either at the mRNA level, post transcriptional 
or translational level or both, when exposed to their ligand (Ashokkumar, B. et al. 2007, Tactacan, 
G.B. et al. 2012). Conversely, Under FA deficiency conditions both receptor types are over 
expressed (Thakur, S. and Kaur, J. 2015). This negative association is caused by reduced promoter 
activity, reduced messenger RNA (mRNA) levels (Ashokkumar, B. et al. 2007) and sequestration 
of RFC protein in the endoplasmatic reticulum (Hou, Z. et al. 2014).  
1.11 Epigenetics 
  Epigenetic is defined as changes in gene expression, some of which are heritable, with no change 
in the DNA sequence (Chuang, J.C. and Jones, P.A. 2007). A lack of dependence on the genomic 
sequence, and their hereditary nature sets epigenetic mechanisms apart from gene expression 
control mechanisms that rely on transcription factors, enhancers and promoters, the latter having 
a transient effect on gene expression, and rely on the sequence of the genetic material (Tammen, 
S.A. et al. 2013).  
1.11.1 Epigenetic Factors 
  The DNA double strand which make up the genetic data in each cell is wrapped around 
specialized protein structures called histones, which are made up of four sets of homodimers. A 
unit made up of a histone and the DNA wrapped around it is called a nucleosome (Rothbart, S.B. 
and Strahl, B.D. 2014). These units make up the chromatin. This form of packaging makes it 
possible for vast amounts of genetic material to be stored inside the nucleus in chromosomal form 
(Tammen, S.A. et al. 2013). Each one of these structures – the DNA, the histone and the chromatin, 
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can go through several modifications that will make the genetic material more or less accessible 
for expression (Rothbart, S.B. and Strahl, B.D. 2014). The histone, for example, has its N terminal 
end protruding from outside of the globular structure. This part of the protein can go through 
several types of modifications such as methylation and acetylation (Allfrey, V.G. et al. 1964). 
Methylating the histone would make the nucleosome structure bind more firmly together into a 
structure called Heterochromatin, making it difficult or even impossible to transcribe the genes 
present in that structure, depending on the amount of methylation done to the site (mono-, di- or 
trimethylation). Acetylating the histone, on the other hand, has the opposite effect. Due to the 
change in the electrical charge of the histone post acetylation the chromatin will become less 
tightly wrapped and more available for the transcription process (Euchromatin), thus allowing 
access to the genes wrapped around those histones (Allfrey, V.G. et al. 1964). Other histone 
modifications include phosphorylation, ubiquitination and biotinylation (Tammen, S.A. et al. 
2013). The effect of each modification on the structure of the histone and the availability of the 
genetic code is called the histone code (Rothbart, S.B. and Strahl, B.D. 2014).   
1.12 DNA Methylation 
  Like histones, the DNA can also be methylated. Most methylation occurs on the 5’ carbon on 
cytosines that are part of a cytosine-guanine (CpG) dinucleotide, although some methylation has 
been shown to occur on other nucleotides. It is an enzymatic reaction, carried out by the enzyme 
family DNA methyltransferases (DNMT) by using S-adenosylmethionine (SAM) as a methyl 
donor (Crider, K.S. et al. 2012). 
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  The methyl donor used in the process of methylation, SAM, is a derivative of FA. When FA is 
absorbed in the intestine it is reduced enzymatically in the enterocytes into tetrahydrofolate (THF). 
THF is converted into 5-methyl tetrahydrofolate (5-mTHF) in the liver and is then released into 
the circulation (Hebert, K. et al. 2005). Other derivatives of this substance are used in DNA 
synthesis, while 5-mTHF is used to convert homocysteine to methionine. Methionine is then 
reduced to SAM, which is used by the DNMT enzyme family (Crider, K.S. et al. 2012). While FA 
can be obtained dietarily, through foods like beans, asparagus and avocados (Wald, D.S. et al. 
2001), some components of the gut flora, like the Bifidobacterium spp. can produce this vitamin, 
making them a model probiotic species (Pompei, A. et al. 2007). Other dietary methyl donors 
include betaine, choline, methionine, vitamin B12 and vitamin B6. These donors all converge into 
the homocysteine-methionine pathway described above (Olthof, M.R. et al. 2005).  
  Epigenetic regulation in general, and specifically DNA methylation, is not a transient process. 
These control mechanisms are in charge of determining the gene expression profile of the cell type. 
i.e., which genes will be available for transcription at every stage of the cells life (Ghoshal, K. and 
Bai, S. 2007). Furthermore, that profile is hereditary, ensuring the daughter cells, being the same 
type as the mother cell, will have the same genes available for transcription. There are two types 
of DNA methylation processes that are separated by their function and the enzymes that are used. 
DNMT3a and DNMT3b carry out nonhereditary, or “de-novo methylation”. This process 
establishes methylation patterns during early development as well as in maternally imprinted genes 
in oocytes (Gowher, H. and Jeltsch, A. 2001). DNMT3a and DNMT3b have the ability to 
methylate cytosines regardless of other methylated sites on the DNA strand. This process has been 
shown to work in differentiated somatic cells as well, but at a slower rate (Gowher, H. and Jeltsch, 
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A. 2001, Hata, K. et al. 2002). Conversely, DNMT1 is responsible for “maintenance methylation”. 
This type of methylation is possible due to the semi conservative model of DNA replication in 
eukaryotic cells. In this model, each daughter strand has one strand for the mother cell and one 
new strand. DNMT1 identifies locations on the mother strand where the cytosines are methylated, 
and methylates the corresponding cytosines on the new strand (Ghoshal, K. and Bai, S. 2007). In 
any case, methylation of a group or single CpG dinucleotides acts as steric interference, inhibiting 
transcription factor binding to the region.  
  Another way in which DNA methylation inhibits gene expression is the recruitment of methylated 
DNA binding proteins such as Methyl CpG binding protein (MeCP2), methylated DNA binding 
protein (MBD)1 and MBD2 (Russ, B.E. et al. 2013). These protein complexes recruit histone 
methyltransferases and histone deacetylases, which have the ability to “close” the chromatin, 
forming heterochromatin. In this way, these two major mechanics of epigenetic control interact 
with each other to ensure complete opening or closing of the target loci (Russ, B.E. et al. 2013).  
  In stem cells and cells that have not yet fully differentiated, methylated sites begin to appear on 
the DNA sequence (due to DNMT 3a and DNMT 3b) (Okano, M. et al. 1999). Through the 
differentiation of the cell areas in the genome containing genes that are irrelevant for that cells 
function are placed in a heterochromatin formation (Li, E. 2002). The end result is a gene 
expression profile specific for that type of cell. A fully differentiated cell that is part of a specific 
system or organ has a gene expression profile that best suits the function of this cell. The profile 
will be passed on to the progeny of the cell because of the function of DNMT1 (Bestor, T.H. 2000).  
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1.13 Apoptosis and DNA methylation 
  The relationship between apoptosis and DNA methylation is a two way street. As DNA 
methylation in general and the function of DNMT1 specifically are essential for the proper 
development of the organism, lack of a proper methylation profile may lead to apoptosis of the 
cell (Jackson-Grusby, L. et al. 2001). This is also apparent in neoplastic cells, where inactivation 
of DNMT1 also results in programmed cell death (Chen, T. et al. 2007). Hypermethylation of 
promoter regions has a crucial role in cell differentiation and embryogenesis (Geiman, T.M. and 
Muegge, K. 2010). However, it was found that in certain types of recurring cancers the promoter 
region of caspase 8 is hypermethylated, inhibiting apoptosis of cancerous cells, which contributes 
to their progression (Martinez, R. et al. 2007). Hypermethylation can also interfere with the 
intrinsic apoptotic pathway, as has been shown for the proapoptotic Bcl-2-associated X protein 
(Bax) gene (Hervouet, E. et al. 2013). 
1.14 TLR2b and DNA methylation 
  The relationship between TLR2 promoter methylation and expression varies between cell types. 
For example, in bronchial epithelial cells hypermethylation of the promoter region resulted in 
increased sensitivity to TLR2 ligand (Shuto, T. et al. 2006), while in endothelial cells, mRNA 
levels were not affected by changes in the TLR2 promoter region methylation status. 
Hypermethylating the promoter region of TLR2 in gingival epithelial cells resulted in down 
regulation of the mRNA and an increased susceptibility to disease (Benakanakere, M. et al. 2015). 
In chickens, treatment with 5-Aza-2′-deoxycytidine, a demethylation agent, did not have any effect 
on the expression of TLR2b, while the expression of TLR2a was upregulated (Gou, Z. et al. 2012). 
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1.15 The BCR signal transfer moiety and DNA methylation 
  For the mammalian B cell to express Igα, a complex made up of the paired box protein (Pax)5 
and the E26 transformation-specific proteins (ETs) is required to act as a transcription factor for 
the CD79a gene (Maier, H. et al. 2003b). The formation of this complex is only possible when the 
CD79a promoter site is hypomethylated (Maier, H. et al. 2003a), which is its status in B lineage 
cells (Maier, H. et al. 2003a). In other cells a single CpG dinucleotide in the promoter region of 
CD79a is methylated, which interferes with the formation of the Pax5-Ets complex (Maier, H. et 
al. 2003a). Furthermore, there is some evidence that mammalian Igβ is also under DNA 
methylation control (Malone, C.S. et al. 2006). Examination of epigenetic controls placed on the 
Igβ promoter region in chicken cells revealed that in tissues where the gene is not transcribed the 
promoter region is highly methylated (Itaya, K. et al. 2011, Minbuta, T. and Ono, M. 2011). 
However, others described the Igβ gene in chicken B cells to be epigenetically controlled through 
histone modification, with no changes to the methylation status of the promoter region even after 
the formation of euchromatin through histone acetylation (Shimada, N. et al. 2006). Both proteins 
increase the efficiency of another B cell trait – antigen presentation through MHC II (Bonnerot, C. 
et al. 1995). 
1.16 Major histocompatibility complex class II and DNA methylation 
  While it is true that some cells can be induced to express MHC class II, some cells will not express 
this complex even when exposed to interferon-γ. These include sperm (Kuhlmann, D. et al. 1986), 
oocytes (Dohr, G.A. et al. 1987) and trophoblasts (Redman, C.W. et al. 1984). Thus, these types 
of cells can evade maternal immune recognition, allowing for a successful pregnancy (van den 
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Elsen, P.J. et al. 2003). This lack of expression of MHC is not due to absence of the transcription 
factors but rather due to the methylation of the promoter regions of the genes involved. While there 
are several factors necessary for MHC II expression, there is one crucial factor that is needed. This 
protein is constitutively expressed in antigen presenting cells, however in cells that do not express 
MHCII, the promoter for class II transactivator (CIITA) is highly methylated (van den Elsen, P.J. 
et al. 2003). In this way, MHC II expression is regulated through indirect DNA methylation. 
Treatment of these cells with 5’ deoxyazacytidine, a known DNA demethylator, resulted in both 
CIITA and MHC II expression following exposure to IFN-γ (van den Elsen, P.J. et al. 2000). The 
hypermethylation of the CIITA promoter is also apparent in leukemic T cells, where it effectively 
inhibits MHC II expression (van den Elsen, P.J. et al. 2003).  
  The HLA class II gene family expression pattern exhibit all three possible relationships with 
promoter methylation. While some genes are downregulated when their promoter is 
hypermethylated, others are upregulated and in a third case there is no correlation between 
promoter methylation and gene expression (Levine, F. and Pious, D. 1985). To the best of our 
knowledge, no papers examining the effect of promoter methylation on MHCII expression in 
chickens have been published.  
  As B cell development is sensitive to methyl supply due to their high proliferation rate, 
characterization and evaluation of methylation patterns in TCR, BCR and MHC II expression and 
their association with apoptosis induction are warranted. Specifically, the need to determine 
whether nutritional bioactive folate is able to influence methylation patterns in the genes involved 
in the formation of TCR, BCR and MHC II affecting immune and health status. 
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1.17 Hypothesis 
  Inclusion of FA influences methylation patterns in B cell precursor development in chicken 
embryos affecting innate and acquired immune responses in B cells through TLR2, BCR, and 
MHCII gene expression status. 
1.18 Research objectives 
  1. To study epigenetic changes in the proximal promoter region associated with TLR2b, BCR 
intracellular signaling protein Igβ, and MHCII genes in B cell precursors and to identify genes 
under methylation regulation. In order to achieve this objective the proximal promoter region 
(200 bp upstream of the start codon) will be sequenced to determine the number and location of 
CpG dinucleotides.   
  2. To determine whether inclusion of a methyl donor will affect DNA methylation in the 
proximal promoter region of TLR2b, Igβ, and MHCII genes. In order to achieve this objective 
cells will be incubated with a methyl donor. The DNA from these cells will be treated with 
bisulfite and the promoter region amplified and sequenced to determine which of the CpGs in 
this region are methylated and which are not.   
  3. To determine whether epigenetic programming by DNA methylation regulates gene 
expression. In order to achieve this objective RNA from the treated cells will be used to 
determine changes in TLR2b, Igβ and MHCII β chain expression following treatment with a 
methyl donor.  
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  The aim of the thesis is to characterize the epigenetic mechanism of DNA methylation, as playing 
a role in embryonic B cells precursors and in expression of cell sIg and subsequent B cell 
proliferation in bursal follicles. DNA modification involves methylation of cytosine at the carbon-
5 position (5-methyl cytosine; 5mC) in CpG dinucleotides. Furthermore, chromatin remodeling is 
mediated by DNA methylation and demethylation. FA will be used as a methyl donor model to 
evaluate the epigenetic changes in chicken embryo B cells and the impact that folate has on 
expression of TLR-2, Igβ (BCR), and MHC II genes. 
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2. General Materials and methods 
2.1 Ethical considerations 
  All the experimental procedures that chicken embryos were subjected to are consistent with the 
guidelines set out by the Canadian Council on Animal Care as approved by the University of Prince 
Edward Island Animal Care Committee. 
2.2 Experimental designs for experiments conducted with DT-40 cell line 
  The first series of experiments was conducted on samples containing 1x106 cells from a cell line 
derived from an avian leukosis virus induced bursal lymphoma (DT-40) cells. The cell culture was 
pipetted gently before distributing the cells for each treatment to achieve completely randomized 
sampling. The design of the experiments is presented in Figure 2.1 
Figure 2.1 DT-40 cell line experiments design flow chart 
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2.2.1 Association between FA and proximal promoter methylation of TLR2b, Igβ and 
MHCII β chain 
  FA was tested at three levels: 0 mM FA, 1.72 mM FA and 3.96 mM FA. Each treatment was 
repeated three times independently for both 4 and 8 hours of incubation for a total of 9 samples for 
each gene at each incubation time. 
2.2.2 Association between percent of promoter methylation and mRNA levels of TLR2b, 
Igβ and MHCII β chain 
  Samples from all three levels of FA treatment groups (0 mM FA, 1.72 mM FA and 3.96 mM FA) 
were analyzed, for a total of 9 samples for each gene at each incubation time.  
2.2.3 The Effect of incubation time and FA on mRNA levels of TLR2b, Igβ and MHCII β 
chain 
  FA concentration and incubation time are the two main factors in this design. FA was tested at 
three levels: 0 mM FA, 1.72 mM FA and 3.96 mM FA. Incubation time was tested at two levels: 
4 hours and 8 hours. Each treatment was repeated three times for a total of 9 samples for each gene 
at each incubation time. 
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2.2.4 The effect of LPS and FA on the mRNA levels of TLR2b, Igβ and MHCII β chain 
  FA and LPS are the two main factors in this design. FA was tested at three levels: 0 mM FA, 1.72 
mM FA and 3.96 mM FA. LPS was tested at three levels: 0 μg/ml, 1 μg/ml and 10 μg/ml. Each 
treatment was repeated three times for a total of 27 samples for each gene.  
2.2.5 The effect of FA on the mRNA levels of TLR2b, Igβ and MHCII β 
  Each FA treatment was repeated three times for either 4 or 8 hours of incubation and the response 
was analyzed separately for each incubation time. The 0 mM FA treatment acted as a control group 
for each gene (n=3). 
2.2.6 The effect of FA on mRNA levels after treatment with LPS 
  Each FA treatment was repeated three times on samples containing cells treated with either 1 or 
10 μg/ml LPS and the response was analyzed separately for each LPS treatment. The 0 mM FA 
treatment acted as a control group for each gene (n=3). 
2.3 Experimental designs for experiments conducted with cells extracted from embryonic 
BoF 
  The second series of experiments was conducted on samples containing 1x106 cells harvested 
from embryonic BoF. Fertile eggs used to harvest the cells were randomly selected and the cell 
culture was pipetted gently before distributing the cells for each treatment to achieve completely 
randomized sampling. The design of the experiments is presented in Figure 2.2 
Figure 2.2 Bursal B cells experiments design flow chart 
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2.3.1 The effect of ED and incubation time on the percent of live cells 
    ED and incubation time are the two main factors in this design. ED was tested at three levels: 
ED15, ED18 and ED21. Incubation time was tested at two levels: 0 hours and 4 hours. Each 
treatment was repeated three times for a total of 18 samples. 
2.3.2 The effect of ED and incubation time on the proportions of the cell populations 
expressing low, medium and high levels of surface IgM  
  ED and incubation time are the two main factors in this design. ED was tested at three levels: 
ED15, ED18 and ED21. Incubation time was tested at two levels: 0 hours and 4 hours. Each 
treatment was repeated three times for a total of 18 samples. 
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2.3.3 The effect of ED and incubation time on the proportions of live and dead cell 
populations expressing low, medium and high levels of surface IgM 
  ED and incubation time are the two main factors in this design. ED was tested at three levels: 
ED15, ED18 and ED21. Incubation time was tested at two levels: 0 hours and 4 hours. Each 
treatment was repeated three times for a total of 18 samples. 
2.3.4 The effect of ED and FA on the percent of live cells population, proportions of sIgM 
expression and double stained cell populations 
  ED and FA are the two main factors in this design. ED was tested at three levels: ED15, ED18 
and ED21. FA was tested at three levels: 0 mM FA, 1.72 mM FA and 3.96 mM FA. Each treatment 
was repeated three times for a total of 27 samples. The same model was used to examine the effect 
of ED and FA on the population proportions of sIgM expression and double stained cell 
populations. 
2.3.5 The effect of incubation time and FA on mRNA levels of the reduced folate carrier 
(RFC), TLR2b, Igβ and MHCII β mRNA levels 
  The same model was used to examine the effect of FA on mRNA levels. Each FA treatment was 
repeated three times on cells harvested from embryos at ED15, D18 and ED21, and the response 
was analyzed separately for each age. For each gene the 0 mM FA treatment acted as a control 
group (n=3). 
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2.3.6 Association between FA and proximal promoter methylation of TLR2b, Igβ and 
MHCII β chain and association between proximal promoter methylation and expression of 
these genes.  
  FA was tested at three levels: 0 mM FA, 1.72 mM FA and 3.96 mM FA. Each treatment was 
repeated three times independently on cells harvested from embryo at ED15, ED18 and ED21 for 
a total of 9 samples for each gene at each embryonic age.  
  To examine the relation between percent of promoter methylation and mRNA levels of TLR2b, 
Igβ and MHCII β chain a total of 9 samples were tested for each gene at each incubation time. 
2.4 DT-40 Cell culture  
  Chicken B cell derived DT-40 cell line cultures (American type culture collection (ATCC), 
Manassas, VA, USA) were grown overnight and counted on a Reichert Bright line Hemocytometer 
(Hausser Scientific, Horsham, PA, USA) using trypan blue (Sigma Aldrich, Oakville, ON, 
Canada) exclusion test to establish viability. Cells were diluted with growth medium consisting of 
Dulbecco's Modified Eagle's Medium (DMEM) (ATCC, Manassas, Virginia, USA) supplemented 
with 10% fetal bovine serum, 5% chicken serum, 55 μM 2-mercaptoethanol and 1% 
penicillin/streptomycin to a concentration of 1x106 cells/ml, and 1 ml was seeded in each well of 
a 48-well plate (Corning Inc., Corning, NY, USA). The plate was incubated overnight in an MCO-
19AIC incubator (Panasonic, Wood Dale, IL, USA) at 37°C under 5% CO2 with the described 
growth media as per manufacturer’s instructions. Cells were then treated with 0, 1.72 or 3.96 mM 
FA (6R, S)-5-formyl-5, 6, 7, 8-tetrahydrofolic acid, calcium salt (FA) (Schircks Laboratories, Jona, 
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Switzerland). 1.72 mM FA is the concentration found in the egg yolk of a hen fed a normal NRC 
approved diet and 3.96 mM FA is the maximal amount found in the yolk taken from a hen fed  a 
diet supplemented with FA (House, J.D. et al. 2002). Cells were challenged with 0, 1 or 10 μg/ml 
of Escherichia coli O26:B6 LPS (Sigma Aldrich, Oakville, ON, Canada). These LPS 
concentrations have been used before to challenge DT-40 cells (Hawkins, B.J. et al. 2010, Kim, 
W.H. et al. 2014) 
2.5 Egg incubation 
  Sixty fertilized eggs from Ross broiler breeder layers were supplied by Atlantic Poultry Inc. 
(Atlantic Poultry Inc., Port Williams, NS, Canada) and incubated in a Humidaire egg incubator 
until needed. Temperature was kept at 37°C and relative humidity was kept at 55%, both were 
monitored daily by using Traceable Hygrometer (Thermo Fisher Scientific, Waltham, MA, USA). 
The incubator was set to rotate every 6 hours. Egg candling was performed daily starting from at 
7th day of incubation to observe angiogenesis and determine which eggs were fertile.  
2.6 BoF extraction from embryos 
  In a biological safety cabinet embryos were removed from the egg and euthanized by cervical 
dislocation which was confirmed by palpation. The abdomen of the embryo was opened using 
scissors and the skin above the joint connecting the femur to the ilium was cut to allow for freedom 
of movement. All internal organs were removed and the colon was used as a guide to the BoF 
location. Sterile gauze was applied as needed to clear fluids and obstructions. BoF was removed 
whole and placed immediately in sterile water, to allow for excess cells outside the BoF to go 
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through a lysis process. The BoF remained in water until the next BoF was ready to be excised. 
The BoF was then transferred to growth medium ATCC DMEM supplemented with 10% fetal 
bovine serum, 10% chicken serum, 55 μM 2-mercaptoethanol and 1% penicillin/streptomycin.  
2.7 BoF Cells extraction  
  Pools of BoF were placed in a glass homogenizer together with 2 ml of the above described 
growth media. The number of BoF from each age needed for the experiments varies from age to 
age. Thirty BoF were extracted from ED15 embryos, 10 from ED18 embryos and 4 from ED21 
embryos. The BoF were gently homogenized using a loose fitting glass homogenizer (Compton, 
M.M. and Waldrip, H.M. 1998). The homogenate was then passed through a 40 μM filter (Thermo 
Fisher Scientific, Waltham, MA, USA) and the filtrate retained. The material that did not pass the 
sieve was incubated for 10 minutes at 37°C with 0.5% trypsin in 1xsterile phosphate buffered 
saline (PBS) and 1% penicillin/streptomycin. Growth media was added to counter the effect of the 
trypsin and the material filtered using a 40 μM filter. Both filtrations were filtered with 100 μM 
filter (Thermo Fisher Scientific, Waltham, MA, USA), and the filtrate centrifuged for 5 minutes at 
400 G. The supernatant was discarded and the cell pellet re-suspended with fresh growth media. 
Cells were counted using a Reichert Bright line Hemocytometer and trypan blue exclusion test 
was used to determine viability. 
2.8 Total RNA Extraction and Reverse Transcription 
  Total ribonucleic acid (RNA) was extracted from the DT-40 cell cultures using Ambion TRIzol® 
Reagent (Thermo Fisher Scientific, Waltham, MA, USA) following the manufacturer’s 
34 
 
 
 
instructions. The ethanol precipitate was cleaned using the Qiagen RNeasy minikit (Qiagen, 
Toronto, ON, Canada) according to the manufacturer’s instructions. Genomic deoxyribonucleic 
acid (DNA) was extracted from DT-40 cell culture using Qiagen DNeasy blood and tissue kit 
(Qiagen, Toronto, ON, Canada). RNA, DNA and protein were extracted from BoF cells using a 
TRIzol®LS Reagent (Thermo Fisher Scientific, Waltham, MA, USA) according to 
manufacturer’s instructions. Concentration of RNA and DNA of all samples was determined at an 
optical density of 260 nm and RNA purity was verified by evaluating the ratio of optical density 
of 260 nm to optical density of 280 nm using the ND-1000 Nanodrop (Thermo Fisher Scientific, 
Waltham, MA, USA). Reverse transcription of RNA samples was done using the High Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, Mississauga, ON, Canada) following the 
manufacturer’s protocol in a Techne TC-412 thermocycler (Bibby Scientific, Burlington, NJ, 
USA). The complementary DNA (cDNA) was stored at –20°C. 
2.9 Cloning 
  Primers were designed to flank the annealing sites of the real time detection assay primers of 
TLR2b, Igβ and RFC. After the reverse transcription process a sample was run with these primers 
and the product cleaned using QIAquick polymerase chain reaction (PCR) purification kit. The 
cleaned PCR product was then used in a cloning procedure using Topo TA cloning kit (Thermo 
Fisher Scientific, Waltham, MA, USA) as per manufacturer’s instructions. Cloning primers, the 
annealing temperatures used and the expected amplicons are presented in Table 2.1. The plasmid 
and primer set for the house keeping gene β-actin was supplied by Dr. Rodriguez’s lab, and the 
plasmid for MHCII β chain was a kind gift courtesy of Dr. Sharif (Ontario Veterinary College, 
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University of Guelph, Guelph, ON, Canada). It arrived on Whatman paper that was soaked for 30 
minutes with 50 µl Tris(hydroxymethyl)aminomethane-Ethylenediaminetetraacetic acid (TE) 
buffer. This was used to transform bacteria as recommended by the cloning kit manufacturer.  
  Selective agar plates were made by dissolving 1% bacto tryptone, 0.5% bacto yeast extract and 
1% NaCl in water. pH was adjusted to 7.5 with 5N NaOH. Granulated agar (1.5%) was added and 
the mix autoclaved (All materials purchased from Thermo Fisher Scientific, Waltham, MA, USA). 
After cooling to 55°C ampicillin was added to a final concentration of 0.1 mg/ml and the broth 
was poured into sterile petri dishes (Thermo Fisher Scientific, Waltham, MA, USA) and then left 
at room temperature to solidify. Plates were stored at 4°C until needed. 
  The transformed bacteria were plated and incubated overnight at 37°C. White colonies were 
selected and plated on a master plate, which was incubated under the same conditions. Colonies 
were then tested using a direct colony PCR with the primers designed for the real time assay (Table 
2.2). Briefly, a small portion of the colony was picked with a sterile loop and placed in 10 μl of 
water inside a 1.5 ml Eppendorf tube. The tube caps where sealed with parafilm to avoid 
evaporation, boiled for 5 minutes and placed directly on ice. A 1 μl sample was used in the reaction. 
Colonies which were positive for the insert were placed on a new plate.  
2.10 Miniprep procedure 
  Broth (2xYT) was made using 1.6% Bacto Tryptone, 1% Bacto Yeast Extract and 0.5 % NaCl in 
water, adjusted to pH7 with 5N NaOH and autoclaved. Three positive colonies were incubated 
overnight in 5 ml of 2xYT broth with 50 µg/ml ampicillin at 37°C while lightly shaken. The 
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cultures then went through and alkaline lysis miniprep procedure. Briefly, the culture was 
centrifuged and the supernatant discarded. A lysis buffer (50mM glucose, 10 mM 
Ethylenediaminetetraacetic acid (EDTA), 25 mM Tris pH8) was added to the pellet followed by 
an alkaline solution (0.2N NaOH + 1% Sodium dodecyl sulfate (SDS)) and 3M Potassium 5M 
acetate solution. Plasmid DNA was then precipitated using 95% Ethanol. The pellet was re 
suspended using TE buffer with 20 µg/ml RNase A. Concentration and purity of the plasmid DNA 
was measured using the Nanodrop (Thermo Fisher Scientific, Waltham, MA, USA) as described.  
2.11 Calibration curves and efficiency values for quantitative Real-Time PCR assays 
  For each gene of interest, the miniprep product was serially diluted in log10 increments and the 
dilutions used to optimize the assays in order to have an efficiency curve between 90% and 110%. 
Each dilution was run 3 times, together with three negative controls, where the sample was 
replaced with water. Regression analyses of mean cycle threshold (Ct) values of six sequential 
dilutions were used to generate a standard curve. The slope of the curve was used to calculate the 
efficiency of the reaction as: E = -1+10(−1/slope). This process was repeated three times throughout 
the project to ensure that the real time PCR systems maintain their ability to work in an acceptable 
efficiency. 
2.12 Quantitative Real-Time PCR 
  Quantitative real-time PCR was performed in triplicate for each sample for TLR2b, Igβ, MHCII 
β chain and β-actin expression using the “CFX connect” real time system (Bio-Rad, Mississauga, 
ON, Canada) on a 96-well plate with 10 μl of total reaction volume containing 4 μl sample, 5 μl 
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“SsoAdvanced™Universal SYBR® Green Supermix” (Bio-Rad, Mississauga, ON, Canada) and 
0.5 μl of each primer (20 μM). Genebank database (National Center for Biotechnology Information 
(NCBI), Bethesda, MD, USA) sequences corresponding to each quantified gene were used to 
design primers (Table 2.2), which were obtained from Mobix laboratories (Mobix laboratories, 
Hamilton, ON, Canada). The thermal cycling protocol consisted of an initial denaturation at 95°C 
for 3 min, followed by amplification for 40 cycles at 95°C for 10 seconds, annealing as described 
in Table 2.2 for each of the primer pairs, and extension at 72°C for 30 seconds. Expected product 
sizes are described in Table 2.2. A sample containing 100 ng/μl plasmid bearing an insert for the 
corresponding gene was used as a positive control, and water was used as a non-template control.  
2.13 Bisulfite modification 
  Qiagen’s EpiTect kit for bisulfite conversion (Qiagen, Toronto, ON, Canada) was used according 
to manufacturer’s instructions. Briefly, 2 µg DNA in a 20 µl volume was used for each reaction 
which was mixed with 85 µl bisulfite mix and 35 µl DNA protect buffer. Bisulfite conversion was 
performed in a Techne TC-412 thermocycler as follows: 99°C for 5 minutes (min), 60°C for 25 
min, 99°C for 5 min, 60°C for 85 min, 99°C for 5 min, 60°C for 175 min and 20°C indefinitely. 
The bisulfite-treated DNA was recovered by EpiTect spin column.  
2.14 Bisulfite Sequencing PCR 
  Primers for the proximal promoter region, 200 bp directly upstream of the translation start site of 
TLR2b, Igβ and MHCII β chain genes were designed for bisulfite treated and untreated template 
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and purchased from Mobix Laboratories (Mobix Laboratories, Hamilton, ON, Canada). Primers, 
accession numbers and running conditions are presented in Table 2.3.  
  Three PCR products for each gene of interest were cleaned using QIAquick PCR purification kit 
(Qiagen, Toronto, ON, Canada), the sample was sent to Mobix laboratories for sequencing using 
ABI BigDye terminator chemistry. The process is fully automated from sample loading to data 
analysis. The sequence was compared to the untreated promoter region sequences found in the 
NCBI database, and analyzed for methylated and unmethylated CpG dinucleotides using the Biq 
analyzer software (Max-Planck-Institute for Informatics, Saarland University, Saarbrücken, 
Germany). The software excludes any sequences with less than 90% homology to the published 
promoter regions. 
2.15 Flow cytometry 
  Cells were harvested from the BoF and placed in Falcon 5 ml polystyrene round bottom tubes. 
Cells were then washed with 2 ml 1xPBS+1% bovine serum albumin (BSA) twice and re-
suspended with 200 µl 1xPBS+1% BSA. Control group of cells included unstained cells, an 
isotype control using Mouse IgG2B-FITC (clone A-1), mouse anti chicken IgM-FITC (clone M-
1) and Propidium iodide (PI) (Sigma Aldrich, Oakville, ON, Canada). Samples were double 
stained with mouse anti chicken IgM-FITC (clone M-1) and Propidium iodide. All antibodies were 
purchased from Southern Biotech (Southern Biotech, Birmingham, Alabama, USA). Samples were 
incubated with the corresponding antibodies (1 µg clone M-1, 10 µl isotype antibody or 2 µg PI 
for 30 minutes in the dark. Cells were washed with 0.5 ml 1xPBS+1% BSA. Flow cytometry was 
done using BD FACSCalibur flow cytometry machine (BD Biosciences, San Jose, CA, USA). All 
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samples were read in triplicates, with 10,000 events per read. For the IgM analysis, the population 
was divided according to Fluorescein isothiocyanate (FITC) signal intensity into low (100-100.5 
FITC signal intensity), medium (100.5-101 FITC signal intensity) and high (101-104 FITC signal 
intensity). For PI analysis the population was divided into negative (100-101 fluorescence level 
(FL) units) and positive (101-104 FL units) populations. For the double stain analysis the population 
was divided according to FITC and PI fluorescence intensities into quadrants as described in 
Figure 2.1. 
Figure 2.3 Quadrant division for IgM-PI double stained population analysis. 
 
2.16 Staining slides preparation 
  Between 300 and 400 μl of a suspension containing 1x106 cells/ml were applied to slides using a 
sterile cell funnel, with  a piece of cardboard placed between the funnel and slide to absorb excess 
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fluids. The slides were then centrifuged using the Shandon Cytospin II cytocentrifuge (Thermo 
Fisher Scientific, Waltham, MA, USA) at 80 G for 5 minutes. The funnel and cardboard were 
removed carefully to avoid disturbing the cells, which formed a circle on the slide, roughly half a 
centimeter in diameter. 
2.17 Wright-Giemsa staining 
  Wright-Giemsa stain was applied to the slide and incubated at room temperature for 4 minutes. 
The slide was then incubated with PBS for 10 minutes more. The slides was then rinsed with PBS 
and dried at room temperature. The stain was done by the Diagnostic Services in our institiute 
(Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PE, Canada) 
2.18 Electron Microscopy 
  Cells from BoF were collected in 1.5 ml Eppendorf tubes, fixed in 2% glutaraldehyde, and treated 
with 1% OsO4 in 0.1 M sodium cacodylate at 4°C for 1 hour. The samples were dehydrated with 
ethanol gradient washes from 50% to 100%, followed by propylene oxide treatment. They were 
then embedded in 100% Spurrs Resin and heated overnight at 65°C. Sections of 2 μm were placed 
on copper grids and examined at 80 kV with a transmission electron microscope. 
2.19 Calculations and Statistical Analysis 
  Exact amplification efficiencies of target and reference genes were verified separately before 
normalizing the expression of the target gene to that of the housekeeping gene. Briefly, mean 
relative expressions of triplicates of each gene were calculated based on the expression of the 
housekeeping gene, β-actin, using Pfaffl’s formula (Pfaffl, M.W. 2001). Gene expression after 4 
41 
 
 
 
or 8h incubation was presented as fold changes relative to the control. Gene expression following 
1 or 10 µg/ml LPS treatment was presented as fold changes relative to the control group. Gene 
expression following 4 hour incubation in growth media was presented as fold changes relative to 
the 0h incubation group. Gene expression fold changes, standard error (SE), and statistical 
significance were calculated using REST 2009 (Qiagen, Toronto, ON, Canada) (Pfaffl, M.W. 
2001). The relative expression ratios were used to determine differences in gene expression among 
different groups using a general linear model ANOVA test.  
  A 2x3 ANOVA design was used to analyze the effect of incubation time and FA on mRNA levels. 
The same design was used to analyze the effect of embryonic age and incubation time on cell 
viability, sIgM expression and double stained cells. A 3X3 ANOVA design was used to analyze 
the effect of LPS and FA on the mRNA levels. The ANOVA analysis was followed by a post hoc 
Tukey test if interactions between the main effects were significant. Test was corrected using the 
Bonferroni correction for multiple comparisons. Associations between factors were tested using 
the Pearson correlation method. All results were considered significantly different at P < 0.05. 
ANOVA, Tukey and Pearosn’s correlation were all performed using Minitab 17 statistical software 
(Minitab Inc., State College, PA, USA).  
2.20 Statistical designs 
2.20.1 Association between FA and proximal promoter methylation of TLR2b, Igβ and 
MHCII β chain 
Yx1 = β0+rβ1x1+εx1κ 
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  Where: Yx1 = number of methylated cytosines that are part of a cytosine guanine dinucleotide 
(CpG) / total number of CpGs in the examined region X 100 (% Methylation); β0 = % Methylation 
with no treatment; r = correlation coefficient; β1x1 = FA concentration in mM and εx1,x2 = 
experimental error. 
2.20.2 Association between percent of promoter methylation and mRNA levels of TLR2b, 
Igβ and MHCII β chain 
Yx1 = β0+rβ1x1+εx1κ 
  Where: Yx1 = mRNA levels of the gene normalized to reference gene expression (mRNA levels); 
β0 = mRNA levels with no treatment; r = correlation coefficient; β1x1 = % Methylation and εx1,x2 = 
experimental error.   
2.20.3 The Effect of incubation time and FA on mRNA levels of TLR2b, Igβ and MHCII β 
chain 
Yx1x2=β0+β1x1+β2x2+(β1β 2)x1x2 + εx1x2κ 
  Where: Yx1,x2 = response of mRNA levels of each gene normalized to housekeeping mRNA levels 
(mRNA level response) ; β0 = mRNA levels when the main effects are 0; β1x1 = the effect of FA 
on mRNA levels; β2x2 =  the effect of incubation time on mRNA levels; (β1β 2)x1x2 = the effect on 
mRNA levels due to interaction between FA concentration and incubation time and εx1,x2 = 
experimental error. 
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2.20.4 The effect of LPS and FA on the mRNA levels of TLR2b, Igβ and MHCII β chain 
Yx1x2=β0+β1x1+β2x2+(β1β 2)x1x2 + εx1x2κ  
  Where: Yx1,x2 = mRNA level response; β0 = mRNA levels when the main effects are 0; β1x1 = the 
effect of FA on mRNA levels; β2x2 =  the effect of LPS on mRNA levels; (β1β 2)x1x2 = the effect on 
mRNA levels due to interaction between FA and LPS and εx1,x2 = experimental error. 
2.20.5 The effect of FA on the mRNA levels of TLR2b, Igβ and MHCII β 
Yx1 = β0+β1x1+εx1κ 
  Where Yx1 = mRNA level response; β0 = mRNA levels with no treatment; β1x1 = mRNA level 
response to FA treatment and     εx1 = experimental error. 
2.20.6 The effect of FA on mRNA levels after treatment with LPS 
Yx1 = β0+β1x1+εx1κ 
  Where Yx1 = mRNA level response; β0 = mRNA levels with no treatment; β1x1 = mRNA level 
response to FA treatment and εx1 = experimental error.  
2.20.7 The effect of ED and incubation time on the percent of live cells 
Yx1x2=β0+β1x1+β2x2+(β1β 2)x1x2 + εx1x2κ 
  Where: Yx1x2 = response in the proportion of live cell population; β0 = response when the main 
effects are 0; β1x1 = the effect of ED on live cell population; β2x2 = the effect of incubation time on 
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live cell population; (β1β 2)x1x2 = the effect on percent of live cells due to interaction between ED 
and incubation time and εx1,x2 = experimental error.  
2.20.8 The effect of ED and incubation time on the proportions of the cell populations 
expressing low, medium and high levels of surface IgM 
Yx1x2=β0+β1x1+β2x2+(β1β 2)x1x2 + εx1x2κ 
  Where: Yx1x2 = response in the proportion of cell populations expressing low, medium and high 
levels of surface IgM (sIgM expression); β0 = response when the main effects are 0; β1x1 = the 
effect of ED on sIgM expression; β2x2 = the effect of incubation time on sIgM expression; (β1β 
2)x1x2 = the effect on sIgM expression due to interaction between ED and incubation time and εx1,x2 
= experimental error.  
2.20.9 The effect of incubation time and FA on mRNA levels of the reduced folate carrier 
(RFC), TLR2b, Igβ and MHCII β mRNA levels 
Yx1 = β0+β1x1+εx1κ 
  Where Yx1 = mRNA level response; β0 = mRNA levels with no treatment; β1x1 = mRNA level 
response to incubation time and εx1 = experimental error.  
2.20.10 The effect of ED and incubation time on the proportions of live and dead cell 
populations expressing low, medium and high levels of surface IgM 
Yx1x2=β0+β1x1+β2x2+(β1β 2)x1x2 + εx1x2κ 
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  Where: Y x1,x2 = response in the proportion of live and dead cell populations expressing low, 
medium and high levels of surface IgM (double stained cell populations) ; β0 = response when the 
main effects are 0; β1x1 = the effect of ED on double stained cell populations; β2x2 =  the effect of 
incubation time on double stained cell populations; (β1β 2)x1x2 = the effect on double stained cell 
populations due to interaction between ED and incubation time and εx1,x2 = experimental error. 
2.20.11 The effect of ED and FA on the percent of live cells population, proportions of sIgM 
expression and double stained cell populations 
Yx1x2=β0+β1x1+β2x2+(β1β 2)x1x2 + εx1x2κ 
  Where: Yx1,x2 = response in the proportion of live cell population; β0 = response when the main 
effects are 0; β1x1 = the effect of ED on live cell population; β2x2 = the effect of FA on live cell 
population; (β1β 2)x1x2 = the effect on mRNA levels due to interaction between ED and incubation 
time and εx1,x2 = experimental error.
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Table 2.1 Primers used for cloning TLR2b, Igβ and RFC 
TLR – Toll like receptor; Ig – Immunoglobulin; MHCII – Major Histocompatibility complex; RFC - Reduced folate carrier 
 
Genes  Accession no. Primer sequences (5' to 3') Annealing temperature (°C) Product size (bp) 
      
TLR2b  NM_001161650.1 CATGCGATGCCACTCAGTCA 55 797 
 
 
 
CCACTTTCCAGTGCCCAAGA 
  
Igβ  NM_001006328.2 GACAGCAAGAACCTCACGGA 55 702 
 
 
 
GGTCACCAGCATAGCACCTT 
  
RFC  NM_001006513.1 ACCGGAAACATCTGGCTCTG 57 431 
   CCATCCATCCGTCTGTCCTG   
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Table 2.2 Primers used for real time PCR for TLR2b, Igβ, MHCII β chain and β actin mRNA gene expression levels 
Genes  Accession no. Primer sequences (5' to 3') Starting annealing temp. (°C) Product size (bp) 
      RFC  NM_001006513.1 TCTTCGGGGTCAACACATTCTT 58 152 
   CATCAGCAGGTAGACCAGTGC   
TLR2b  JN544177 CGTTTGGCTCTCAGGGGAAA 55 388 
 
 
 
ATGGCAGAGTGCAGAAGGTC 
  
Igβ  NM_001006328.2 GGAAAGGCCTGAGGAAGACC 56 318 
 
 
 
GGATGCAACCAAGCAAGAGC 
  
MHCII β chain  NM_001044679.2 CCACGGACGTGATGCAGAAC 50 321 
   CTGAGCGACTTCTTGGGGAG 
  
β actin  NM_205518.1 CAACACAGTGCTGTCTGGTGGTA 55 205 
   ATCGTACTCCTGCTTGCTGATCC   
TLR – Toll like receptor; Ig – Immunoglobulin; MHCII – Major Histocompatibility complex; RFC - Reduced folate carrier 
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Table 2.3 Primers used for PCR post bisulfite conversion for the amplification of the proximal promoter region of TLR2b, Igβ, MHCII β chain 
genes. 
Genes 
 
Accession no. Primer sequences (5' to 3') 
Starting annealing 
temp. (°C) Product size (bp) 
      
TLR2b  NW_003763738.1 GGTAAAATGAATTAATTAATTTTTGAAA 53.5 312 
 
 
 
CCCATAAAAAAACAATTACATAAC 
  
Igβ  NW_003764296.1 GGTGTTTAAGTTTATGGAGTAAAGGTAGGT 63.5 661 
 
 
 
TACATAACTTTACAAACCCAAAATTAACATTACC 
  
MHCII β chain  NW_003763991.1 GAATATGGGGTTATTATGGTTATAT 56.5 324 
 
 
 
CCAACAATACCACCAACA 
  
TLR – Toll like receptor; Ig – Immunoglobulin; MHCII – Major Histocompatibility complex 
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3. In vitro epigenetic characterization of the effect of folic acid on the proximal promoter 
area and mRNA gene expression of B cell receptors in the chicken DT-40 cell line 
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3.1 Abstract 
  FA is one of the principal nutritional methyl group donors involved in the DNA methylation 
process, an epigenetic control mechanism generally associated with gene expression control. In 
the present study, the effect of FA on the proximal promoter methylation profile and expression 
of TLR2b, Igβ and MHCII β chain in chicken B cells was examined. DT-40 cell line cultures were 
incubated with 0, 1.72 or 3.96 mM of FA for 4 or 8 hours (h). The cells incubated for 8h were 
treated with 0, 1 or 10 µg/ml of LPS in triplicate. Positive association was found between FA 
concentration and percent of Igβ promoter methylation. A negative association between FA 
concentration and percent of MHCII β chain promoter methylation was demonstrated at 4h. 
Incubation time affected Igβ and MHCII β expression resulting in downregulation of the two genes 
after 8h compared to 4h. At 4h incubation, 1.72 mM FA upregulated TLR2b and 3.96 mM FA 
upregulated MHCII β chain expression. At 8h, 3.96 mM FA downregulated TLR2b and 
upregulated Igβ expression. A significantly higher TLR2b expression was observed with a 
combination of 1.72 mM FA for 4 hours. Under LPS treatment 1.72 mM FA–1 µg/ml LPS 
combination upregulated Igβ expression, while 3.96 mM FA-10 µg/ml LPS downregulated the 
same gene. Treatment with LPS had a significant downregulatory effect on TLR2b expression. 
Taken together, it is possible to infer that FA has a potential immunomodulatory effect on chicken 
B cells, possibly affecting their recognition abilities by both TLR and BCR pathways, as well as 
their ability to present antigen through the MHCII presentation pathway.  
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3.2 Introduction 
  In recent years, the importance of epigenetic mechanisms in regulation of immune system gene 
expression has been extensively studied (Baumann, K. 2015). These types of modifications, which 
include chromatin remodeling, histone tail modification, DNA methylation, non-coding RNA and 
microRNA gene regulation, acting alone or in combination, have the potential to effect gene 
expression in an organism, and are meiotically and mitotically heritable (Gyorffy, B. et al. 2016). 
One of the most widely studied mechanisms of epigenetic modifications is DNA methylation, the 
enzymatic addition of a methyl group to cytosines found in CpG dinucleotides (Ettig, R. et al. 
2011). Methylating cytosines in the DNA sequence will, in most cases, protect from undesired 
gene expression by either recruiting histone methylation or deacetylation enzymes to alter the 
chromatin formation in the loci (Fuks, F. et al. 2000) or by directly interfering with binding of 
transcription factors (TF) (Tate, P.H. and Bird, A.P. 1993). The binding ability of some TFs, like 
specific protein (SP)1, are unaffected by the methylation status of their binding site (Holler, M. et 
al. 1988).  
  The methyl group originates from several nutritional cofactors such as betaine, choline, 
methionine or FA (Obeid, R. 2013). The latter, a natural dietary methyl donor, has been shown to 
improve health (Preynat, A. et al. 2010), performance (Preynat, A. et al. 2010), and embryonic 
development (Wang, X. et al. 2015). 
  The regulation of gene expression is particularly crucial in regard to the immune system, which 
is important in protecting the organism from any foreign insult, but if left unchecked, could cause 
harm to the host in the form of tissue damage (Hanash, A.M. et al. 2012) and autoimmune disease 
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(Salomon, B. et al. 2000). The genes participating in host defense are controlled by an array of 
stringent activating conditions, TFs (Szabo, S.J. et al. 2000), inhibitors (Stamper, C.C. et al. 2001) 
and activators (Stetson, D.B. and Medzhitov, R. 2006). In recent years, studies have shed light on 
the role of epigenetic mechanisms in general (Liu, Y. et al. 2015), and DNA methylation in 
particular (Pacis, A. et al. 2015) in maintaining immune system regulation and homeostasis. 
  One of the principal participants in host defense in the chicken is the B cell population, which 
express cell surface receptors that are associated with both the innate and adaptive immune 
systems. In the context of the innate response, B cells express TLRs, a family of pattern recognition 
receptors that recognize and bind specific MAMPS (St Paul, M. et al. 2012a). With regard to the 
adaptive immune system, the BCR complex includes an antigen capture moiety (sIg) and a signal 
transfer moiety. The latter is made up of two non-covalently bound proteins named Igα and Igβ, 
which are involved in the activation of the cell and the rigorous selection process of B cells in the 
BoF (Pike, K.A. and Ratcliffe, M.J. 2005). Furthermore, B cells constitutively express MHCII 
(Muhlethaler-Mottet, A. et al. 1997), which allows processing of captured antigens that culminates 
in presentation of peptides in the context of the MHCII complex – a heterodimer made up of α and 
β chains (Baecher-Allan, C. et al. 2006). T-independent antigens, such as LPS, do not have to be 
processed and presented to T cells to elicit antibody production. This MAMP is recognized by the 
TLRs on B cells without involving the BCR or the MHCII system, resulting in the production of 
low affinity antibodies (Pone, E.J. et al. 2015). Furthermore, recognition of MAMPs by TLRs can 
be followed by a cross linking and engagement between the TLRs and BCR that can lead to 
antibody class switching in both T cell independent (Macpherson, A.J. et al. 2000) and dependent 
manners (Matter, M.S. and Ochsenbein, A.F. 2008).  
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  The importance of the B cell’s role in both the innate and adaptive immune system through their 
receptors and effectors mechanism, as well as the known influence of FA on immunological 
pathways, support additional research into the effect of FA on the capacity of B cells to recognize, 
process and present antigen. Therefore, the current study was conducted to assess the effect of FA 
on the proximal promoter methylation profile and gene expression of TLR2b, BCR Igβ and MHCII 
β chain in chicken DT-40 B cell line. 
3.3 Materials and Methods 
  The materials and methods used to examine the effect of FA and LPS challenge on DT-40 B cell 
line culture are described in chapter 2. Briefly, cells were incubated for either 4 or 8 h with 0, 1.72 
or 3.96 mM of FA. After 4 h 0, 1 or 10 µg/ml LPS was added to the cultures in the 8 h incubation 
group for the duration of the experiment. The expression of TLR2b, Igβ and MHCII β chain was 
examined and compared to the expression of the house keeping gene β-actin. The effect of FA on 
the methylation status of the promoter region of the genes of interest was examined using DNA 
bisulfite conversion followed by PCR and sequencing.   
3.4 Results 
3.4.1 Proximal promoter region methylation patterns of TLR2b, Igβ and MHCII β chain 
  The effects of FA incubation on the methylation patterns of the proximal promoter regions of 
TLR2b, Igβ and MHCII β chain are presented in Fig. 1. The single CpG dinucleotide in the 
promoter region of the TLR2b gene positioned at -160 from the start codon remained methylated 
when the cells were exposed to 0, 1.72 or 3.96 mM of FA, for either 4 or 8h of incubation (Fig. 
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3.1 A). The promoter region of the Igβ gene (Fig. 3.1 B) contains 13 CpG dinucleotides. Positions 
-193, -180, -138, -135, -73 and -52 remained unmethylated and positions -104, -67 and -60 
remained methylated regardless of FA concentration and incubation time. Position -101 was 
unmethylated only when the cells were incubated without FA for 4h. Position -82 was methylated 
only when the cells were incubated with 3.96 mM of FA for 4h. Lastly, position -50 was 
methylated only when the cells were incubated with either 1.72 or 3.96 mM of FA for 8h. The 
MHCII β chain gene promoter region (Fig. 3.1 C) contains 24 CpG dinucleotides. The cytosines 
situated at -173, -131, -125, -108, -94, -91, -88, -85 and -82 remained unmethylated while positions 
-55, -49, -40, -30, -18, -14, and -11 remained methylated regardless of FA concentration and 
incubation time. At 4h incubation, position -166 remained methylated while it was unmethylated 
after 8h regardless of FA concentration. Cytosines at the -158 and -101 positions were methylated 
when incubated with either no FA or 1.72 mM of FA for 4h, and were unmethylated under all 
other conditions. Positions -98 and -62 were unmethylated only when the cells were exposed to 
3.96 mM FA. The cytosine positioned at -61 was methylated except when incubated for 4h without 
FA or with 3.96 mM FA. Lastly, CpG dinucleotides situated at -47 and -38 bases upstream of the 
start codon were methylated except when incubated without FA for 8h. 
55 
 
 
 
Figure 3.1. Proximal Promoter area methylation of TLR2b, Igβ and MHCII β chain. 
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(A) TLR2b, (B) Igβ, and (C) and MHC β chain. Each circle represents a single CpG dinucleotide. Methylated and unmethylated cytosines are 
shown by (●) and (○), respectively. Numerical values represent the location of the cytosine relative to the start codon. A break in the line 
indicates a sequence of at least 15 base pairs without CpG dinucleotides.  
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3.4.2 Association between FA concentration and percent of proximal promoter methylation 
of TLR2b, Igβ and MHCII β chain 
  Only promoter regions with changes in methylation are presented. A positive association was 
found between FA concentration and percent of methylation of the Igβ promoter region at both 4h 
incubation (Fig. 3.2 A, r=0.997, P < 0.05) and 8h incubation (Fig. 3.2 B, r=0.83, P < 0.05). 
However, a negative association was found between FA concentration and percent of MHCII β 
chain promoter methylation after 4h incubation (Fig. 3.2 C, r=-0.666, P < 0.05).  
3.4.3 Effect of incubation time and FA concentration on TLR2b, Igβ and MHCII β chain 
mRNA levels  
  The effect of incubation time and FA concentration on mRNA expression of TLR2b, Igβ and 
MHCII β chain are presented in Table 3.1. While the incubation time had a significant 
downregulatory effect on the mRNA levels of Igβ and MHCII β chain (P < 0.05), it did not have 
a significant effect on the mRNA levels of TLR2b (P > 0.05). An interaction effect of incubation 
time by FA concentration on TLR2b mRNA level was observed. A Post hoc Tukey test (Fig. 3.3) 
revealed that in the 1.72 mM FA treatment, TLR2b mRNA level was higher than the level in the 
control group after 4h incubation than after 8h incubation (P < 0.05). No significant interaction 
effect of FA concentration by time was observed on the expression of the other genes of interest. 
FA concentration had a significant effect on TLR2b mRNA levels (P < 0.05), with expression at 
1.72 mM FA significantly higher than that observed at 3.96 mM FA. FA concentration did not 
have a significant effect on the mRNA levels of the other genes of interest (P > 0.05). 
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 Figure 3.2. FA concentration association with percent of Igβ and MHCII β chain promoter 
methylation.  
A 
 
B 
 
30
34
38
42
46
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5
%
 M
et
h
y
la
ti
o
n
 (
Ig
β
, 
4
h
)
FA concentration (mM)
S 0.54
R-Sq 99.4%
38
40
42
44
46
48
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5
%
 M
et
h
y
la
ti
o
n
 (
Ig
β
, 
8
h
)
FA concentration (mM)
S 2.32
R-Sq 68.2%
59 
 
 
 
C 
 
Significant association plots between FA concentration and percent of promoter methylation for 
(A) Igβ after 4 hours (r2=0.994) (B) Igβ after 8 hours (r2=0.682) and (C) MHCII β chain after 4 
hours (r2=0.444).  
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Table 3.1 FA conc. and incubation time effect on TLR2b, Igβ and MHCII β chain expression 
   Time (h) FA (mM) SEM  P values 
            
Gene  4 8 0 1.72 3.96 
 
 Time FA Time × FA 
TLR2  2.3 1.6 1.39(ab) 3.32(a) 1.14(b) 0.42  0.259 0.022 0.031 
Igβ  1.02(a) 0.36(b) 0.65 0.6 0.81 0.09  <0.001 0.141 0.684 
MHCII 
β chain 
 1.89(a) 0.33(b) 0.7 1.36 1.28 0.26  <0.001 0.243 0.141 
Values represent mean relative gene expression from three independent experiments repeated three 
times, normalized to the expression of the reference gene (β actin). Means sharing no common 
superscript letter differ significantly (P < 0.05). 
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Figure 3.3. Interaction plot for FA concentration and incubation time effect on TLR2b expression.  
 
Effect of incubation time and FA concentration combinations on TLR2b expression. Points 
represent mean relative expression levels from three independent experiments repeated three 
times. Lines represent standard error (SE) Differences are significant at (P < 0.05). 
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3.4.4 The effect of FA concentration at 4 and 8 h incubation time on mRNA levels of 
TLR2b, Igβ and MHCII β chain 
  The effect of each FA concentration on mRNA levels after 4h or 8h of incubation time are 
presented in Fig. 3.4. Compared to control, when incubated for 4 hours, 1.72 mM FA significantly 
upregulated the expression of TLR2b, while 3.96 mM FA significantly upregulated the mRNA 
level of the MHCII β chain gene (Fig. 3.4 A. P < 0.05 and P < 0.05, respectively). After 8h 
incubation, 3.96 mM FA significantly downregulated the mRNA level of TLR2b while 
upregulating that of Igβ (Fig. 3.4 B. P < 0.05 and P < 0.05 respectively). No significant changes 
were observed for the other genes of interest (P > 0.05). 
3.4.5 The effect of LPS on expression of TLR2b, Igβ and MHCII β chain  
  The effect of LPS and FA concentration on mRNA levels TLR2b, Igβ and MHCII β chain is 
presented in Table 3.2. An interaction effect of FA by LPS concentrations was observed on Igβ 
expression of (P < 0.05). The post hoc Tukey test revealed that the highest expression of Igβ was 
achieved after a 1.72 mM FA and 1 μg/ml LPS treatment combination (Fig. 3.5) although no 
combination was significantly different than the others (P > 0.05). There were no significant 
interactions of FA by LPS concentrations observed on TLR2b and MHCII β chain. LPS treatment 
resulted in significant TLR2b downregulation (P < 0.05) while no change in Igβ and MHCII β 
chain was observed (P > 0.05). 
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Figure 3.4. Expression of TLR2b, Igβ and MHCII β chain following incubation with FA.  
 
 
Values presented as relative fold change after normalization to reference gene (β actin) following 
a (A) 4h or (B) 8h incubation period. Values shown are means of triplicates of three independent 
experiments. Lines represent SE. * indicate significant difference from control group (0 mM FA 
for 4 or 8h, respectively) (P<0.05).
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3.4.6 The effect of FA concentration and LPS treatment on expression of BCR  
  The effect of each FA concentration on mRNA levels of the genes of interest under both 1 and 
10 µg/ml LPS treatments are presented in Fig. 3.6. Treatment with 1.72 mM of FA and treatment 
with 1 µg/ml of LPS resulted in a significant upregulation of Igβ mRNA levels compared to the 
control (P < 0.05) while no significant change was observed in TLR2b, and MHCII β chain 
expression (P > 0.05) (Fig. 3.6 A). Similarly, there was no significant (P>0.05) change in gene 
expression in the group treated with 10 μg/ml LPS (irrespective of FA concentration), except for 
a downregulation of Igβ with 3.96 mM FA treatment (P < 0.05) (Fig. 3.6 B). 
3.4.7 Association between percent of proximal promoter methylation and gene expression 
  No significant association was observed between the methylation percent of the promoter region 
of the genes of interest and their respective mRNA levels, regardless of incubation time. 
Association between the methylation percent of the promoter region and TLR2b expression was 
not tested as there was no change in the methylation profile in the promoter area of that gene. 
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Table 3.2 Effect of FA and LPS conc. on TLR2b, Igβ and MHCII β chain expression 
 
 LPS (µg/ml) FA (mM) SEM  P values 
        
Gene  0 1 10 0 1.72 3.96 
 
 LPS FA LPS × FA 
TLR2  0.9(a) 0.62(b) 0.58(b) 0.7 0.71 0.65 0.03  <0.001 0.33 0.404 
Igβ  1.27 1.14 1.08 1 1.55 0.99 0.16  0.863 0.19 0.036 
MHCII 
β chain 
 0.87 1.12 1.27 1.3 0.98 1.03 0.08  0.134 0.33 0.247 
Values represent mean relative gene expression from three independent experiments repeated three 
times, normalized to the expression of the reference gene (β actin). Means sharing no common 
superscript letter differ significantly (P < 0.05).
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Figure 3.5. Interaction plot for FA and LPS conc. effect on Igβ expression.  
  
Effect of FA and LPS concentration combinations on Igβ expression. Points represent mean relative expression levels from three 
independent experiments repeated three times. Lines represent standard error. Differences are significant at (P < 0.05). 
0.35
0.85
1.35
1.85
2.35
2.85
0 1.72 3.96
F
o
ld
 c
h
a
n
g
e
FA concnetration (mM)
0 ug/ml LPS
1 ug/ml LPS
10 ug/ml LPS
67 
 
 
 
Figure 3.6. Expression of TLR2b, Igβ and MHCII β chain following treatment with FA and LPS.  
 
 
Values presented as relative fold change after normalization to reference gene (β actin) after a 4h 
incubation with 0, 1.72 or 3.96 mM FA followed by 4h of (A) 1 μg/ml LPS or (B) 10 μg/ml LPS 
treatment. Values shown are means of triplicates of three independent experiments. Bars represent 
standard error. * indicate significant difference from control group (No FA with 1 μg/ml or 10 
μg/ml, respectively) (P<0.05). 
* 
* 
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3.5 Discussion 
  TLR2b is one of the two avian orthologues to mammalian TLR2 (Temperley, N.D. et al. 2008). 
After dimerization with TLR1 or TLR6, the complex binds to several microbial components such 
as peptidoglycan, lipomannan and lipopeptides (Farhat, K. et al. 2008), all components of Gram-
positive bacterial cell wall (St Paul, M. et al. 2012a). TLR2 also has the ability to recognize fungal 
(Farhat, K. et al. 2008), protozoan (Wong-Baeza, I. et al. 2010) and viral (Klein Klouwenberg, P. 
et al. 2009) ligands. In this experiment, methylation of the proximal promoter region of TLR2b 
was unaffected by FA, regardless of concentration or incubation time. The fact that there is only a 
single CpG dinucleotide in the examined region and that the methylation pattern of this CpG was 
unchanged throughout the experiment suggests that the expression of the TLR2b gene is not under 
direct proximal promoter methylation control. In fact, the same lack of relationship between the 
methylation pattern of the TLR2 promoter and the expression of the gene can be seen in human 
endothelial cells (Diesel, B. et al. 2012). Other instances where FA addition did not change the 
methylation pattern of the promoter region of a gene are documented (Kotsopoulos, J. et al. 2008). 
Although incubation with FA did not change the methylation profile of the proximal promoter 
region of the TLR2b gene in the current study, it upregulated its expression after 4h incubation 
with 1.72 mM FA. Instances where FA affected gene expression without changing the DNA 
methylation profile of their promoters have been demonstrated (Price, R.J. et al. 2015). Other 
possibilities are that the methylation pattern of different TLR2b regulatory region or regions, or 
even that of the gene itself, was affected by the treatment, which, in turn, affected the gene 
expression. This kind of upregulation can be beneficial for the immune system. Previous 
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publications have shown that injecting lipoteichoic acid (LTA) (a TLR2 ligand) in ovo caused an 
increase in pro-infalmmatory mediators and reduced infectious laryngotracheitis virus infection 
post hatch (Thapa, S. et al. 2015). Furthermore, trerating chicks intranasaly with a TLR2 ligand 
reduced avian influenze shedding post infection (Barjesteh, N. et al. 2015a). In the current study, 
incubation with 3.96 mM FA for 8h downregulated TLR2b expression. It is possible that the high 
concentration and/or incubation time resulted in the methylation of a different region, causing the 
described effect. LPS caused a downregulation of TLR2b. This type of downregulatory effect has 
been reported before, where a 2h LPS challenge downregulated TLR2 in the chicken liver (Zhang, 
Y. et al. 2013).  
  While the membrane bound immunoglobulins recognize antigen, Igβ, together with Igα, make up 
the signal transduction moiety of the complex (Bruhl, H. et al. 2015), and as such, are crucial for 
both B cell selection (Pike, K.A. and Ratcliffe, M.J. 2005) and activation (Van Kooten, C. et al. 
1997). The results of this research show that the percentage of methylation in the proximal 
promoter region of the Igβ gene was positively associated with the amount of FA used, regardless 
of incubation time. A positive association between FA and percent of methylation was described 
before (Anderson, O.S. et al. 2012). In the current study, incubation with 3.96 mM FA for 8h 
significantly upregulated Igβ expression. This expression profile may fit a state favorable for 
antigen recognition by the BCR complex, Interestingly, in this study, a 1.72 mM FA and 1 µg/ml 
LPS combination resulted in upregulation of the Igβ gene, while a 3.96 mM FA and 10 µg/ml LPS 
combination resulted in its downregulation. It is possible to infer that a 3.96 mM FA and 10 µg/ml 
LPS combination shifts the receptor expression in B cells in a way that favors antigen binding by 
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the TLR pathway, rather than the BCR pathway. It has been reported previously that binding of T 
cell independent antigens, such as Macrophage activating lipopeptides (MALP-2) (Borsutzky, S. 
et al. 2005) and Staphylococcus aureus Protein A (Bekeredjian-Ding, I. et al. 2007) (both of them 
TLR2 ligands), to TLR receptors on B cells may result in the production of low affinity IgM 
antibodies, without antigen presentation to T cells (Chen, X. et al. 1997). These “natural” 
antibodies play a major role in the primary line of defense against infections (Casali, P. and 
Schettino, E.W. 1996), and findings from the current study may point to the beneficial role of FA 
in readying the B cells for the production of this type of antibodies.  
  It has been speculated previously that other than the pathway leading to natural antibody 
production, a TLR-BCR crosslink can induce B cell activation and production of antigen specific 
antibodies (Pone, E.J. et al. 2012b). Whichever of these pathways are activated, the production of 
antibodies is independent of antigen presentation to effector T cells positive for CD4 protein 
expression (Matter, M.S. and Ochsenbein, A.F. 2008), and depends on the nature of the antigen 
(Ochsenbein, A.F. and Zinkernagel, R.M. 2000). On the other hand, recognition through a BCR 
cross link, or a joint TLR-BCR engagement may also result in a T dependent B cell activation 
(Jendholm, J. et al. 2009). After the T cell is activated by recognizing the antigen-MHCII complex 
through the T cell receptor (TCR), it will produce and secrete cytokines (Damdinsuren, B. et al. 
2010). These cytokines will induce affinity maturation processes of the antibodies produced by the 
B cell, as well as proliferation and differentiation of the cell (Palm, N.W. and Medzhitov, R. 2009). 
For this reason, it was our aim to observe changes in the B cells ability to present antigens. The 
MHCII β chain gene is part of the class II antigen family that enables B cells to present antigens 
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to effector CD4+ T cells (Giles, J.R. et al. 2015). In the present study, a negative association 
between the FA concentration and the percent of methylation of the promoter region of the MHCII 
β chain was observed. Moreover, there was no association between MHCII β chain expression and 
the percent of promoter methylation. It has been demonstrated that genes belonging to the MHCII 
family in mammals present all the possible variations of association (positive, negative or non-
existent) between CpG methylation and gene expression (Yuan, X.J. et al. 1994). An upregulation 
of MHCII β chain expression was observed when the B cells were incubated with 3.96 mM of FA 
for 4 hours, and incubation time with FA was a factor affecting MHCII β chain expression.  
  While it is possible that the effects observed in this experiment are due to a direct influence of 
FA on the promoter of MHCII β chain, it is also possible that FA incubation affected another 
MHCII regulatory gene like the class II, MHC trans-activator (CIITA) (Holling, T.M. et al. 2004). 
Therefore, more research is needed to establish the pathway in which FA affects the expression of 
the MHCII β chain gene. Since the effect of FA addition on methylation, and the effect of promoter 
methylation on gene expression are tissue, gene and sex specific (Anderson, O.S. et al. 2012), 
different FA supplementation regimens might be optimal for different poultry production systems 
and age of birds. 
3.6 Conclusions 
  In conclusion, incubation with FA is associated with changes in the methylation profile of the 
proximal promoter regions of Igβ and MHCII β chain, and modified expression of TLR2b, Igβ and 
MHCII β chain. However, FA concentration and exposure time seem to be integral factors in its 
effect. For cells not treated with LPS, incubation with FA might change the chicken B cells ability 
72 
 
 
 
to recognize antigen through the TLR2b pathway or the BCR. Furthermore, the inferred increase 
in MHCII expression may be indicative of improved antigen capture and presentation abilities by 
B cells. Incubation with high concentrations of FA in this experiment upregulated the MHCII β 
chain gene and Igβ gene while downregulating the TLR2b gene. This change in expression may 
fit the profile of B cells primed to present antigens to activated effector CD4+ T cells. This 
interaction may initiate a series of activities that belong to the adaptive immune response, which 
includes B cell proliferation and differentiation, and affinity maturation of the antibodies produced 
by the cell. On the other hand, this interaction will initiate cytokine production by the effector T 
cell, which will regulate the immune response. The results presented here support previous 
findings published by our group regarding the role of FA as a dietary immunomodulator 
(Munyaka, P.M. et al. 2012), and strengthens the notion that immune modifications can be 
achieved through epigenetic mechanisms.  
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4. Ex vivo epigenetic characterization of the effect of folic acid on the proximal promoter 
area and mRNA gene expression of chicken B cell receptors in chicken cells harvested from 
the bursa of Fabricius 
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4.1 Abstract 
  FA is a vitamin that acts as a principal nutritional methyl group donor involved in the DNA 
methylation process, an epigenetic mechanism associated with gene expression control. The aim 
of this study is to examine the effect FA addition has on the promoter methylation profile and 
expression TLR2b, BCR Igβ and MHCII β chain in embryonic BoF chicken B cells, as well as 
whether it has an effect on cell viability and surface IgM levels. Cultured BoF cells have been 
known to lose viability rapidly. Doubling the amount of chicken serum in the growth media helped 
maintain the cells viability for the duration of the experiment.  At ED15, removing the cells from 
the BoF environment for 4 hours lowered the population of IgMlow/med cells and increased the 
population of IgMhigh cells, accompanied by an upregulation of the Igβ gene expression. At ED18 
TLR2b expression was downregulated, and at ED21 TLR2b and MHCII β chain expression were 
downregulated, as well as the expression of the reduced folate carrier (RFC), a major FA 
transporter. To examine the effect of FA, cells taken from ED15, 18 and 21 were incubated with 
either 0, 1.72 or 3.96 mM FA for 4 hours. The result indicate that FA did not have an effect on cell 
viability. Treatment with 3.96 mM FA at ED15 reduced the population of IgMmed cells, and both 
concentrations did the same at ED18. At ED21, 3.96 mM FA increased the IgMhigh population. At 
ED15, both concentrations caused a downregulation of Igβ, and at ED18 1.72 mM FA caused a 
downregulation of RFC expression. The promoter methylation profile was not affected by FA or 
incubation time. The results demonstrate the immune modulating capabilities of FA in the 
developing B cell, the importance of the bursal environment in B cell development and a novel 
method for maintaining the viability of embryonic chicken B cells in an ex vivo culture. 
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4.2 Introduction 
  Infectious diseases have a significant impact on the poultry industry due to mortality, decreased 
production and risk of contamination leading to zoonotic diseases (Patterson, J.A. and 
Burkholder, K.M. 2003). Until recently, the solution was prophylactic treatment with antibiotics 
added to the feed (Leitner, G. et al. 2001). However, in recent years the use of these growth 
promoters has come under scrutiny due to concerns regarding antibiotic resistance (Witte, W. 
2000), the effect on nutrient absorption (Knarreborg, A. et al. 2004) and the effect on normal gut 
microbiota (Yitbarek, A. et al. 2013). As a result of these concerns the use of antibiotic growth 
promoters has been banned in several countries (Capita, R. and Alonso-Calleja, C. 2013). This 
became a driving force to find alternative solutions that can be used to help protect the animal 
from the wide variety of pathogens.  
  One solution is nutritional intervention. Past research has shown the link between specific 
nutrients such as vitamins (Katona, P. and Katona-Apte, J. 2008) and amino acids (Kidd, M.T. et 
al. 2001) and the immune capabilities of the chicken. FA is an example of a nutrient that has 
been shown to have an effect on the chicken immune capabilities, including T cell populations 
(Wintergerst, E.S. et al. 2007) and cytokine expression (Munyaka, P.M. et al. 2012). It is 
recognized by two types of transporters. The first is the proton coupled folate carrier (PCFT), 
which mediates FA absorption in the upper part of the intestine and works best under low pH 
conditions (Visentin, M. et al. 2014). The second type of transport is the RFC, which is more 
diversely expressed (Whetstine, J.R. et al. 2002), has a higher affinity for its ligand than the 
PCFT (Zhao, R. et al. 2001) and its activity is optimal under neutral pH conditions (Sierra, E.E. 
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et al. 1997). While this compound is used by the organism for DNA synthesis (Crider, K.S. et al. 
2012), it is also a methyl donor, which is utilized in the process of DNA methylation. This 
enzymatic process involves adding a methyl group to the 5’ carbon of cytosines that are part of a 
cytosine-guanine dinucleotide in the DNA (Ghoshal, K. and Bai, S. 2007). This process can 
happen anywhere on the DNA including in the promoter region of a gene. When cytosines are 
methylated in this region they act as both steric interference for the binding of transcription 
factors, as well as a recruitment site for proteins that further inhibit the availability of the gene 
for transcription (Russ, B.E. et al. 2013). This process is part of a family of mechanisms 
protecting the organism from unwanted gene expression and are named epigenetic mechanisms, 
as they control gene expression though the alteration of the structure of the genetic material, as 
opposed to changes to its sequence (Chuang, J.C. and Jones, P.A. 2007).  
  While many cells participate in the protection of the organism, the chicken B cell has a unique 
role in the immune reaction. It expresses receptors that allow the cell to function under the 
mantle of both the innate and adaptive immune systems. B cells express TLRs, a family of 
pattern recognition receptors that recognize and bind MAMPs (St Paul, M. et al. 2012a). Such a 
recognition will result in the rapid production of low affinity antibodies by the B cell, 
independent of interactions with T cells (Pone, E.J. et al. 2012a). B cells also express BCR, 
which is made up of an antigen capture moiety, the sIg, and a signal transfer moiety (Chu, P.G. 
and Arber, D.A. 2001). Igα and Igβ are non-covalently bound proteins that make up the signal 
transduction portion that is involved in the activation of the cell once the antigen is recognized 
(Lee, W.Y. and Tolar, P. 2013). The BCR and TLRs can interact. This interaction will result in 
class switching of the antibodies produced by the B cell, also without any need for interaction 
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with T cells (Pone, E.J. et al. 2010). Conversely, if an antigen is recognized by cross linked 
BCRs, it will be internalized, processed and presented in the context of the MHCII, once that 
complex is recognized by CD4 positive helper T cells, it will cause the B cells to go through 
antibody class switching and somatic hypermutation, which will improve the affinity of the 
produced antibody towards the presented antigen. The interaction between the cells will also 
signal the B cells to differentiate into plasma cells and memory cells (Pone, E.J. et al. 2012b).  
  While many cell types like T cells (Chen, C.H. et al. 1994) and macrophages (Garceau, V. et al. 
2015) follow the same developmental route in chickens as the one known in mammals, the B 
cells follow a different developmental path, using the BoF instead of the bone marrow (Ciriaco, 
E. et al. 2003). Situated between the sacrum and the cloaca (Casteleyn, C. et al. 2010), this sac-
like formation is visible from ED5. During development, folds are formed, which are colonized 
between ED10 and ED15 by B cell precursors (Nagy, N. et al. 2004). These cells will continue to 
develop and proliferate, and by the time of hatch (day 21), 90% of cells in this organ will be IgM 
positive (McCormack, W.T. et al. 1991). These cells go through a two stage selection process to 
ensure that they can be activated by the BCR complex (van der Burg, M. et al. 2002), and that 
they are not highly responsive against self-antigens (Luning Prak, E.T. et al. 2011). For reasons 
not entirely clear, roughly 95% percent of these cells go through apoptosis (Paramithiotis, E. et 
al. 1995). Around hatch, mature naïve B cells emigrate from the BoF to the periphery where they 
can fulfil their role as immune cells.  
  One of the TLRs expressed by the chicken B cell is TLR2b. While other TLRs work as 
homodimers to recognize a specific MAMP, TLR2b binds to either TLR1 or TLR6 to recognize 
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a wide variety of molecular patterns, including those components of Gram-positive bacteria, 
Gram-negative bacteria, fungi (Farhat, K. et al. 2008), protozoa (Wong-Baeza, I. et al. 2010) and 
viruses (Klein Klouwenberg, P. et al. 2009). In chickens, TLR2 mediated recognition activates 
anti-viral responses (Barjesteh, N. et al. 2015a) and both Th1 and Th2 like responses (St Paul, M. 
et al. 2012b). This versatility in recognition as well as downstream activation makes TLR2 
ligands a powerful adjuvant. This can be seen in the immune responses in chickens to avian 
influenza (Barjesteh, N. et al. 2015a) and laryngotracheitis vaccines (Thapa, S. et al. 2015), in 
both mature animals and in ovo (Thapa, S. et al. 2015). 
  The need for alternatives to antibiotic growth promoters, the importance of the B cell in protecting 
the organism through the use and interactions of three types of receptors (TLRs, BCR and MHCII) 
combined with the presence of an organ solely dedicated to the development and selection of these 
cells warrant the examination of the effect of FA on the methylation status of the promoter regions 
of these genes, and the effect it has on their expression during the B cell maturation process.  
4.3 Materials and Methods 
  The materials and methods used to examine the effect of FA on B cells harvested from embryonic 
BoF are described in chapter 2. Briefly, cells were harvested from BoF at embryonic ages 15 (30 
BoF), 18 (10 BoF) and 21 (4 BoF). Cells were either immediately analyzed (0 hour) or incubated 
for 4 hours with 0 mM, 1.72 mM or 3.96 mM FA, with 1x106 cells per treatment. The cells were 
stained for surface IgM, propidium iodide (PI) or both, and analyzed using flow cytometry.  The 
expression of TLR2b, Igβ and MHCII β chain was compared to the expression of the house keeping 
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gene β-actin. The effect of FA on the methylation statues of the promoter region of the genes of 
interest was examined using DNA bisulfite conversion. 
4.4 Results 
4.4.1 Wright-Giemsa stain for cells extracted from BoF at embryonic day 15, 18 and 21 
  In all images, cells can be seen with a high nucleus to cytoplasm ratio, marked in black arrows. 
A few red blood cells can be seen in the image of ED15, marked with white arrows (Fig. 4.1 A).  
Cells with a high nucleus to cytoplasm ratio are also seen in the images taken from ED18 and 
ED21 (Fig. 4.1 B and C, respectively). A macrophage is visible in the ED18 and ED21 images, 
circled in black.  
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Figure 4.1 Wright-Giemsa stain of cells extracted from embryonic BoF at different ages 
 
A 
10 μM 
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Cells from each time point were stained with Wright-Giemsa and observed with light microscopy 
under 100X oil immersion lens. (A) ED15, (B) ED18, (C) ED21. Black arrows - cells with 
lymphocyte phenotype White arrows - Erythrocytes. Magnification, x 
C 
10 μM 
B 
10 μM 
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4.4.2 Transmission electron microscopy imaging of BoF cells at different embryo ages 
  Images of single cells taken after extraction from the BoF are presented in Figure 4.2. The three 
cells taken from ED15 (Fig. 4.2 A), ED18 (Fig. 4.2 B) and ED21 (Fig. 4.2 C) exhibit a high 
nucleus/cytoplasm ratio, although this is more noticeable in the image of the cell taken from an 
ED18 embryo. Rough endoplasmic reticulum is almost not apparent in the cells. Golgi complexes 
are visible in the cytoplasm of ED15 and ED21 cells. Lysosomes are visible in the cytoplasm of 
ED15 and ED18. The ED15 cell exhibits the most mitochondria than the other two cell types. 
4.4.3 Effect of incubation time on embryonic chicken B cell viability 
  The effect of incubation time on cell viability for each embryonic age is presented in Table 4.1. 
A significant interaction between age and time was observed for the live cell population (Fig. 4.3) 
(P < 0.05). An ED21-4 hour combination had the highest percent of live cells than any other 
combination except for the ED21-0 hour combination. Age had a significant effect, as the 
percentage of live cells was significantly lower at ED15 than ED18 and ED21 (P < 0.05).  The 
population of dead cells in the ED21-4 hour combination was significantly lower than all other 
combinations (P < 0.05). Age had a significant effect on this cell population as well, as the 
percentage of dead cells at ED15 was higher than that found in ED18 regardless of the incubation 
time. There was no significant difference between the populations of dead cells at ED18 and ED21 
in the 0 h incubation group. However, after 4 hours the population of dead cells at ED18 was 
significantly higher than the one at ED21 (P < 0.05).  
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Figure 4.2 Transmission electron microscopy images of cells extracted from embryonic BoF at different ages 
 
 
Transmission electron microscopy of cells extracted from BoF at (A) ED15, (B) ED18 and (C) ED21, X20, 000 magnification. Nuclear 
envelope is pointed at with black arrows. N - Nucleus H - Heterochromatin E - Euchromatin G - Golgi complex; M - Mitochondria; R - 
rough endoplasmic reticulum; 
B C A 
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Table 4.1: Effect of incubation time on cell viability according to embryonic age 
 Status  Embryo age (days) Time (hours) SEM  P values 
      
 15 18 21 0 4    ED Time EDxT 
Live 93.65(a) 97.55(b) 98.31(c ) 97.06(a) 96.11(b) 0.07  < 0.01 < 0.01 < 0.01 
Values represent percent of live cell population means from three independent experiments 
repeated three times. Cells were examined with no incubation (0 hours) and after 4 hours 
incubation at ED15, 18 and 21. Means sharing no common superscript letter differ significantly (P 
< 0.05).  
Figure 4.3 Interaction plot for the effect of incubation time and embryo age on cell viability 
 
Points represent mean relative expression from three independent experiments repeated three 
times. The graphs represent interactions between embryo ages and incubation time effect on live 
embryonic B cell population. Lines represent SE. Significant differences (P < 0.05) between means 
were tested post hoc by Tukey's test. 
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4.4.4 Effect of incubation time on embryonic chicken B cell receptor-IgM (BCR)  
  The effects of incubation time on cell surface IgM expression by embryonic age are presented in 
Table 4.2. An interaction between age and incubation time was observed for all cell populations 
(P < 0.05). ED21-4 hour and ED18-0 hour combinations had a significantly higher population of 
IgMlow cells than any other combination (Fig. 4.4 A). Age had a significant effect on this 
population as it was significantly lower at ED15 than in the two other ages examined (P < 0.05). 
IgMmed cell population was significantly higher at ED21-0 hour than any other combination (Fig. 
4.4 B). All other combination but ED15-4 hours are not significantly different from one another 
(P > 0.05). ED15-4 hours had the lowest level of IgMmed cells than any other combination (P < 
0.05) (Fig. 4.4 B). The highest IgMhigh cell population (Fig. 4.4 C) was expressed at ED15 after 4 
h incubation (P < 0.05) followed by ED15-0 hour combination. ED21-0 hour and ED18-0 hour, 
while not significantly different from each other, had the lowest proportion of IgMhigh cells (P < 
0.05). Age had a significant effect on this population, being significantly higher at ED15 than the 
two other ages observed (P < 0.05). 
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Table 4.2: Effect of incubation time on embryonic chicken BCR according to embryonic age 
 Population  Embryo age (days) Time (hours) SEM  P values 
       
   15 18 21 0 4    ED Time EDxT 
IgMlow  63.4(a) 72.69(b) 72.99(b) 71.75(a) 68.58(b) 0.11  < 0.001 < 0.001 < 0.001 
IgMmed  21.23(a) 23.2(b) 23.75(b) 23.63(a) 21.82(b) 0.09  < 0.001 < 0.001 < 0.001 
IgMhigh  14.83(a) 4.04(b) 3.26(c) 4.16(a) 8.09(b) 0.08  < 0.001 < 0.001 < 0.001 
 Values represent means of percent of cell population fitting each category from three independent experiments repeated three times. 
Cells were examined with no incubation (0 hours) and after 4 hours incubation at ED15, 18 and 21. Means sharing no common 
superscript letter differ significantly (P < 0.05). 
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Figure 4.4 Interaction plot for the effect of incubation time and embryo age on BCR expressing 
cell populations 
A 
 
B 
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Points represent mean from three independent experiments repeated three times. The graphs 
represent the effect of age and time interactions on (A) IgMlow, (B) IgMmed and (C) IgMhigh cell 
populations. Lines represent SE. Significant differences between age and time combinations were 
tested post hoc by Tukey's test. Differences between combinations in each cell population are 
significant at (P < 0.05). 
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4.4.5 Effect of incubation time on staining embryonic B cell populations for both surface 
IgM and Propidium Iodide  
  The effect of the age of the embryo, as well as the effect of incubation time on cell staining for 
both surface IgM and PI are presented in Table 4.3. An interaction was observed between age and 
time post extraction for all populations except dead IgMlow/med cells. For the population of dead 
IgMhigh cells, ED21-4 hours had a significantly lower percentage than both other ages examined 
(P < 0.05) (Fig. 4.5 A). However, 21-0 and 21-4 combinations are not significantly different from 
one another. The effect of age is significant, as the percent of dead IgMhigh cells is higher at ED15 
than ED18 and ED21 (P < 0.05). The population of live IgMlow/med cells is highest at ED21 
regardless of time post extraction and at ED18-0 hour combination (Fig. 4.5 B). ED15 has a 
significantly lower live IgMlow/med cell population than that observed at the two other ages 
examined (P < 0.05). The live IgMhigh cell population was highest at ED15 regardless of time post 
extraction (Fig. 4.5 C). However, ED18 and ED21 cells that were in growth media for 4 hours had 
a significantly higher population of Live IgMhigh cells than ED18 and ED21 immediately post 
extraction. The population of dead IgMlow/med cells was effected by age and time post extraction, 
with this population significantly declining as development progresses, and when incubated in 
growth media for 4 hours when compared to 0 hours (immediately post extraction) (P < 0.05).  
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Table 4.3: Effect of incubation time on staining embryonic B cell populations for both surface IgM and PI according to embryonic age 
Population   Embryo age (days) Time (hours) 
 
 P values 
       
   15 18 21 0 4 SEM  ED Time EDxT 
Dead IgMlow/med   0.87(a) 0.47(b) 0.37(b) 0.81(a) 0.35(b) 0.02  < 0.001 < 0.001 0.269 
Dead IgMhigh   5.36(a) 2.01(b) 1.36(c) 2.06(a) 2.9(b) 0.04  < 0.001 < 0.001 < 0.001 
Live IgMlow/med   83.64(a) 95.25(b) 96.34(c) 94.55(a) 90.08(b) 0.1  < 0.001 < 0.001 < 0.001 
Live IgMhigh   9.32(a) 1.95(b) 1.85(b) 2.02(a) 5.17(b) 0.06  < 0.001 < 0.001 < 0.001 
Values represent means of percent of cells found in each quadrant from three independent experiments. Cells were examined with no 
incubation (0 hours) and after 4 hours incubation at ED15, 18 and 21. Means sharing no common superscript letter differ significantly. 
Significant differences (P < 0.05) between means were tested post hoc by Tukey's test. 
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Figure 4.5 Interaction plot for the effect of incubation time and embryo age on staining 
embryonic B cell populations for both surface IgM and PI 
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Points represent means from three independent experiments repeated three times. The graphs 
represent the effect of age and time interactions on (A) dead IgMhigh, (B) live IgMlow/med and (C) 
live IgMhigh cell populations. Lines represent SE. Significant differences between age and time 
combinations were tested post hoc by Tukey's test. Differences between combinations in each cell 
population are significant at (P < 0.05). 
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4.4.6 Effect of FA on embryonic chicken B cell viability 
  The effects of FA on cell viability at different embryo ages are presented in Table 4.4. The age 
of the embryo had a significant effect on cell viability (P < 0.05), with the live cell population 
increasing as embryonic development progresses (P < 0.05). FA did not have a significant effect 
on cell viability (P > 0.05).   
4.4.7 Effect of FA on embryonic chicken B cell receptor-IgM (BCR) 
  The effects of FA on BCR expression according to age are presented in Table 4.5. There was a 
significant interaction between FA and age for all cell populations (P < 0.05). The population of 
IgMlow cells was not significantly different at ED21 embryos regardless of FA concentration used. 
The IgMlow population at ED21 was not significantly different that that found in an ED18-3.96 
mM FA combination (P < 0.05) (Fig. 4.6 A). The effects of embryo age on the IgMlow population 
can be observed for this population, as the IgMlow population was significantly lower at ED15 
compared to the other two ages examined. Interaction was also observed for the IgMmed cell 
population (P < 0.05) (Fig. 4.6 B). This population was significantly higher in the ED18-0 mM FA 
group combination than any other combination (P < 0.05). The IgMmed cell population was 
significantly lower in cells originating from ED15 embryos compared to all other combinations (P 
< 0.05). A significant interaction is also seen between age and FA for the IgMhigh cell population 
(P < 0.05) (Fig. 4.6 C). This population was significantly lower in the ED21 embryos regardless 
of treatment. The main effect of embryo age can be observed here as well, with the IgMhigh 
population rising with age (P < 0.05). 
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Table 4.4: Effect of FA on cell viability according to embryonic age 
 Status  Embryo age (days) FA (mM) SEM  P values 
       
   15 18 21 0 1.72 3.96    ED FA Age X FA 
Live  92.04(a) 97.55(b) 98.63(c) 96.11 96.29 96.32 0.19  < 0.001 0.529 0.965 
Values represent means of percent of cell population fitting each category from three independent experiments. Cells from ED15, 18 
and 21 embryos were incubated with 0, 1.72 or 3.96 mM FA. Means sharing no common superscript letter differ significantly. Significant 
differences (P < 0.05) between means were tested post hoc by Tukey's test.  
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4.4.8 Effect of FA on staining embryonic B cell populations for both surface IgM and 
Propidium Iodide 
  The effect of FA on double stained cell populations according to age are presented in Table 4.6. 
Embryo age had a significant effect on all cell populations (P < 0.05). The dead IgMlow/med cell 
population significantly decreased from ED15 to ED18 (P < 0.005). The population of dead IgMhigh 
cells significantly decreased with age (P < 0.005), while the fraction of the population of live 
IgMlow/med cells significantly increased with age (P < 0.005). For the live IgMhigh cell population 
an interaction between age and FA was observed (Fig. 4.7) (P < 0.05). An ED21-0 mM FA group 
combination exhibited the lowest population of this kind compared to any other combination 
except the ED21-1.72 mM FA combination. The effect of embryo age is observed, as this 
population was significantly higher at ED15 then both of the other examined ages. 
4.4.9 Effect of incubation time on embryonic chicken B cell RFC, TLR2b, Igβ and MHCII 
β chain mRNA gene expression by age  
  The effect of incubation time at different embryo ages on the mRNA levels of the genes of interest 
are presented in Figure 4.8. TLR2b expression was significantly downregulated in cells taken from 
ED18 and ED21 embryos after 4 hours compared to their expression at these ages with no 
incubation (control) (Fig. 4.8 A) (P < 0.05). At ED15 expression of Igβ was upregulated after 4 
hours of incubation compared to control (Fig. 4.8 B) (P < 0.05). Four hours incubation caused a 
downregulation in RFC (Fig. 4.8 C) (P < 0.05) and MHCII β (Fig. 4.8 D) (P < 0.05) chain 
expression in cells from ED21 embryos.  
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Table 4.5: Effect of FA on cell surface IgM expression according to embryonic age 
Population  Embryo age (days) FA concentration (mM) SEM  P values 
             
 
 15 18 21 0 1.72 3.96 
 
 ED FA EDXFA 
IgMlow  57.27(a) 71.91(b) 74.12(c) 68.57(a) 69.37(ab) 69.76(b) 0.19  <0.001 0.03 0.023 
IgMmed  19.13(a) 21.72(b) 22.37(c) 21.8(a) 20.89(b) 20.42(c) 0.06  <0.001 <0.001 <0.001 
IgMhigh  23.749(a) 5.74(b) 4.13(b) 6.94(a) 7.24(ab) 7.59(b) 0.12  <0.001 0.044 <0.001 
Values represent means of percent of cell population fitting each category from three independent experiments. Cells from ED15, 18 
and 21 embryos were incubated with 0, 1.72 or 3.96 mM FA. Means sharing no common superscript letter differ significantly. Significant 
differences (P < 0.05) between means were tested post hoc by Tukey's test 
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Figure 4.6 Interaction plot for FA and embryo age effect on BCR expressing cell populations 
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Points represent mean of % of population from three independent experiments repeated three 
times. The graphs represent the effect of age and FA interactions on (A) IgMlow, (B) IgMmed and 
(C) IgMhigh populations. Lines represent SE. Significant differences between age and FA 
combinations were tested post hoc by Tukey's test. Differences between combinations in each cell 
population are significant at (P < 0.05). 
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Table 4.6: Effect of FA on staining embryonic B cell populations for both surface IgM and PI according to embryonic age 
 Population  Embryo age (days) FA concentration (mM) SEM  P values 
             
   15 18 21 0 1.72 3.96    ED FA ED X FA 
Dead IgMlow/med   0.48(a) 0.23(b) 0.21(b) 0.33 0.27 0.26 0.02  < 0.001 0.307 0.841 
Dead IgMhigh    7.15(a) 2.29(b) 1.32(c) 2.53 2.43 2.46 0.09  < 0.001 0.852 0.496 
Live IgMlow/med   74.61(a) 94.03(b) 95.63(c) 90.08 90.15 89.6 0.28  < 0.001 0.166 0.351 
Live IgMhigh   16.24(a) 3.42(b) 2.79(c) 4.38(a) 4.67(ab) 5.02(b) 0.09  < 0.001 0.007 0.001 
Values represent means of percent of cells found in each quadrant from three independent experiments. Cells from ED15, 18 and 21 
embryos were incubated with 0, 1.72 or 3.96 mM FA. Means sharing no common superscript letter differ significantly. Significant 
differences (P < 0.05) between means were tested post hoc by Tukey's test. 
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Figure 4.7 Interaction plot for FA and embryo age effect on live IgMhigh cell population 
  
 Points represent means from three independent experiments repeated three times. The graphs represent the effect of age and FA 
interactions on live IgMhigh cell population. Lines represent SE. Significant differences between age and FA combinations were tested 
post hoc by Tukey's test. Differences between combinations are significant at (P < 0.05). 
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Figure 4.8 Effect of incubation time on TLR2b, Igβ, RFC and MHCIIβ chain mRNA gene 
expression 
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Fold expression of A) TLR2b, B) Igβ, C) RFC, and D) MHCII β chain after 4 hours of incubation. 
at ED15, ED18 and ED21 normalized against β actin expression. Values shown are means and 
SEM of triplicates of three independent experiments. Bars with * are significantly different 
compared to control (No incubation, dotted line) (P < 0.05).  
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Figure 4.9 Effect of FA on TLR2b, Igβ, RFC and MHCIIβ chain mRNA gene expression 
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Fold expression of A) TLR2b, B) Igβ, C) RFC, and D) MHCII β chain after treatment with 1.72 
and 3.96 mM FA at ED15, ED18 and ED21 normalized against β actin expression. Values 
shown are means and SEM of triplicates of three independent experiments. Bars with * are 
significantly different compared to control (0 mM FA treatment for cells from each age, dotted 
line) (P < 0.05). Bars with different letters differ significantly between treatments within age 
group (P < 0.05). 
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4.4.10 Effect of FA on RFC, TLR2b, Igβ and MHCII β chain mRNA gene expression at 
different embryo ages 
  The effect of FA on the mRNA levels of the genes of interest at different embryo ages are 
presented in Figure 4.9. TLR2b mRNA levels were not significantly different from those 
demonstrated in the control group regardless of treatment or age (Fig. 4.9 A) (P > 0.05). At ED15 
incubation with 1.72 mM FA or 3.96 mM FA resulted in a significant downregulation of Igβ (P < 
0.05). While the FA treatments did not result in significant change in Igβ expression when 
compared to the expression of the same gene in the control group, there was a significant difference 
in the expression of this gene between the cells treated with 1.72 mM FA and those treated with 
3.96 mM FA (P < 0.05) (Fig. 4.9 B). RFC expression was downregualtred in cells extracted from 
ED18 embryos (Fig. 4.9 C). FA did not have a significant effect on MHCII β chain expression at 
any age (P > 0.05) (Fig. 4.9 D). 
4.4.11 Effect of incubation time on the methylation profile of TLR2b, Igβ and MHCII β 
chain 
  The methylation profile of each promoter region at ED15, ED18 and ED21 after 0 h of incubation 
and after 4 hours of incubation is presented in Figure 4.10. The proximal promoter region of 
TLR2b remained 100% methylated regardless of age or incubation time except for one replicate 
from ED15 taken from cells incubated for 4 hours (Fig. 4.10 A). At ED15, the Igβ promoter region 
was hypermethylated, with 100% promoter methylation after 0 h incubation except for one 
unmethylated CpG in one replicate after 4 hours. At ED18 a 100% methylation observed after 4 
hours, except for one unmethylated CpG in one replicate from the 0 h incubation group. At ED21, 
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the promoter region of Igβ is hypomethylated, with only one dinucleotide methylated in one 
replicate from the 0 h cell group, and a completely unmethylated promoter in the other two 
replicates. After 4 hours, the promoter region remains hypomethylated, with 2 CpGs methylated 
in one replicate, and no methylation seen in the other two (Fig. 4.10 B). The MHCII β chain 
promoter region was completely unmethylated in all replicates of the 0 h incubation treatment 
group at all three time points, and remained completely unmethylated after 4 hour when the cells 
originated from ED18 embryos. The same can be seen in two replicates out of three for ED15 and 
ED21 cells after 4 hours of incubation. Three dinucleotides were methylated in the remaining 
replicate at ED15 and 8 CpGs were methylated in the remaining replicate at ED21 (Fig. 4.10 C).  
4.4.12 Effect of FA on the methylation profile of TLR2b, Igβ and MHCII β chain 
  The methylation profile of each promoter region at ED15, ED18 and ED21 following treatment 
with 0, 1.72 or 3.96 mM FA is presented in Figure 4.11. The TLR2b promoter region remained 
methylated regardless of age or FA treatment, except one replicate taken from cells treated with 0 
mM FA at ED15 (Fig. 4.11 A). The Igβ promoter region remained hypermethylated at ED15 and 
ED18, demonstrating a 100% of CpGs methylated in all replicates regardless of treatment, except 
one replicate at ED15 taken from cells treated with 0 mM FA, where one dinucleotide was 
unmethylated. At ED21, the promoter region is hypomethylated, as all CpG dinucleotides are 
unmethylated except for one replicate taken from 0 mM FA treated cells, where 2 dinucleotides 
were methylated (Fig. 4.11 B). The MHCII β chain promoter region demonstrated 
hypomethylation throughout treatments and ages, with no methylation observed in the sequences 
except three CpGs in one replicate taken from ED15 cells treated with 0 mM FA. The same 
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methylation level was seen in one replicate originating from ED21 cells treated with 3.96 mM FA, 
and 5 CpGs were methylated in one replicate taken from cells treated with 0 mM FA taken from 
that time point (Fig. 4.11 C).  
4.4.13 Association between concentration of FA and percent of TLR2b, Igβ and MHCII β 
chain promoter methylation 
  No association was found between the concentration of FA used in the treatments and the percent 
of promoter methylation of the TLR2b, Igβ and MHCII β chain promoters.  
4.4.14 Association between percent of TLR2b, Igβ and MHCII β chain promoter 
methylation and gene expression 
  No association was found between the percent of promoter methylation of the TLR2b, Igβ and 
MHCII β chain promoters and the expression of the respective genes.  
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Figure 4.10 Incubation time effect on proximal promoter methylation profile of TLR2b, Igβ and MHCII β chain at ED15, ED18 and 
ED21 
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B  
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Sequence analysis following a bislufite conversion of the proximal promoter region (200 bp upstream of the start codon) after no 
incubation (0 h) and 4 hours incubation (4 h) of (A) - TLR2b, (B) - Igβ and (C) - MHCII β chain at ED15, ED18 and ED21. Each 
treatment was triplicated and each replicate converted, amplified and sequenced independently. (○) - unmethylated CpG dinucleotide 
(●) - methylated CpG dinucleotide. Numerical values represent the location of the cytosine relative to the start codon. A break in the 
line indicates a sequence of at least 15 base pairs without CpG dinucleotides. 
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Figure 4.11 FA effect on the proximal promoter methylation profile of TLR2b, Igβ and MHCII β chain at ED15, ED18 and ED21 
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Sequence analysis following a bislufite conversion of the proximal promoter region (200 bp upstream of the start codon) after treatment 
with either 0, 1.72 or 3.96 mM FA of (A) - TLR2b, (B) - Igβ and (C) - MHCII β chain at ED15, ED18 and ED21. Each treatment was 
triplicated and each replicate converted, amplified and sequenced independently. (○) - unmethylated CpG dinucleotide (●) - methylated 
CpG dinucleotides Numerical values represent the location of the cytosine relative to the start codon. A break in the line indicates a 
sequence of at least 15 base pairs without CpG dinucleotides. 
C 
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4.5 Discussion 
  The goal of this study was to determine the effects of FA on the ability of the chicken B cell to 
function as an immune cell by examining its effect on TLR2b, Igβ and MHCII β chain. The ex-
vivo model chosen presented a problem, B cells extracted from the BoF had a significant loss in 
viability, which was also reported elsewhere (Compton, M.M. and Waldrip, H.M. 1998, Luna-
Acosta, J.L. et al. 2015). In these studies cell viability declined to 63% after only 4 hours. In the 
current study the addition of 5% of chicken serum to the growth media generated viabilities above 
90% for the duration of the experiment (4 hours) (data not shown). The effect is evident when the 
viability of the cells was tested using PI staining in flow cytometry. Cells originating from ED18 
and ED21 embryos showed no significant loss of viability when not incubated or after 4 hour 
incubation. The population of viable cells harvested from ED15 embryos was significantly lower 
than the initial 0 hour populations of the other two time periods. At ED15 the migration of pre-B 
cells to the BoF has just ended. However, the distinct cortical and medullary areas of each follicle 
are not fully developed by this time (Funk, P.E. and Palmer, J.L. 2003). It is possible that the 
trypsin treatment used to extract the cells damaged the target cells of this experiment, which would 
explain the lower population of viable cells at ED15 when the cells were not incubated. This time 
point was also the only one during which a significant difference was observed between the 
viability of cells in the T(0) group and the T(4) group. The BoF expresses several compounds that 
limit apoptosis during development, such as Survivin (Johnson, A.L. et al. 2002), growth hormone 
(Luna-Acosta, J.L. et al. 2015), B cell activating factor (BAFF) (Koskela, K. et al. 2004) and 
Blimp1 (Wan, Z. et al. 2014). At least one of which (Blimp-1) is expressed up to ED18 and then 
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downregulated (Wan, Z. et al. 2014). Furthermore, interactions between developing chicken B 
cells and the bursal epithelium has also been shown to inhibit apoptosis (Funk, P.E. and Thompson, 
C.B. 1998). It has also been demonstrated that as B cell development progresses, they lose 
expression of some of their membrane proteins such as CD38, CD10 and CD39 (Thellin, O. et al. 
1998). Taken together, we can infer that B cells from ED15 embryos were more dependent on anti-
apoptotic signals in the BoF, and thus removing them from that environment resulted in greater 
death of these cells than that observed in cells extracted from ED18 and ED21 embryos.  
  There are several factors that may affect the amount of BCR expressed on the surface of the cells 
during the chicken B cell development process. Heavy and light chain rearrangement, a process 
that occurs in pre B cells before they immigrate to the BoF (Reynaud, C.A. et al. 1991) and during 
the first days after immigration, can result in cells with non-functional BCRs. However, these cells 
are not selected for a productive BCR, and they will go through another step in antibody 
diversification - gene conversion, taking place while the cells rapidly proliferate in the follicles 
(Reynolds, J.D. 1987). During this process, B cells that are unable to initiate a signaling cascade 
via Igα and Igβ, are autoreactive (Davani, D. et al. 2014a) or are unable to produce a functional 
BCR in the conversion process go through apoptosis (Sayegh, C.E. et al. 1999). However, before 
this process is initiated, a downregulation of surface BCR is observed (Paramithiotis, E. et al. 
1995). The results of this study are in agreement with this observation, as an increase in the IgMlow 
population was observed between ED15, the end of the migration wave, and ED18, when cells 
start to emigrate out of the BoF and colonize secondary lymphoid tissue (Davani, D. et al. 2014b).  
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  The role of the BoF in maintaining these cells can be observed here as well, as a significant 
reduction in the IgMlow population can be seen when ED15 cells were incubated outside the BoF 
for 4 hours. In later stages of B cell development cells expressing low levels of IgM will go through 
apoptosis (Paramithiotis, E. et al. 1995), a fact that can be seen by the significant reduction in this 
population between ED18 and ED21. It is possible that removing the cells from the bursal 
environment resulted in removal of the pro-apoptotic signal, which could account for the observed 
significant increase in this population between 0 hours and 4 hours of incubation at ED21. While 
the interaction between the BoF and IgMlow cells between ED18 and ED21 results in reduction of 
this population, the opposite was observed for the IgMmed population. When a distinction was made 
between live and dead IgMlow/med cells, the portion of dead cells was observed to be significantly 
lower than any other population, remaining below 1% regardless of age or incubation time. For 
that reason, the changes seen in the live IgM low/med are the sum effect of both IgMlow and IgMmed 
populations. For example, a significant rise of IgMlow cells between ED15 and ED18, with no 
change in the IgMmed population was observed as a rise in live IgMlow/med cells between those time 
points. The observed upregulation in live IgMlow/med cells between ED15 and ED18 after 4 hours 
of incubation out of the BoF is in accordance with the raise of both IgMlow and IgMmed populations 
under the same conditions. While in the BoF, this population is signaled to proliferate rather than 
die. That signal appears to be lost once the cells are removed from the BoF. It is possible that these 
IgMmed cells are signaled to proliferate as they will become IgMhigh cells that are ready to colonize 
the periphery. This notion is strengthened by the fact that between ED18 and ED21 there is no 
significant change in the population of live IgMlow/med cells, as they act as a reservoir for the IgMhigh 
population. The IgMhigh population at ED15, like the other IgM expressing populations, is the most 
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sensitive to environmental change compared to the same population at ED18 and ED21. However, 
harvesting these cells has the opposite effect compared to the other two populations. i.e., 
incubating the cells outside of the bursal environment resulted in a higher percentage of this 
population at ED15. Since the gene expression assays were done on the general cell population for 
each examined age, we cannot distinguish whether the Igβ upregulation observed at ED15 happens 
solely in the IgMhigh population. However, it is tempting to pair the upregulation of this gene with 
the increase in the IgMhigh population, as the effect of 4 hours incubation on ED15 IgMlow and 
IgMmed populations was inhibitory. This could possibly indicate the presence of either a compound 
in the chicken serum that induces the expression of the BCR complex, a BCR inhibitory compound 
in the BoF, or both. However, to the best of our knowledge no research has been published on the 
subject. As seen before, cells from ED18 and ED21 are less sensitive to the environmental change, 
and the ratio of IgMhigh cells remains steady during these days. The IgMhigh population is 
committed to peripheral and secondary lymphoid tissue colonization (Narabara, K. et al. 2009). 
Interestingly, both live and dead populations of IgMhigh increased when ED15 cells were incubated 
for 4 hours. As mentioned before, the increase in live cells was concurrent with a rise in Igβ 
expression. The rise in dead cells, though significant, was small (4.7%), and it is possible that the 
proportion of these type of cells increased as the proportion of live IgMlow/med decreased. No 
significant difference was found between the populations of live IgMhigh cells between ED18 and 
ED21, and the same is true for the dead IgMhigh population. As B cells start to emigrate out of the 
BoF around ED18 (Davani, D. et al. 2014b), it is possible that an equilibrium between proliferation 
and apoptosis processes keeps these populations stable between the start of emigration and day of 
hatch. It has been previously described that the vast majority (95%) of B cells in the BoF die in 
118 
 
 
 
situ, while only the remaining 5% emigrate out of the BoF and colonize the periphery 
(Paramithiotis, E. and Ratcliffe, M.J. 1993). Although the proportion of live IgMhigh we observed 
at ED21 was 1.5%, it points towards the same conclusion - The B cell population in the BoF is 
heavily selected against before hatch, with most of the population not surviving the process.  
  While the effect of incubation time on Igβ expression at ED15 is discussed above, the changes in 
RFC, TLR2b and the MHCII β chain were also examined at all time points under these conditions. 
At ED18, a downregulation of TLR2b was observed. There is no published data on the role of 
TLR2b in the BoF, or in B cell maturation in the chicken or any other animal, and for this reason, 
it is hard to confirm whether the observed downregulation is due to the removal of the cells from 
the BoF or because there is an inhibitory signal for TLR2b expression in the chicken serum, or 
both. Because of the lack of knowledge on this subject, it is hard to conclude whether this 
downregulation has any biological significance, and needs to be further studied. At ED21 a 
downregulation of TLR2b was also observed. These changes in gene expression were not 
associated with any changes in the methylation of the promoter region of the TLR2b gene, which 
remained methylated throughout all experiments. A likely conclusion would be that the expression 
of the TLR2b gene is not controlled by proximal promoter DNA methylation. At time of hatch, 
ED21, a significant downregulation of the reduced folate carrier (RFC) and the MHCII β chain 
was observed as well. These changes in MHCII expression were found not to be associated with 
changes in the methylation profile of its promoter, as the region remained hypomethylated 
regardless of age or incubation time. These results are in agreement with others who found no 
association between the methylation status of this gene and its expression (Levine, F. and Pious, 
D. 1985, Yuan, X.J. et al. 1994). Igβ appeared lower compared to control, however that change 
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was not significant. The methylation status of the Igβ promoter region was the only one that 
changed during these experiments. It was completely hypermethylated at ED15 and ED18 cells, 
but hypomethylated at ED21 regardless of incubation time. These results indicate that removing 
the cells out of the BoF for 4 hours does not affect the methylation profile of the proximal promoter 
regions of the genes of interest.  
  While placing cells in a culture has been shown to affect DNA methylation, the shortest period 
of time of incubation that resulted in such changes is three days (Nestor, C.E. et al. 2015).  It is 
possible that the control over the expression of the examined genes is not epigenetic. In mice a 
transcription factor, MARCH-1, was found expressed by mature B cells, where it downregulated 
the expression of MHCII (Matsuki, Y. et al. 2007). In the same animal it was also found that mature 
and resting B cells express less surface IgM than immature or transitional ones (Carsetti, R. et al. 
1995). However, this has not been studied in chickens and the nature of these BoF dependent gene 
upregulations, their downregulation outside of the bursal environment, or indeed the existence of 
both signals, remains to be elucidated.  
  Observations of the viability of the cells when those are removed from the BoF and cultured ex 
vivo permitted the observation of the effect of FA treatment on the developing chicken B cells, as 
above 90% of cells remained viable after the incubation period. Our results show no significant 
effect of FA treatment on cell viability. Most work on the relationship between FA and cell 
viability describe only FA deficiency as an affecting factor (Courtemanche, C. et al. 2004, Moussa, 
C. et al. 2015). This effect is more likely related to the role FA has in DNA synthesis, rather than 
methylation, as it was previously described that FA deficiency results in an increase in DNA 
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instability, including breakage and defective repair (Duthie, S.J. and Hawdon, A. 1998). The effect 
of FA on cell viability (Williams, P.J. et al. 2011, Ahmed, T. et al. 2016) is an increased apoptotic 
rate in cells treated with FA concentrations one hundred times higher than physiological levels 
(Williams, P.J. et al. 2011). The growth media that was used in our experiments contained a basal 
amount of FA (0.008 mM), which suggests that the cells were not FA deficient throughout the 
experiment. Furthermore, the concentrations of FA added to the bursal cells are the ones found in 
the yolk sac when the hens were fed a normal NRC approved diet (1.72 mM FA) or the maximal 
amount of FA found in these animals after the diet was enriched with FA (3.96 mM FA). The latter 
concentration represents yolk sac saturation levels, as adding more it to the diet did not increase 
FA in the yolk sac (House, J.D. et al. 2002). Using these concentrations meant that the cells were 
not exposed to excessive or supraphysiological amounts of FA, which would explain the lack of 
effect of FA on cell viability observed in this study.  
  The lack of interactions between FA concentration and age allows better observation on the effect 
of age on cell viability. More viable cells were found as embryo age progressed. It is possible to 
infer that FA concentration in the yolk sac, achieved through a normal or an enriched diet, will not 
have an effect on the number of B cells proliferating in the embryonic BoF.  
  An interaction between embryonic age and FA concentration was observed affecting BCR levels 
on the cells surface. Pairwise comparison has shown that there was no significant difference 
between treatments for each age tested. Furthermore, when the cells were treated with either 0 or 
1.72 mM FA the number of IgMlow cells rose as age progressed. However, the population of IgMlow 
cells from ED18 and ED21 that was treated with 3.96 mM FA was not significantly different 
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(although both were higher than the IgMlow ED15 cell population). The behavior of the IgMlow cell 
populations is comparable to that seen for IgMlow cells incubated for 4 hours out of the BoF. 
However, it seems that treatment with 3.96 mM FA halted the proliferation of these cells between 
ED18 and ED21. Inhibition of cell proliferation by FA has been described before (Carmody, B.J. 
et al. 1999, Jaszewski, R. et al. 1999). However, we demonstrated that while in the BoF the IgMlow 
cell population is reduced between ED18 and ED21. This effect of 3.96 mM FA on IgMlow cells, 
while interesting, does not have a physiological relevance. The effect of FA is most visible on 
IgMmed cells. At ED15, this population was significantly lower when the cells were treated with 
3.96 mM FA. At ED18, treatment with both 1.72 mM FA and 3.96 mM FA resulted in significantly 
lower populations of IgMmed compared to the 0 FA group. At ED21 there was no significant 
difference between the populations of IgMmed cells.  
  One of the stages in which FA is utilized in the DNA synthesis pathway is when the cells are 
replicating. In a process of maintenance methylation, the enzyme DNMT1 uses the methylated 
mother DNA strand as a template for the methylation of the daughter strand (Ghoshal, K. and Bai, 
S. 2007). The fact that the IgMmed population was the most responsive to FA treatment strengthens 
the notion that these cells are the ones to proliferate and act as a reservoir for the IgMhigh B cells 
that will emigrate out of the BoF. In fact, we demonstrated that while in the BoF, this population 
increases from ED18 to ED21, an effect that is not observed in any of the groups incubated out of 
the BoF for 4 hours. It is possible that FA treatment applied directly to the BoF will reduce the 
proliferation of the IgMmed cell population, which in turn might affect the IgMhigh population 
leaving the BoF, however this needs to be studied further.  
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  As with the pairing of Igβ upregulation at ED15 with the increase of the IgMhigh population at this 
time point at 4 hours of incubation, it cannot be determined in which population the observed 
downregulation of this gene occurred (the downregulation is significant when ED15 cells treated 
with either 1.72 or 3.96 mM FA). However, the ED15 IgMmed population is the only one that 
decreased with FA treatment. The only significant difference observed in the IgMhigh population 
was when the cells originated from ED21 embryos. This population was significantly higher after 
the cells were treated with 3.96 mM FA compared to 0 FA treatment. Although significant, the 
change in population size is around 1% (3.7% of the population at 0 mM FA to 4.7% of the 
population at 3.96 mM FA), which leads us to conclude that FA treatment will not affect cells 
expressing high levels of IgM in a way that will affect the immune capabilities of the cell or the 
organism. The effect of age on each population observed was comparable to the effect of this factor 
when incubation time effect was examined. When a distinction was made between live and dead 
cells in each population, age had the same effect as the one observed in the incubation time 
experiments. The age effect was clearer in the FA experiments, as FA did not have an effect on 
dead or alive IgMlow/med cells or on the dead IgMhigh cells. The only population in which FA had 
an effect on and an interaction with the age factor was the live IgMhigh population. The pairwise 
comparison gave identical results to those observed for the total IgMhigh population. A single 
significant difference between the 0 mM FA and 3.96 mM FA groups harvested from ED21 
embryos, with a 1% difference between the means of each group. 
  Treatments with FA were conducted to determine its effect on the expression of the genes that B 
cells rely on for their immunological functions. The downregulation of Igβ expression at ED15 
was discussed above, and that was the only significant change observed at this age regardless of 
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treatment. Treatment with FA did not affect the mRNA levels of TLR2b, Igβ and MHCIIβ chain 
in ED18 and ED21 cells in a significant manner. Inspecting the methylation status of the promoter 
regions of these genes, there was no significant association observed between FA treatment and 
percent of methylation, and between the latter and gene expression. As observed in the comparison 
between cells that were not incubated and cells incubated for 4 hours, the TLR2b promoter region 
was hypermethylated regardless of FA treatment. This is true for the Igβ promoter region in ED15 
and ED18 cells as well. Conversely, the Igβ promoter region at ED21, as well as the MHCII β 
promoter region at all examined ages remained hypomethylated regardless of FA treatment.  
  The results regarding the association between FA treatment and the promoter methylation of Igβ 
and MHCII β chain are contradictory to the results obtained when DT-40 cells were used. In these 
cells a significant association between these two factors was observed (Elad O. et. al., unpublished 
results). When examining the differences between the Igβ and MHCII β chain promoter 
methylation profile in DT-40 cell line and the primary cell culture, it appears that the CpG 
dinucleotides closer to the start codon are hypermethylated in the cell line, and hypomethylated in 
the primary cell culture. This result is in agreement with other publications, which found that 
cancer linked hypermethylation is concentrated around the transcription start site region, and can 
occur around genes that are not linked to cancer progression (Ehrlich, M. 2002). 
  Another discrepancy between the work done with DT-40 and the work done on primary chicken 
B cell cultures is that treating DT-40 cells with 1.72 mM FA resulted in significant upregulation 
of TLR2b, and a 3.96 mM FA treatment resulted in upregulation of MHCII β chain expression, 
while both genes were not significantly affected in primary B cells. According to the 
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manufacturer’s information, DT-40 cells are prepared from 1 day old chicks. Looking at the effect 
FA had on ED21 cells (the closest date to 1 day old chicks examined), one can observe a trend of 
upregulation of both TLR2b and MHCII β chain as FA concentration increases. However, these 
changes are not statistically significant. C-rel and v-rel, two oncogenes inserted into the B cell as 
part of the production of DT-40 cells, are known to upregulate MHCII expression (Hrdlickova, R. 
et al. 1994). If this effect is cumulative or synergistic with the effect of FA on this gene, it could 
provide an explanation as to why the upregulation of the MHCII β chain gene was significant in 
the DT-40 cells and not the primary B cell culture. The uniqueness of the DT-40 cell line might 
also explain the upregulation of TLR2b. It was demonstrated that TLR2 can bind and be activated 
by viruses (Chen, S. et al. 2013). As DT-40 cells secrete low levels of infectious RAV-1, perhaps 
the difference in the significance of upregulation of TLR2b between the two cell types is due to 
recognition of RAV-1 by the DT-40 expressed TLR2b. To the best of our knowledge, no work has 
been published on the effect interaction between oncogenes and FA has on MHCII expression, as 
well as research about the recognition of RAV-1 through the chicken TLR2b.  
  At ED18, the RFC gene expression was downregulated when the cells were treated with 1.72 
mM FA. It appears that this trend of downregulation continues when the cells were treated with 
3.96 mM FA, however it was not significantly lower than the expression observed in the control 
group. Previous research has demonstrated that both the RFC and PCFT, the two main FA 
transporters, are downregulated when the cells that express them are exposed to FA. This reduction 
is observed both for mRNA as well as protein levels (Ashokkumar, B. et al. 2007). The effect of 
FA supplementation was also examined in chicken intestines where it caused an insignificant 
reduction in RFC mRNA levels in the jejunum (Jing, M. et al. 2009). The reason behind the 
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reduction in RFC expression being significant when the cells were treated with a low amount of 
FA, and insignificant when the higher concentration was used is unclear. However, the response 
to the treatment with FA at this time point is a reduction in mRNA levels of this gene, which is in 
agreement with the articles mentioned above.  
4.6 Conclusions 
A novel method by which chicken B cells extracted from embryonic BoF can be kept viable for 
longer periods of time than previously published is demonstrated in this work. This method can 
enhance research investigating the processes that chicken B cells go through while maturing. It 
can also be used to better understand the effect of compounds in the BoF on the developing B cell, 
at different stages of embryogenesis. By removing the B cells from the bursal environment, we 
have demonstrated the importance of the BoF in B cell development in both selection and 
proliferation. Treatment with FA, while not associated with direct changes to the proximal 
promoter region of TLR2b, Igβ and MHCII β chain, has affected the expression of Igβ at ED15. 
As Igβ is required in order to pass the selection process in the BoF, FA treatment might change 
the proportion of B cells that leave the BoF. It was demonstrated here that treatment with FA 
reduces the proportion of the population expressing medium levels of IgM, and that it is likely that 
the observed reduction in Igβ expression is paired with the reduction of this population, although 
this has to be further studied. Taken together, FA has been shown to have immunomodulatory 
properties affecting B cell development in the chicken embryo. Whether these changes affect the 
immune capabilities of the mature B cells needs to be further examined. 
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5. General discussion 
5.1 DNA methylation 
  Methylation on the 5’ carbon on cytosines, which are part of CpG dinucleotides is an enzymatic 
reaction, carried out by the enzyme family DNA methyltransferases (DNMT) (Crider, K.S. et al. 
2012). The methyl donor used in the process of methylation, SAM, is a derivative of FA, which 
can be obtained nutritionally (Wald, D.S. et al. 2001), or by the use of probiotics (Pompei, A. et 
al. 2007). DNA methylation is not a transient process. The methylation profile is hereditary, 
ensuring the daughter cells, being the same type as the mother cell, will have the same genes 
available for transcription (Gowher, H. and Jeltsch, A. 2001). It was believed that methylation of 
a group or single CpG dinucleotides act as steric interference, inhibiting transcription factor 
binding to the region. Alternatively, it can act as a recruitment factor for other epigenetic 
mechanisms such as histone modification related proteins (Russ, B.E. et al. 2013). Changes in the 
methylation profile observed in the experiments conducted with the B cell line derived from a DT-
40 cell line were not associated with changes in gene expression. Furthermore, while the 
association between FA concentration and major MHCII β chain promoter methylation was a 
negative one, some associations where positive. i.e., an increase in FA was associated with an 
increase in gene expression, as was the case with Igβ. These results strengthen the results published 
by others that have shown that the relationship between methylation and gene expression is not as 
clear cut as previously thought. Moreover, it is tissue, gene and sex specific (Anderson, O.S. et al. 
2012). The lack of association between promoter methylation and gene expression was also seen 
in the work done with embryonic B cells, FA treatment changed the expression of Igβ while the 
changes in the methylation profile of the promoter region of that gene seem to be age related. 
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Overall, the proximal promoter methylation profile of all the genes of interest seem to be 
unaffected by FA treatment.  
5.2 B cell receptors 
5.2.1 Effect of FA on TLR2b expression and proximal promoter methylation 
  TLR2b, as opposed to other TLRs functions as part of a heterodimer with other TLRs (Farhat, K. 
et al. 2008). It recognizes a vast array of microbial associated molecular patterns (Farhat, K. et al. 
2008) and may induce a strong pro inflammatory response (Cogswell, J.P. et al. 1994). Due to its 
potency ligands of TLR2b are used as adjuvants in several types of vaccines both in adult birds 
and in ovo (Barjesteh, N. et al. 2015). The proximal promoter region of chicken TLR2b has only 
one cytosine-guanine (CpG) dinucleotide in 200 base pairs (bp) upstream of the start codon, and 
the cytosine in that dinucleotide remained methylated regardless of treatment. This might indicate 
that this genes expression is not regulated by proximal promoter methylation. The expression of 
the gene, however, did increase with FA treatment in DT-40 cells, while an insignificant increase 
in expression was seen in cells harvested from ED21 embryos. Although it is unclear through 
which pathway FA treatment affected TLR2b, the observed raise in expression in B cells at day of 
hatch might increase the efficiency of vaccines given with TLR2b ligands as adjuvants in ovo or 
perhaps even immediately post hatch. This is one area in which this study hints at the 
immunomodulatory properties of FA. 
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5.2.2 Effect of FA on Igβ expression and proximal promoter methylation 
  The BCR is the link of the B cell to the adaptive immune system, as well as a requisite for passing 
the selection process that in avian species takes place in the BoF. Specifically, the signal transfer 
moiety made up of Igα and Igβ (Wienands, J. and Engels, N. 2001). This ability might signal the 
cell to activate, proliferate and secrete antibodies (Cambier, J.C. et al. 2007). In DT-40 cells an 
association between the proximal promoter methylation and FA concentration was observed. 
However, there was no significant change in expression following FA treatment. The association 
between FA concentration and promoter methylation was not observed in embryonic B cells. In 
these cells, the proximal promoter region was almost completely methylated in cells harvested 
from ED15 and ED18 embryos, and almost completely unmethylated in cells harvested from ED21 
embryos. However, FA treatment did decrease the expression levels of Igβ in cells harvested from 
ED15 embryos. This might have an effect on the selection process of the B cells in the BoF, as it 
relies on the capability of Igα and Igβ to initiate signal transduction. This effect was not observed 
in the two other embryonic days examined. This result raises the possibility that the timing of 
treatment with FA or the developmental stage of the embryo might be factors in determining how 
efficient the treatment is. Research into the effect of FA on the immune system in general or 
specifically on the immune capabilities and development of the chicken B cell might have to take 
this into account.  
5.2.3 Effect of FA on MHCII β chain expression and proximal promoter methylation 
  Endogenously, only dendritic cells, macrophages and B cells express MHCII (Boss, J.M. and 
Jensen, P.E. 2003, van den Elsen, P.J. et al. 2003). Presentation through this complex serves 
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different functions in different cells. Antigen presentation by B cells expressing this complex to 
CD4 positive effector T cells might lead to a humoral immune response (Hu, J. et al. 2013). In the 
DT-40 cell line a negative association was found between FA concentration and the percent of 
proximal promoter methylation of the MHCII β chain. Furthermore, the expression of the gene 
increased after treatment. Conversely, in embryonic B cells FA had no significant effect on MHCII 
β chain proximal promoter methylation or gene expression. These results are concurrent with past 
publications that pointed at the methylation of the class II transactivator (CIITA) gene as a mean 
to control MHCII expression (van den Elsen, P.J. et al. 2003). Research into the effect of FA 
treatment on the methylation of CIITA would help shed light on the indirect epigenetic control of 
MHCII expression.  
5.3 The role of the BoF in chicken B cell development 
  The BoF is crucial for the development and maturation of the chicken B cell. Pre B cells are 
homing to this site (Meyer, R.K. et al. 1959), here they are selected and leave the BoF as mature 
naïve B cells, ready to colonize the periphery and secondary lymphoid tissues (Paramithiotis, E. 
and Ratcliffe, M.J. 1994). A decrease in the IgMlow and IgMmed population was observed when 
cells from ED15 were removed from the bursal environment. This could point to the existence of 
a survival signal in the BoF which the young cells are more sensitive to than the cells from the 
other examined ages. Conversely, the IgMhigh population taken from the same age increased when 
removed from the bursal environment. This might hint at a bursal signal that keeps the B cell 
population in check, perhaps inhibiting proliferation. B cells have the potential to cause 
autoimmune diseases if they are not developed and selected properly (Grimaldi, C.M. et al. 2005). 
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Understanding the profile of bursal signals as embryo development progresses, as well as the 
sensitivity of the developing B cells to those signals should be further investigated to better 
understand the role of the BoF in not only B cell development, but also population control. 
5.4 The effect of incubation time on embryonic B cell viability  
  Past publications have shown that after harvesting chicken B cells from the BoF, the cells begin 
to die rapidly (Compton, M.M. and Waldrip, H.M. 1998, Luna-Acosta, J.L. et al. 2015). The death 
rate is so high that it was impossible to carry out the experiment as was planned. By doubling the 
chicken serum concentration in the growth media from 5% to 10%, the cells maintained viability 
above 90% for longer than the time needed for the completion of the experiment. This novel 
growth media might present a solution for maintaining embryonic bursal B cells viable for longer 
periods of time, thereby allowing for more research to be done on these cells.   
5.5 Conclusions 
5.5.1 TLR2b, Igβ and MHCII β chain and proximal promoter methylation control 
The first objective of this study was to determine if TLR2b, Igβ and MHCII β chain are under 
potential proximal promoter methylation control. Sequencing of the proximal promoter regions of 
these genes revealed that TLR2b has 1 CpG dinucleotide in this region, while Igβ has 13 CpGs 
and the MHCII β chain has 24 CpG dinucleotides in its proximal promoter region. Since it has 
been previously described that a single CpG in the promoter region has the potential to affect the 
expression of the gene (Maier, H. et al. 2003a), the genes examined in this study are all under 
potential promoter methylation control.  
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5.5.2 The effect of adding FA on the methylation profile of the proximal promoter region of 
TLR2b Igβ and MHCII β chain 
As a second objective, we wanted to determine how inclusion of a methyl donor such as FA will 
affect the methylation profile of our genes of interest. While TLR2b promoter methylation profile 
was unchanged after incubation with FA regardless of cell type used, there was a discrepancy 
between the result obtained with the DT-40 cell line and the embryonic chicken B cells regarding 
Igβ and MHCII β chain. Specifically, FA addition affected the promoter methylation profile of Igβ 
and MHCII β chain in DT-40 cells, while this profile remained unaffected in embryonic chicken 
B cells. Furthermore, the promoter methylation profile of Igβ and MHCII β chain was different 
between the two types of cells even before FA treatment. Overall, these results are pointing at the 
possibility that tumoral cells have a different methylation profile and response to FA treatment 
than embryonic chicken B cells.   
5.5.3 The effect of changes in TLR2b, Ig β and MHCII β chain proximal promoter 
methylation profile on gene expression 
The third objective of the study was to determine whether changes in the methylation profile in 
the proximal promoter region belonging to TLR2b, Igβ and MHCII β chain are associated with 
changes in the expression of those genes. While an association between percent of promoter 
methylation and gene expression was not found in this study regardless of cell type, it is 
demonstrated in this study that addition of FA did have an effect on the expression of all three 
genes in the DT-40 cells, and on Igβ expression in embryonic chicken B cells. Together, the results 
suggest that while FA has an effect on gene expression, it is not due to changes in the proximal 
132 
 
 
 
promoter region of the genes in question. Whether FA addition affects the methylation of another 
genomic region, or through another mechanism altogether remains to be further studied.  
5.5.4 Future research 
The objectives described at the beginning of this thesis were fulfilled. However, there are several 
ways in which research into the effect of FA on chicken B cells can be improved. It is apparent 
from the results brought here that cell lines and normal cells respond differently to FA treatment. 
For that reason, results applicable for the poultry industry would be achieved using cells harvested 
from the organism. Furthermore, the evidence from this study suggests that during embryonic 
development the only factor that significantly affected the methylation profile was the age of the 
embryo. This is a good point in chicken embryo development to study the effect of FA as a methyl 
donor, as B cells are highly proliferative at this stage in the BoF, and the DNA in these cells is 
open to accept a methyl group. Mature naïve B cells can be induced to proliferate in vitro by adding 
a variety of factors to the culture. Testing the effect of FA addition on a culture of proliferating 
mature naïve B cells has two advantages. First, these cells can survive longer in cultures than 
embryonic chicken B cells can. Second, different activating factors can be used to activate the B 
cell. It is possible that ex vivo B cell proliferation can be achieved through signals that are 
exclusive to the T cell dependent or T cell independent pathways. This will help clarify the role of 
a methyl donor in each of the activation pathways. 
It was established in this study that the changes in gene expression was not due to changes in the 
proximal promoter region methylation profile of TLR2b, Igβ and MHCIIβ chain. The location of 
these changes remains to be further studied. As it is known which of the methyl groups in FA is 
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used in the DNA methylation process, marking this group fluorescently or radioactively together 
with a full genome methylation analysis might aid in discovering where it was incorporated, and 
what is the role of these locations in relation to TLR2b, Igβ and MHCIIβ chain expression. 
Finally, the experiments presented here are a proof of concept regarding nutritional intervention 
with FA in the laying hen and its effects on the progeny. It is possible that a prolonged diet 
supplemented with FA will have an effect on the embryo that was not detectable after only 4 hours 
of incubation ex-vivo. For this reason, the dietary study should be carried out, as this would mean 
that the embryos would be exposed to FA from the start of their development. Carrying out this 
study will give a better idea about the effect of FA as a nutritional factor on chicken embryonic B 
cell development and function in both the innate and adaptive immune systems. 
5.6 Concluding remarks 
  Finding ways to boost the immune system of production animals such as the chicken is a 
beneficial endeavour for the animal itself as well as for the consumer. With the help of nutritional 
intervention and probiotics one can potentially raise the quality of life of these animals and lower 
the risk of morbidity that comes with an intensive growth used in the poultry industry. Epigenetics 
presents a possible double benefit, as it has the potential to aid not just the organism, but their 
progeny as well.  
  The experiments shown in this study demonstrate that FA does indeed have immunomodulatory 
capabilities in chicken B cells, affecting the expression of genes that are directly linked to the 
ability of the cell to recognize antigen. The possible explanation for the differences in results 
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between the cell line and the primary cell culture lies in the methylation changes occurring in 
cancerous cells. While the changes FA induces on immune related genes may not lie in changes to 
the methylation profile of the proximal promoter region, the results indicate that immune related 
changes in expression do occur, and that their effect on the immune capabilities of the animal, as 
well as their offspring should be studied further. Research into embryonic bursal B cells is made 
easier, as the growth media described here helps maintain these cells live for longer periods of 
time. This might help to learn more about chicken B cell development as well as the dynamics in 
the bursal environment. Past research into the role of the BoF aided in understating the role of the 
bone marrow in mammals (Abdou, N.I. and Abdou, N.L. 1972), the future research proposed here 
might aid not only in our understating of avian immunology, but general immunology as well.  
 
 
 
 
  
135 
 
 
 
6. References 
Abdou, N. I. and N. L. Abdou (1972). "Bone marrow: the bursa equivalent in man?" Science 
175(4020): 446-448. 
Abraham, R. T. and A. Weiss (2004). "Jurkat T cells and development of the T-cell receptor 
signalling paradigm." Nat Rev Immunol 4(4): 301-308. 
Aderem, A. and R. J. Ulevitch (2000). "Toll-like receptors in the induction of the innate immune 
response." Nature 406(6797): 782-787. 
Ahmed, T., I. Fellus, J. Gaudet, A. J. MacFarlane, B. Fontaine-Bisson and S. A. Bainbridge (2016). 
"Effect of folic acid on human trophoblast health and function in vitro." Placenta 37: 7-15. 
Akira, S. (2006). "TLR signaling." Curr Top Microbiol Immunol 311: 1-16. 
Akira, S. and T. Kishimoto (1992). "IL-6 and NF-IL6 in acute-phase response and viral infection." 
Immunol Rev 127: 25-50. 
Allfrey, V. G., R. Faulkner and A. E. Mirsky (1964). "Acetylation and Methylation of Histones 
and Their Possible Role in the Regulation of Rna Synthesis." Proc Natl Acad Sci U S A 51: 786-
794. 
Anderson, O. S., K. E. Sant and D. C. Dolinoy (2012). "Nutrition and epigenetics: an interplay of 
dietary methyl donors, one-carbon metabolism and DNA methylation." J Nutr Biochem 23(8): 
853-859. 
136 
 
 
 
Arakawa, H. and J. M. Buerstedde (2004). "Immunoglobulin gene conversion: insights from bursal 
B cells and the DT40 cell line." Dev Dyn 229(3): 458-464. 
Arakawa, H., J. Hauschild and J. M. Buerstedde (2002). "Requirement of the activation-induced 
deaminase (AID) gene for immunoglobulin gene conversion." Science 295(5558): 1301-1306. 
Arbibe, L., J. P. Mira, N. Teusch, L. Kline, M. Guha, N. Mackman, P. J. Godowski, R. J. Ulevitch 
and U. G. Knaus (2000). "Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-
dependent pathway." Nat Immunol 1(6): 533-540. 
Ariizumi, K., G. L. Shen, S. Shikano, S. Xu, R. Ritter, 3rd, T. Kumamoto, D. Edelbaum, A. Morita, 
P. R. Bergstresser and A. Takashima (2000). "Identification of a novel, dendritic cell-associated 
molecule, dectin-1, by subtractive cDNA cloning." J Biol Chem 275(26): 20157-20167. 
Ashokkumar, B., Z. M. Mohammed, N. D. Vaziri and H. M. Said (2007). "Effect of folate 
oversupplementation on folate uptake by human intestinal and renal epithelial cells." Am J Clin 
Nutr 86(1): 159-166. 
Avalos, A. M. and H. L. Ploegh (2014). "Early BCR Events and Antigen Capture, Processing, and 
Loading on MHC Class II on B Cells." Front Immunol 5: 92. 
Baecher-Allan, C., E. Wolf and D. A. Hafler (2006). "MHC class II expression identifies 
functionally distinct human regulatory T cells." J Immunol 176(8): 4622-4631. 
137 
 
 
 
Bai, S. P., A. M. Wu, X. M. Ding, Y. Lei, J. Bai, K. Y. Zhang and J. S. Chio (2013). "Effects of 
probiotic-supplemented diets on growth performance and intestinal immune characteristics of 
broiler chickens." Poult Sci 92(3): 663-670. 
Bailey, S. R., M. H. Nelson, R. A. Himes, Z. Li, S. Mehrotra and C. M. Paulos (2014). "Th17 cells 
in cancer: the ultimate identity crisis." Front Immunol 5: 276. 
Banchereau, J. and R. M. Steinman (1998). "Dendritic cells and the control of immunity." Nature 
392(6673): 245-252. 
Barjesteh, N., J. T. Brisbin, S. Behboudi, E. Nagy and S. Sharif (2015a). "Induction of antiviral 
responses against avian influenza virus in embryonated chicken eggs with toll-like receptor 
ligands." Viral Immunol 28(4): 192-200. 
Barjesteh, N., B. Shojadoost, J. T. Brisbin, M. Emam, D. C. Hodgins, E. Nagy and S. Sharif 
(2015b). "Reduction of avian influenza virus shedding by administration of Toll-like receptor 
ligands to chickens." Vaccine 33(38): 4843-4849. 
Baslund, B., J. Gregers and C. H. Nielsen (2008). "Reduced folate carrier polymorphism 
determines methotrexate uptake by B cells and CD4+ T cells." Rheumatology (Oxford) 47(4): 
451-453. 
Baumann, K. (2015). "Epigenetics: Methylation in paternal inheritance." Nat Rev Mol Cell Biol 
16(11): 641. 
138 
 
 
 
Bekeredjian-Ding, I., S. Inamura, T. Giese, H. Moll, S. Endres, A. Sing, U. Zahringer and G. 
Hartmann (2007). "Staphylococcus aureus protein A triggers T cell-independent B cell 
proliferation by sensitizing B cells for TLR2 ligands." J Immunol 178(5): 2803-2812. 
Benakanakere, M., M. Abdolhosseini, K. Hosur, L. S. Finoti and D. F. Kinane (2015). "TLR2 
promoter hypermethylation creates innate immune dysbiosis." J Dent Res 94(1): 183-191. 
Bestor, T. H. (2000). "The DNA methyltransferases of mammals." Hum Mol Genet 9(16): 2395-
2402. 
Bingaman, A. W., T. C. Pearson and C. P. Larsen (2000). "The role of CD40L in T cell-dependent 
nitric oxide production by murine macrophages." Transpl Immunol 8(3): 195-202. 
Bonnerot, C., D. Lankar, D. Hanau, D. Spehner, J. Davoust, J. Salamero and W. H. Fridman 
(1995). "Role of B cell receptor Ig alpha and Ig beta subunits in MHC class II-restricted antigen 
presentation." Immunity 3(3): 335-347. 
Borsutzky, S., K. Kretschmer, P. D. Becker, P. F. Muhlradt, C. J. Kirschning, S. Weiss and C. A. 
Guzman (2005). "The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates 
B lymphocytes via the TLR2 without the need of accessory cells." J Immunol 174(10): 6308-6313. 
Boss, J. M. and P. E. Jensen (2003). "Transcriptional regulation of the MHC class II antigen 
presentation pathway." Curr Opin Immunol 15(1): 105-111. 
Bruhl, H., J. Cihak, Y. Talke, M. Rodriguez Gomez, F. Hermann, N. Goebel, K. Renner, J. Plachy, 
M. Stangassinger, S. Aschermann, F. Nimmerjahn and M. Mack (2015). "B-cell inhibition by 
139 
 
 
 
cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine 
collagen-induced arthritis." Eur J Immunol 45(3): 705-715. 
Cambier, J. C., S. B. Gauld, K. T. Merrell and B. J. Vilen (2007). "B-cell anergy: from transgenic 
models to naturally occurring anergic B cells?" Nat Rev Immunol 7(8): 633-643. 
Capita, R. and C. Alonso-Calleja (2013). "Antibiotic-resistant bacteria: a challenge for the food 
industry." Crit Rev Food Sci Nutr 53(1): 11-48. 
Carmel, R. (2008). "Nutritional anemias and the elderly." Semin Hematol 45(4): 225-234. 
Carmody, B. J., S. Arora, R. Avena, K. Cosby and A. N. Sidawy (1999). "Folic acid inhibits 
homocysteine-induced proliferation of human arterial smooth muscle cells." J Vasc Surg 30(6): 
1121-1128. 
Carsetti, R., G. Kohler and M. C. Lamers (1995). "Transitional B cells are the target of negative 
selection in the B cell compartment." J Exp Med 181(6): 2129-2140. 
Casali, P. and E. W. Schettino (1996). "Structure and function of natural antibodies." Curr Top 
Microbiol Immunol 210: 167-179. 
Casteleyn, C., M. Doom, E. Lambrechts, W. Van den Broeck, P. Simoens and P. Cornillie (2010). 
"Locations of gut-associated lymphoid tissue in the 3-month-old chicken: a review." Avian Pathol 
39(3): 143-150. 
140 
 
 
 
Chang, Y. S., M. K. Trivedi, A. Jha, Y. F. Lin, L. Dimaano and M. T. Garcia-Romero (2016). 
"Synbiotics for Prevention and Treatment of Atopic Dermatitis: A Meta-analysis of Randomized 
Clinical Trials." JAMA Pediatr 170(3): 236-242. 
Chautan, M., G. Chazal, F. Cecconi, P. Gruss and P. Golstein (1999). "Interdigital cell death can 
occur through a necrotic and caspase-independent pathway." Curr Biol 9(17): 967-970. 
Chen, C. H., T. W. Gobel, T. Kubota and M. D. Cooper (1994). "T cell development in the 
chicken." Poult Sci 73(7): 1012-1018. 
Chen, S., A. Cheng and M. Wang (2013). "Innate sensing of viruses by pattern recognition 
receptors in birds." Vet Res 44: 82. 
Chen, T., S. Hevi, F. Gay, N. Tsujimoto, T. He, B. Zhang, Y. Ueda and E. Li (2007). "Complete 
inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells." Nat Genet 39(3): 391-
396. 
Chen, X., F. Martin, K. A. Forbush, R. M. Perlmutter and J. F. Kearney (1997). "Evidence for 
selection of a population of multi-reactive B cells into the splenic marginal zone." Int Immunol 
9(1): 27-41. 
Cheng, S., C. Y. Hsia, B. Feng, M. L. Liou, X. Fang, P. P. Pandolfi and H. C. Liou (2009). "BCR-
mediated apoptosis associated with negative selection of immature B cells is selectively dependent 
on Pten." Cell Res 19(2): 196-207. 
141 
 
 
 
Chomarat, P., J. Banchereau, J. Davoust and A. K. Palucka (2000). "IL-6 switches the 
differentiation of monocytes from dendritic cells to macrophages." Nat Immunol 1(6): 510-514. 
Chu, P. G. and D. A. Arber (2001). "CD79: a review." Appl Immunohistochem Mol Morphol 9(2): 
97-106. 
Chuang, J. C. and P. A. Jones (2007). "Epigenetics and microRNAs." Pediatr Res 61(5 Pt 2): 24R-
29R. 
Ciriaco, E., P. P. Pinera, B. Diaz-Esnal and R. Laura (2003). "Age-related changes in the avian 
primary lymphoid organs (thymus and bursa of Fabricius)." Microsc Res Tech 62(6): 482-487. 
Cogswell, J. P., M. M. Godlevski, G. B. Wisely, W. C. Clay, L. M. Leesnitzer, J. P. Ways and J. 
G. Gray (1994). "NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B 
binding site and a nonconsensus CRE-like site." J Immunol 153(2): 712-723. 
Compton, M. M. and H. M. Waldrip (1998). "Endogenous activation of apoptosis in bursal 
lymphocytes: inhibition by phorbol esters and protein synthesis inhibitors." Cell Immunol 184(2): 
143-152. 
Cooper, M. D., W. A. Cain, P. J. Van Alten and R. A. Good (1969). "Development and function 
of the immunoglobulin producing system. I. Effect of bursectomy at different stages of 
development on germinal centers, plasma cells, immunoglobulins and antibody production." Int 
Arch Allergy Appl Immunol 35(3): 242-252. 
142 
 
 
 
Cooper, M. D., R. D. Peterson and R. A. Good (1965). "Delineation of the Thymic and Bursal 
Lymphoid Systems in the Chicken." Nature 205: 143-146. 
Courtemanche, C., I. Elson-Schwab, S. T. Mashiyama, N. Kerry and B. N. Ames (2004). "Folate 
deficiency inhibits the proliferation of primary human CD8+ T lymphocytes in vitro." J Immunol 
173(5): 3186-3192. 
Crider, K. S., T. P. Yang, R. J. Berry and L. B. Bailey (2012). "Folate and DNA methylation: a 
review of molecular mechanisms and the evidence for folate's role." Adv Nutr 3(1): 21-38. 
Damdinsuren, B., Y. Zhang, A. Khalil, W. H. Wood, 3rd, K. G. Becker, M. J. Shlomchik and R. 
Sen (2010). "Single round of antigen receptor signaling programs naive B cells to receive T cell 
help." Immunity 32(3): 355-366. 
Davani, D., Z. Pancer, H. Cheroutre and M. J. Ratcliffe (2014a). "Negative selection of self-
reactive chicken B cells requires B cell receptor signaling and is independent of the bursal 
microenvironment." J Immunol 192(7): 3207-3217. 
Davani, D., Z. Pancer and M. J. Ratcliffe (2014b). "Ligation of surface Ig by gut-derived antigen 
positively selects chicken bursal and peripheral B cells." J Immunol 192(7): 3218-3227. 
Deriu, E., J. Z. Liu, M. Pezeshki, R. A. Edwards, R. J. Ochoa, H. Contreras, S. J. Libby, F. C. Fang 
and M. Raffatellu (2013). "Probiotic bacteria reduce salmonella typhimurium intestinal 
colonization by competing for iron." Cell Host Microbe 14(1): 26-37. 
143 
 
 
 
Dibner, J. J. and J. D. Richards (2005). "Antibiotic growth promoters in agriculture: history and 
mode of action." Poult Sci 84(4): 634-643. 
Diesel, B., N. Ripoche, R. T. Risch, S. Tierling, J. Walter and A. K. Kiemer (2012). "Inflammation-
induced up-regulation of TLR2 expression in human endothelial cells is independent of differential 
methylation in the TLR2 promoter CpG island." Innate Immun 18(1): 112-123. 
Dohr, G. A., W. Motter, S. Leitinger, G. Desoye, W. Urdl, R. Winter, M. M. Wilders-Truschnig, 
B. Uchanska-Ziegler and A. Ziegler (1987). "Lack of expression of HLA [corrected] class I and 
class II molecules on the human oocyte." J Immunol 138(11): 3766-3770. 
Dunon, D., N. Allioli, O. Vainio, C. Ody and B. A. Imhof (1999). "Quantification of T-cell 
progenitors during ontogeny: thymus colonization depends on blood delivery of progenitors." 
Blood 93(7): 2234-2243. 
Dunon, D., D. Courtois, O. Vainio, A. Six, C. H. Chen, M. D. Cooper, J. P. Dangy and B. A. Imhof 
(1997). "Ontogeny of the immune system: gamma/delta and alpha/beta T cells migrate from 
thymus to the periphery in alternating waves." J Exp Med 186(7): 977-988. 
Duprez, L., E. Wirawan, T. Vanden Berghe and P. Vandenabeele (2009). "Major cell death 
pathways at a glance." Microbes Infect 11(13): 1050-1062. 
Duthie, S. J. and A. Hawdon (1998). "DNA instability (strand breakage, uracil misincorporation, 
and defective repair) is increased by folic acid depletion in human lymphocytes in vitro." FASEB 
J 12(14): 1491-1497. 
144 
 
 
 
Ehrlich, M. (2002). "DNA methylation in cancer: too much, but also too little." Oncogene 21(35): 
5400-5413. 
Ettig, R., N. Kepper, R. Stehr, G. Wedemann and K. Rippe (2011). "Dissecting DNA-histone 
interactions in the nucleosome by molecular dynamics simulations of DNA unwrapping." Biophys 
J 101(8): 1999-2008. 
Ettinger, R., G. P. Sims, A. M. Fairhurst, R. Robbins, Y. S. da Silva, R. Spolski, W. J. Leonard 
and P. E. Lipsky (2005). "IL-21 induces differentiation of human naive and memory B cells into 
antibody-secreting plasma cells." J Immunol 175(12): 7867-7879. 
Fagerland, J. A. and L. H. Arp (1993). "Structure and development of bronchus-associated 
lymphoid tissue in conventionally reared broiler chickens." Avian Dis 37(1): 10-18. 
Farhat, K., S. Riekenberg, H. Heine, J. Debarry, R. Lang, J. Mages, U. Buwitt-Beckmann, K. 
Roschmann, G. Jung, K. H. Wiesmuller and A. J. Ulmer (2008). "Heterodimerization of TLR2 
with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling." J 
Leukoc Biol 83(3): 692-701. 
Fox, C. J., P. S. Hammerman and C. B. Thompson (2005). "Fuel feeds function: energy 
metabolism and the T-cell response." Nat Rev Immunol 5(11): 844-852. 
Fuks, F., W. A. Burgers, A. Brehm, L. Hughes-Davies and T. Kouzarides (2000). "DNA 
methyltransferase Dnmt1 associates with histone deacetylase activity." Nat Genet 24(1): 88-91. 
145 
 
 
 
Fukui, A., N. Inoue, M. Matsumoto, M. Nomura, K. Yamada, Y. Matsuda, K. Toyoshima and T. 
Seya (2001). "Molecular cloning and functional characterization of chicken toll-like receptors. A 
single chicken toll covers multiple molecular patterns." J Biol Chem 276(50): 47143-47149. 
Funk, P. E. and J. L. Palmer (2003). "Dynamic control of B lymphocyte development in the bursa 
of fabricius." Arch Immunol Ther Exp (Warsz) 51(6): 389-398. 
Funk, P. E. and C. B. Thompson (1998). "Identification of a lectin that induces cell death in 
developing chicken B cells." Cell Immunol 186(1): 75-81. 
Garceau, V., A. Balic, C. Garcia-Morales, K. A. Sauter, M. J. McGrew, J. Smith, L. Vervelde, A. 
Sherman, T. E. Fuller, T. Oliphant, J. A. Shelley, R. Tiwari, T. L. Wilson, C. Chintoan-Uta, D. W. 
Burt, M. P. Stevens, H. M. Sang and D. A. Hume (2015). "The development and maintenance of 
the mononuclear phagocyte system of the chick is controlled by signals from the macrophage 
colony-stimulating factor receptor." BMC Biol 13: 12. 
Geiman, T. M. and K. Muegge (2010). "DNA methylation in early development." Mol Reprod 
Dev 77(2): 105-113. 
Ghoshal, K. and S. Bai (2007). "DNA methyltransferases as targets for cancer therapy." Drugs 
Today (Barc) 43(6): 395-422. 
Giles, J. R., M. Kashgarian, P. A. Koni and M. J. Shlomchik (2015). "B Cell-Specific MHC Class 
II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine 
Lupus." J Immunol 195(6): 2571-2579. 
146 
 
 
 
Gou, Z., R. Liu, G. Zhao, M. Zheng, P. Li, H. Wang, Y. Zhu, J. Chen and J. Wen (2012). 
"Epigenetic modification of TLRs in leukocytes is associated with increased susceptibility to 
Salmonella enteritidis in chickens." PLoS One 7(3): e33627. 
Gowher, H. and A. Jeltsch (2001). "Enzymatic properties of recombinant Dnmt3a DNA 
methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also 
methylates non-CpG [correction of non-CpA] sites." J Mol Biol 309(5): 1201-1208. 
Gozuacik, D. and A. Kimchi (2007). "Autophagy and cell death." Curr Top Dev Biol 78: 217-245. 
Graversen, J. H., R. H. Lorentsen, C. Jacobsen, S. K. Moestrup, B. W. Sigurskjold, H. C. 
Thogersen and M. Etzerodt (1998). "The plasminogen binding site of the C-type lectin tetranectin 
is located in the carbohydrate recognition domain, and binding is sensitive to both calcium and 
lysine." J Biol Chem 273(44): 29241-29246. 
Grimaldi, C. M., R. Hicks and B. Diamond (2005). "B cell selection and susceptibility to 
autoimmunity." J Immunol 174(4): 1775-1781. 
Grosse, S. D. and J. S. Collins (2007). "Folic acid supplementation and neural tube defect 
recurrence prevention." Birth Defects Res A Clin Mol Teratol 79(11): 737-742. 
Gyorffy, B., G. Bottai, T. Fleischer, G. Munkacsy, J. Budczies, L. Paladini, A. L. Borresen-Dale, 
V. N. Kristensen and L. Santarpia (2016). "Aberrant DNA methylation impacts gene expression 
and prognosis in breast cancer subtypes." Int J Cancer 138(1): 87-97. 
147 
 
 
 
Hanash, A. M., J. A. Dudakov, G. Hua, M. H. O'Connor, L. F. Young, N. V. Singer, M. L. West, 
R. R. Jenq, A. M. Holland, L. W. Kappel, A. Ghosh, J. J. Tsai, U. K. Rao, N. L. Yim, O. M. Smith, 
E. Velardi, E. B. Hawryluk, G. F. Murphy, C. Liu, L. A. Fouser, R. Kolesnick, B. R. Blazar and 
M. R. van den Brink (2012). "Interleukin-22 protects intestinal stem cells from immune-mediated 
tissue damage and regulates sensitivity to graft versus host disease." Immunity 37(2): 339-350. 
Hata, K., M. Okano, H. Lei and E. Li (2002). "Dnmt3L cooperates with the Dnmt3 family of de 
novo DNA methyltransferases to establish maternal imprints in mice." Development 129(8): 1983-
1993. 
Hawkins, B. J., K. M. Irrinki, K. Mallilankaraman, Y. C. Lien, Y. Wang, C. D. Bhanumathy, R. 
Subbiah, M. F. Ritchie, J. Soboloff, Y. Baba, T. Kurosaki, S. K. Joseph, D. L. Gill and M. Madesh 
(2010). "S-glutathionylation activates STIM1 and alters mitochondrial homeostasis." J Cell Biol 
190(3): 391-405. 
Hebert, K., J. D. House and W. Guenter (2005). "Effect of dietary folic acid supplementation on 
egg folate content and the performance and folate status of two strains of laying hens." Poult Sci 
84(10): 1533-1538. 
Hegde, S. N., B. A. Rolls and M. E. Coates (1982). "THe effects of the gut microflora and dietary 
fibre on energy utilization by the chick." Br J Nutr 48(1): 73-80. 
Hervouet, E., M. Cheray, F. M. Vallette and P. F. Cartron (2013). "DNA methylation and apoptosis 
resistance in cancer cells." Cells 2(3): 545-573. 
148 
 
 
 
Holler, M., G. Westin, J. Jiricny and W. Schaffner (1988). "Sp1 transcription factor binds DNA 
and activates transcription even when the binding site is CpG methylated." Genes Dev 2(9): 1127-
1135. 
Holling, T. M., N. Van der Stoep and P. J. Van den Elsen (2004). "Epigenetic control of CIITA 
expression in leukemic T cells." Biochem Pharmacol 68(6): 1209-1213. 
Hou, Z., S. Orr and L. H. Matherly (2014). "Post-transcriptional regulation of the human reduced 
folate carrier as a novel adaptive mechanism in response to folate excess or deficiency." Biosci 
Rep 34(4). 
House, J. D., K. Braun, D. M. Ballance, C. P. O'Connor and W. Guenter (2002). "The enrichment 
of eggs with folic acid through supplementation of the laying hen diet." Poult Sci 81(9): 1332-
1337. 
Houssaint, E., A. Mansikka and O. Vainio (1991). "Early separation of B and T lymphocyte 
precursors in chick embryo." J Exp Med 174(2): 397-406. 
Hrdlickova, R., J. Nehyba and E. H. Humphries (1994). "v-rel induces expression of three avian 
immunoregulatory surface receptors more efficiently than c-rel." J Virol 68(1): 308-319. 
Hu, J., C. Havenar-Daughton and S. Crotty (2013). "Modulation of SAP dependent T:B cell 
interactions as a strategy to improve vaccination." Curr Opin Virol 3(3): 363-370. 
Hu, Y., I. Ericsson, K. Torseth, S. P. Methot, O. Sundheim, N. B. Liabakk, G. Slupphaug, J. M. 
Di Noia, H. E. Krokan and B. Kavli (2013). "A combined nuclear and nucleolar localization motif 
149 
 
 
 
in activation-induced cytidine deaminase (AID) controls immunoglobulin class switching." J Mol 
Biol 425(2): 424-443. 
Isolauri, E., Y. Sutas, P. Kankaanpaa, H. Arvilommi and S. Salminen (2001). "Probiotics: effects 
on immunity." Am J Clin Nutr 73(2 Suppl): 444S-450S. 
Itaya, K., K. Chayahara, T. Hirai, T. Minbuta, T. Uchikawa, T. Tanaka, S. Masaki, K. Kuroda and 
M. Ono (2011). "DT40 knock-out and knock-in studies determine the regions necessary and 
sufficient for transcription and epigenetic conversion of the chicken Ig-beta gene." Genes Cells 
16(3): 291-303. 
Jack, D. L., G. A. Jarvis, C. L. Booth, M. W. Turner and N. J. Klein (2001). "Mannose-binding 
lectin accelerates complement activation and increases serum killing of Neisseria meningitidis 
serogroup C." J Infect Dis 184(7): 836-845. 
Jackson-Grusby, L., C. Beard, R. Possemato, M. Tudor, D. Fambrough, G. Csankovszki, J. 
Dausman, P. Lee, C. Wilson, E. Lander and R. Jaenisch (2001). "Loss of genomic methylation 
causes p53-dependent apoptosis and epigenetic deregulation." Nat Genet 27(1): 31-39. 
Jaszewski, R., A. Khan, F. H. Sarkar, O. Kucuk, M. Tobi, A. Zagnoon, R. Dhar, J. Kinzie and A. 
P. Majumdar (1999). "Folic acid inhibition of EGFR-mediated proliferation in human colon cancer 
cell lines." Am J Physiol 277(6 Pt 1): C1142-1148. 
150 
 
 
 
Jendholm, J., M. Morgelin, M. L. Perez Vidakovics, M. Carlsson, H. Leffler, L. O. Cardell and K. 
Riesbeck (2009). "Superantigen- and TLR-dependent activation of tonsillar B cells after receptor-
mediated endocytosis." J Immunol 182(8): 4713-4720. 
Jeurissen, S. H. (1993). "The role of various compartments in the chicken spleen during an antigen-
specific humoral response." Immunology 80(1): 29-33. 
Jimenez-Dalmaroni, M. J., M. E. Gerswhin and I. E. Adamopoulos (2016). "The critical role of 
toll-like receptors - From microbial recognition to autoimmunity: A comprehensive review." 
Autoimmun Rev 15(1): 1-8. 
Jing, M., G. B. Tactacan, J. C. Rodriguez-Lecompte, A. Kroeker and J. D. House (2009). 
"Molecular cloning and tissue distribution of reduced folate carrier and effect of dietary folate 
supplementation on the expression of reduced folate carrier in laying hens." Poult Sci 88(9): 1939-
1947. 
Johnson, A. L., J. S. Langer and J. T. Bridgham (2002). "Survivin as a cell cycle-related and 
antiapoptotic protein in granulosa cells." Endocrinology 143(9): 3405-3413. 
Kanneganti, T. D., M. Lamkanfi and G. Nunez (2007). "Intracellular NOD-like receptors in host 
defense and disease." Immunity 27(4): 549-559. 
Kaplan, S. S. and R. E. Basford (1976). "Effect of vitamin B12 and folic acid deficiencies on 
neutrophil function." Blood 47(5): 801-805. 
151 
 
 
 
Katona, P. and J. Katona-Apte (2008). "The interaction between nutrition and infection." Clin 
Infect Dis 46(10): 1582-1588. 
Keestra, A. M., M. R. de Zoete, L. I. Bouwman, M. M. Vaezirad and J. P. van Putten (2013). 
"Unique features of chicken Toll-like receptors." Dev Comp Immunol 41(3): 316-323. 
Kelly-Scumpia, K. M., P. O. Scumpia, J. S. Weinstein, M. J. Delano, A. G. Cuenca, D. C. 
Nacionales, J. L. Wynn, P. Y. Lee, Y. Kumagai, P. A. Efron, S. Akira, C. Wasserfall, M. A. 
Atkinson and L. L. Moldawer (2011). "B cells enhance early innate immune responses during 
bacterial sepsis." J Exp Med 208(8): 1673-1682. 
Kidd, M. T., E. D. Peebles, S. K. Whitmarsh, J. B. Yeatman and R. F. Wideman, Jr. (2001). 
"Growth and immunity of broiler chicks as affected by dietary arginine." Poult Sci 80(11): 1535-
1542. 
Kim, W. H., J. Jeong, A. R. Park, D. Yim, S. Kim, H. H. Chang, S. H. Yang, D. H. Kim, H. S. 
Lillehoj and W. Min (2014). "Downregulation of chicken interleukin-17 receptor A during Eimeria 
infection." Infect Immun 82(9): 3845-3854. 
Klein Klouwenberg, P., L. Tan, W. Werkman, G. M. van Bleek and F. Coenjaerts (2009). "The 
role of Toll-like receptors in regulating the immune response against respiratory syncytial virus." 
Crit Rev Immunol 29(6): 531-550. 
152 
 
 
 
Knarreborg, A., C. Lauridsen, R. M. Engberg and S. K. Jensen (2004). "Dietary antibiotic growth 
promoters enhance the bioavailability of alpha-tocopheryl acetate in broilers by altering lipid 
absorption." J Nutr 134(6): 1487-1492. 
Koskela, K., P. Nieminen, P. Kohonen, H. Salminen and O. Lassila (2004). "Chicken B-cell-
activating factor: regulator of B-cell survival in the bursa of fabricius." Scand J Immunol 59(5): 
449-457. 
Kotsopoulos, J., K. J. Sohn and Y. I. Kim (2008). "Postweaning dietary folate deficiency provided 
through childhood to puberty permanently increases genomic DNA methylation in adult rat liver." 
J Nutr 138(4): 703-709. 
Kuhlmann, D., G. Dohr, H. H. Pusch, W. Scherbaum, G. Schieferstein, B. Uchanska-Ziegler and 
A. Ziegler (1986). "Absence of HLA class I and class II antigens as well as beta 2-microglobulin 
from normal and pathological human spermatozoa." Tissue Antigens 27(3): 179-184. 
Labbe, K. and M. Saleh (2008). "Cell death in the host response to infection." Cell Death Differ 
15(9): 1339-1349. 
Lanzavecchia, A. (1985). "Antigen-specific interaction between T and B cells." Nature 314(6011): 
537-539. 
Lassila, O. (1989). "Emigration of B cells from chicken bursa of Fabricius." Eur J Immunol 19(5): 
955-958. 
153 
 
 
 
Lebacq, A. M. and M. A. Ritter (1979). "B-cell precursors in early chicken embryos." Immunology 
37(1): 123-134. 
Lee, W. Y. and P. Tolar (2013). "Activation of the B cell receptor leads to increased membrane 
proximity of the Igalpha cytoplasmic domain." PLoS One 8(11): e79148. 
Leitner, G., R. Waiman and E. D. Heller (2001). "The effect of apramycin on colonization of 
pathogenic Escherichia coli in the intestinal tract of chicks." Vet Q 23(2): 62-66. 
Leshchinsky, T. V. and K. C. Klasing (2001). "Divergence of the inflammatory response in two 
types of chickens." Dev Comp Immunol 25(7): 629-638. 
Levine, F. and D. Pious (1985). "Different roles for cytosine methylation in HLA class II gene 
expression." Immunogenetics 22(5): 427-440. 
Li, E. (2002). "Chromatin modification and epigenetic reprogramming in mammalian 
development." Nat Rev Genet 3(9): 662-673. 
Li, Z., C. J. Woo, M. D. Iglesias-Ussel, D. Ronai and M. D. Scharff (2004). "The generation of 
antibody diversity through somatic hypermutation and class switch recombination." Genes Dev 
18(1): 1-11. 
Liu, Y., J. Liao, M. Zhao, H. Wu, S. Yung, T. M. Chan, A. Yoshimura and Q. Lu (2015). "Increased 
expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and 
promotes IL-17 expression through histone modifications." Eur J Immunol 45(9): 2683-2693. 
154 
 
 
 
Liu, Y. J., J. Zhang, P. J. Lane, E. Y. Chan and I. C. MacLennan (1991). "Sites of specific B cell 
activation in primary and secondary responses to T cell-dependent and T cell-independent 
antigens." Eur J Immunol 21(12): 2951-2962. 
Lowry, V. K., M. B. Farnell, P. J. Ferro, C. L. Swaggerty, A. Bahl and M. H. Kogut (2005). 
"Purified beta-glucan as an abiotic feed additive up-regulates the innate immune response in 
immature chickens against Salmonella enterica serovar Enteritidis." Int J Food Microbiol 98(3): 
309-318. 
Luna-Acosta, J. L., C. Alba-Betancourt, C. G. Martinez-Moreno, C. Ramirez, M. Carranza, M. 
Luna and C. Aramburo (2015). "Direct antiapoptotic effects of growth hormone are mediated by 
PI3K/Akt pathway in the chicken bursa of Fabricius." Gen Comp Endocrinol 224: 148-159. 
Luning Prak, E. T., M. Monestier and R. A. Eisenberg (2011). "B cell receptor editing in tolerance 
and autoimmunity." Ann N Y Acad Sci 1217: 96-121. 
Lydyard, P. M., C. E. Grossi and M. D. Cooper (1976). "Ontogeny of B cells in the chicken. I. 
Sequential development of clonal diversity in the bursa." J Exp Med 144(1): 79-97. 
Macpherson, A. J., D. Gatto, E. Sainsbury, G. R. Harriman, H. Hengartner and R. M. Zinkernagel 
(2000). "A primitive T cell-independent mechanism of intestinal mucosal IgA responses to 
commensal bacteria." Science 288(5474): 2222-2226. 
155 
 
 
 
Madej, J. P. and M. Bednarczyk (2016). "Effect of in ovo-delivered prebiotics and synbiotics on 
the morphology and specific immune cell composition in the gut-associated lymphoid tissue." 
Poult Sci 95(1): 19-29. 
Maier, H., J. Colbert, D. Fitzsimmons, D. R. Clark and J. Hagman (2003a). "Activation of the early 
B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site." 
Mol Cell Biol 23(6): 1946-1960. 
Maier, H., R. Ostraat, S. Parenti, D. Fitzsimmons, L. J. Abraham, C. W. Garvie and J. Hagman 
(2003b). "Requirements for selective recruitment of Ets proteins and activation of mb-1/Ig-alpha 
gene transcription by Pax-5 (BSAP)." Nucleic Acids Res 31(19): 5483-5489. 
Majno, G. and I. Joris (1995). "Apoptosis, oncosis, and necrosis. An overview of cell death." Am 
J Pathol 146(1): 3-15. 
Malin, M., H. Suomalainen, M. Saxelin and E. Isolauri (1996). "Promotion of IgA immune 
response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG." Ann 
Nutr Metab 40(3): 137-145. 
Malone, C. S., A. I. Kuraishy, F. M. Fike, R. G. Loya, M. R. Mikkili, M. A. Teitell and R. Wall 
(2006). "B29 gene silencing in pituitary cells is regulated by its 3' enhancer." J Mol Biol 362(2): 
173-183. 
156 
 
 
 
Mamchak, A. A. and P. D. Hodgkin (2000). "Regulation of lipopolysaccharide-induced B-cell 
activation: evidence that surface immunoglobulin mediates two independently regulated signals." 
Immunol Cell Biol 78(2): 142-148. 
Mansikka, A., M. Sandberg, O. Lassila and P. Toivanen (1990). "Rearrangement of 
immunoglobulin light chain genes in the chicken occurs prior to colonization of the embryonic 
bursa of Fabricius." Proc Natl Acad Sci U S A 87(23): 9416-9420. 
Martinez, R., F. Setien, C. Voelter, S. Casado, M. P. Quesada, G. Schackert and M. Esteller (2007). 
"CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common 
hallmark of relapsed glioblastoma multiforme." Carcinogenesis 28(6): 1264-1268. 
Masteller, E. L., R. D. Larsen, L. M. Carlson, J. M. Pickel, B. Nickoloff, J. Lowe, C. B. Thompson 
and K. P. Lee (1995a). "Chicken B cells undergo discrete developmental changes in surface 
carbohydrate structure that appear to play a role in directing lymphocyte migration during 
embryogenesis." Development 121(6): 1657-1667. 
Masteller, E. L., K. P. Lee, L. M. Carlson and C. B. Thompson (1995b). "Expression of sialyl 
Lewis(x) and Lewis(x) defines distinct stages of chicken B cell maturation." J Immunol 155(12): 
5550-5556. 
Matherly, L. H., Z. Hou and Y. Deng (2007). "Human reduced folate carrier: translation of basic 
biology to cancer etiology and therapy." Cancer Metastasis Rev 26(1): 111-128. 
157 
 
 
 
Matsuguchi, T., T. Musikacharoen, T. Ogawa and Y. Yoshikai (2000). "Gene expressions of Toll-
like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in 
mouse macrophages." J Immunol 165(10): 5767-5772. 
Matsuki, Y., M. Ohmura-Hoshino, E. Goto, M. Aoki, M. Mito-Yoshida, M. Uematsu, T. 
Hasegawa, H. Koseki, O. Ohara, M. Nakayama, K. Toyooka, K. Matsuoka, H. Hotta, A. 
Yamamoto and S. Ishido (2007). "Novel regulation of MHC class II function in B cells." EMBO 
J 26(3): 846-854. 
Matter, M. S. and A. F. Ochsenbein (2008). "Natural antibodies target virus-antibody complexes 
to organized lymphoid tissue." Autoimmun Rev 7(6): 480-486. 
McCormack, W. T., L. W. Tjoelker and C. B. Thompson (1991). "Avian B-cell development: 
generation of an immunoglobulin repertoire by gene conversion." Annu Rev Immunol 9: 219-241. 
Melchers, F. (2015). "Checkpoints that control B cell development." J Clin Invest 125(6): 2203-
2210. 
Meyer, R. K., M. A. Rao and R. L. Aspinall (1959). "Inhibition of the development of the bursa of 
Fabricius in the embryos of the common fowl by 19-nortestosterone." Endocrinology 64(6): 890-
897. 
Mezger, M., S. Kneitz, I. Wozniok, O. Kurzai, H. Einsele and J. Loeffler (2008). "Proinflammatory 
response of immature human dendritic cells is mediated by dectin-1 after exposure to Aspergillus 
fumigatus germ tubes." J Infect Dis 197(6): 924-931. 
158 
 
 
 
Minbuta, T. and M. Ono (2011). "Scattered regulatory regions of the chicken immunoglobulin-
beta gene and two adjacent promoters of ubiquitously expressed genes interact with the 
immunoglobulin-beta promoter in DT40 cells." Biol Pharm Bull 34(11): 1710-1716. 
Mogensen, T. H. (2009). "Pathogen recognition and inflammatory signaling in innate immune 
defenses." Clin Microbiol Rev 22(2): 240-273, Table of Contents. 
Motyka, B. and J. D. Reynolds (1991). "Apoptosis is associated with the extensive B cell death in 
the sheep ileal Peyer's patch and the chicken bursa of Fabricius: a possible role in B cell selection." 
Eur J Immunol 21(8): 1951-1958. 
Moussa, C., N. Ross, P. Jolette and A. J. MacFarlane (2015). "Altered folate metabolism modifies 
cell proliferation and progesterone secretion in human placental choriocarcinoma JEG-3 cells." Br 
J Nutr 114(6): 844-852. 
Muhlethaler-Mottet, A., L. A. Otten, V. Steimle and B. Mach (1997). "Expression of MHC class 
II molecules in different cellular and functional compartments is controlled by differential usage 
of multiple promoters of the transactivator CIITA." EMBO J 16(10): 2851-2860. 
Munyaka, P. M., G. Tactacan, M. Jing, K. O, J. D. House and J. C. Rodriguez-Lecompte (2012). 
"Immunomodulation in young laying hens by dietary folic acid and acute immune responses after 
challenge with Escherichia coli lipopolysaccharide." Poult Sci 91(10): 2454-2463. 
Nagy, N., A. Magyar, M. Toth and I. Olah (2004). "Quail as the chimeric counterpart of the 
chicken: morphology and ontogeny of the bursa of Fabricius." J Morphol 259(3): 328-339. 
159 
 
 
 
Nagy, N. and I. Olah (2010). "Experimental evidence for the ectodermal origin of the epithelial 
anlage of the chicken bursa of Fabricius." Development 137(18): 3019-3023. 
Narabara, K., A. Abe, Gerilechaogetu, H. Hanieh and Y. Kondo (2009). "B cell differentiation in 
the bursa of Fabricius and spleen of embryos and chicks immediately after hatching." Anim Sci J 
80(6): 669-677. 
Naukkarinen, A. and T. E. Sorvari (1984). "Involution of the chicken bursa of Fabricius: a light 
microscopic study with special reference to transport of colloidal carbon in the involuting bursa." 
J Leukoc Biol 35(3): 281-290. 
Nestor, C. E., R. Ottaviano, D. Reinhardt, H. A. Cruickshanks, H. K. Mjoseng, R. C. McPherson, 
A. Lentini, J. P. Thomson, D. S. Dunican, S. Pennings, S. M. Anderton, M. Benson and R. R. 
Meehan (2015). "Rapid reprogramming of epigenetic and transcriptional profiles in mammalian 
culture systems." Genome Biol 16: 11. 
Obeid, R. (2013). "The metabolic burden of methyl donor deficiency with focus on the betaine 
homocysteine methyltransferase pathway." Nutrients 5(9): 3481-3495. 
Ochsenbein, A. F. and R. M. Zinkernagel (2000). "Natural antibodies and complement link innate 
and acquired immunity." Immunol Today 21(12): 624-630. 
Okano, M., D. W. Bell, D. A. Haber and E. Li (1999). "DNA methyltransferases Dnmt3a and 
Dnmt3b are essential for de novo methylation and mammalian development." Cell 99(3): 247-257. 
160 
 
 
 
Olah, I., B. Glick and I. Toro (1986). "Bursal development in normal and testosterone-treated chick 
embryos." Poult Sci 65(3): 574-588. 
Olthof, M. R., E. J. Brink, M. B. Katan and P. Verhoef (2005). "Choline supplemented as 
phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine 
concentrations in healthy men." Am J Clin Nutr 82(1): 111-117. 
Opferman, J. T. (2008). "Apoptosis in the development of the immune system." Cell Death Differ 
15(2): 234-242. 
Pacis, A., L. Tailleux, A. M. Morin, J. Lambourne, J. L. Maclsaac, V. Yotova, A. Dumaine, A. 
Danckaert, F. Luca, J. C. Grenier, K. D. Hansen, B. Gicquel, M. Yu, A. Pai, C. He, J. Tung, T. 
Pastinen, M. S. Kobor, R. Pique-Regi, Y. Gilad and L. B. Barreiro (2015). "Bacterial infection 
remodels the DNA methylation landscape of human dendritic cells." Genome Res. 
Palm, N. W. and R. Medzhitov (2009). "Immunostimulatory activity of haptenated proteins." Proc 
Natl Acad Sci U S A 106(12): 4782-4787. 
Paramithiotis, E., K. A. Jacobsen and M. J. Ratcliffe (1995). "Loss of surface immunoglobulin 
expression precedes B cell death by apoptosis in the bursa of Fabricius." J Exp Med 181(1): 105-
113. 
Paramithiotis, E. and M. J. Ratcliffe (1994a). "B cell emigration directly from the cortex of 
lymphoid follicles in the bursa of Fabricius." Eur J Immunol 24(2): 458-463. 
161 
 
 
 
Paramithiotis, E. and M. J. Ratcliffe (1993). "Bursa-dependent subpopulations of peripheral B 
lymphocytes in chicken blood." Eur J Immunol 23(1): 96-102. 
Paramithiotis, E. and M. J. Ratcliffe (1996). "Evidence for phenotypic heterogeneity among B cells 
emigrating from the bursa of fabricius: a reflection of functional diversity?" Curr Top Microbiol 
Immunol 212: 29-36. 
Paramithiotis, E. and M. J. Ratcliffe (1994b). "Survivors of bursal B cell production and 
emigration." Poult Sci 73(7): 991-997. 
Parikh, A. A., A. L. Salzman, C. D. Kane, J. E. Fischer and P. O. Hasselgren (1997). "IL-6 
production in human intestinal epithelial cells following stimulation with IL-1 beta is associated 
with activation of the transcription factor NF-kappa B." J Surg Res 69(1): 139-144. 
Patterson, J. A. and K. M. Burkholder (2003). "Application of prebiotics and probiotics in poultry 
production." Poult Sci 82(4): 627-631. 
Paus, D., T. G. Phan, T. D. Chan, S. Gardam, A. Basten and R. Brink (2006). "Antigen recognition 
strength regulates the choice between extrafollicular plasma cell and germinal center B cell 
differentiation." J Exp Med 203(4): 1081-1091. 
Pfaffl, M. W. (2001). "A new mathematical model for relative quantification in real-time RT-
PCR." Nucleic Acids Res 29(9): e45. 
162 
 
 
 
Pickel, J. M., W. T. McCormack, C. H. Chen, M. D. Cooper and C. B. Thompson (1993). 
"Differential regulation of V(D)J recombination during development of avian B and T cells." Int 
Immunol 5(8): 919-927. 
Pike, K. A., E. Baig and M. J. Ratcliffe (2004). "The avian B-cell receptor complex: distinct roles 
of Igalpha and Igbeta in B-cell development." Immunol Rev 197: 10-25. 
Pike, K. A. and M. J. Ratcliffe (2005). "Dual requirement for the Ig alpha immunoreceptor 
tyrosine-based activation motif (ITAM) and a conserved non-Ig alpha ITAM tyrosine in 
supporting Ig alpha beta-mediated B cell development." J Immunol 174(4): 2012-2020. 
Pink, J. R., O. Vainio and A. M. Rijnbeek (1985). "Clones of B lymphocytes in individual follicles 
of the bursa of Fabricius." Eur J Immunol 15(1): 83-87. 
Plotkin, S. A. (2003). "Vaccines, vaccination, and vaccinology." J Infect Dis 187(9): 1349-1359. 
Pompei, A., L. Cordisco, A. Amaretti, S. Zanoni, D. Matteuzzi and M. Rossi (2007). "Folate 
production by bifidobacteria as a potential probiotic property." Appl Environ Microbiol 73(1): 
179-185. 
Pone, E. J., Z. Lou, T. Lam, M. L. Greenberg, R. Wang, Z. Xu and P. Casali (2015). "B cell 
TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: 
modulation by BCR and CD40, and relevance to T-independent antibody responses." 
Autoimmunity 48(1): 1-12. 
163 
 
 
 
Pone, E. J., Z. Xu, C. A. White, H. Zan and P. Casali (2012a). "B cell TLRs and induction of 
immunoglobulin class-switch DNA recombination." Front Biosci (Landmark Ed) 17: 2594-2615. 
Pone, E. J., H. Zan, J. Zhang, A. Al-Qahtani, Z. Xu and P. Casali (2010). "Toll-like receptors and 
B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance 
to microbial antibody responses." Crit Rev Immunol 30(1): 1-29. 
Pone, E. J., J. Zhang, T. Mai, C. A. White, G. Li, J. K. Sakakura, P. J. Patel, A. Al-Qahtani, H. 
Zan, Z. Xu and P. Casali (2012b). "BCR-signalling synergizes with TLR-signalling for induction 
of AID and immunoglobulin class-switching through the non-canonical NF-kappaB pathway." Nat 
Commun 3: 767. 
Portt, L., G. Norman, C. Clapp, M. Greenwood and M. T. Greenwood (2011). "Anti-apoptosis and 
cell survival: a review." Biochim Biophys Acta 1813(1): 238-259. 
Preynat, A., H. Lapierre, M. C. Thivierge, M. F. Palin, N. Cardinault, J. J. Matte, A. Desrochers 
and C. L. Girard (2010). "Effects of supplementary folic acid and vitamin B(12) on hepatic 
metabolism of dairy cows according to methionine supply." J Dairy Sci 93(5): 2130-2142. 
Price, R. J., K. A. Lillycrop and G. C. Burdge (2015). "Folic acid supplementation in vitro induces 
cell type-specific changes in BRCA1 and BRCA 2 mRNA expression, but does not alter DNA 
methylation of their promoters or DNA repair." Nutr Res 35(6): 532-544. 
164 
 
 
 
Ramasamy, K. T., P. Verma and M. R. Reddy (2014). "Toll-like receptors gene expression in the 
gastrointestinal tract of Salmonella serovar Pullorum-infected broiler chicken." Appl Biochem 
Biotechnol 173(2): 356-364. 
Ratcliffe, M. J. (2006). "Antibodies, immunoglobulin genes and the bursa of Fabricius in chicken 
B cell development." Dev Comp Immunol 30(1-2): 101-118. 
Ratcliffe, M. J. and K. A. Jacobsen (1994). "Rearrangement of immunoglobulin genes in chicken 
B cell development." Semin Immunol 6(3): 175-184. 
Redman, C. W., A. J. McMichael, G. M. Stirrat, C. A. Sunderland and A. Ting (1984). "Class 1 
major histocompatibility complex antigens on human extra-villous trophoblast." Immunology 
52(3): 457-468. 
Resta, S. C. (2009). "Effects of probiotics and commensals on intestinal epithelial physiology: 
implications for nutrient handling." J Physiol 587(Pt 17): 4169-4174. 
Reynaud, C. A., V. Anquez and J. C. Weill (1991). "The chicken D locus and its contribution to 
the immunoglobulin heavy chain repertoire." Eur J Immunol 21(11): 2661-2670. 
Reynaud, C. A., B. A. Imhof, V. Anquez and J. C. Weill (1992). "Emergence of committed B 
lymphoid progenitors in the developing chicken embryo." EMBO J 11(12): 4349-4358. 
Reynolds, J. D. (1987). "Mitotic rate maturation in the Peyer's patches of fetal sheep and in the 
bursa of Fabricius of the chick embryo." Eur J Immunol 17(4): 503-507. 
165 
 
 
 
Roberfroid, M. B. (2000). "Prebiotics and probiotics: are they functional foods?" Am J Clin Nutr 
71(6 Suppl): 1682S-1687S; discussion 1688S-1690S. 
Roche, P. A. and K. Furuta (2015). "The ins and outs of MHC class II-mediated antigen processing 
and presentation." Nat Rev Immunol 15(4): 203-216. 
Rodriguez-Lecompte, J. C., A. Yitbarek, J. Brady, S. Sharif, M. D. Cavanagh, G. Crow, W. 
Guenter, J. D. House and G. Camelo-Jaimes (2012). "The effect of microbial-nutrient interaction 
on the immune system of young chicks after early probiotic and organic acid administration." J 
Anim Sci 90(7): 2246-2254. 
Rossi, M., A. Amaretti and S. Raimondi (2011). "Folate production by probiotic bacteria." 
Nutrients 3(1): 118-134. 
Rothbart, S. B. and B. D. Strahl (2014). "Interpreting the language of histone and DNA 
modifications." Biochim Biophys Acta 1839(8): 627-643. 
Russ, B. E., J. E. Prier, S. Rao and S. J. Turner (2013). "T cell immunity as a tool for studying 
epigenetic regulation of cellular differentiation." Front Genet 4: 218. 
Salomon, B., D. J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe and J. A. Bluestone 
(2000). "B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ 
immunoregulatory T cells that control autoimmune diabetes." Immunity 12(4): 431-440. 
Sanders, M. E. (2008). "Probiotics: definition, sources, selection, and uses." Clin Infect Dis 46 
Suppl 2: S58-61; discussion S144-151. 
166 
 
 
 
Sayegh, C. E., S. L. Demaries, K. A. Pike, J. E. Friedman and M. J. Ratcliffe (2000). "The chicken 
B-cell receptor complex and its role in avian B-cell development." Immunol Rev 175: 187-200. 
Sayegh, C. E., M. A. Rao and M. J. Ratcliffe (1999). "Avian B cell development: lessons from 
transgenic models." Vet Immunol Immunopathol 72(1-2): 31-37. 
Senhaji, N., K. Kojok, Y. Darif, C. Fadainia and Y. Zaid (2015). "The Contribution of 
CD40/CD40L Axis in Inflammatory Bowel Disease: An Update." Front Immunol 6: 529. 
Seto, F. (1981). "Early development of the avian immune system." Poult Sci 60(9): 1981-1995. 
Seyoum, E. and J. Selhub (1998). "Properties of food folates determined by stability and 
susceptibility to intestinal pteroylpolyglutamate hydrolase action." J Nutr 128(11): 1956-1960. 
Sharma, J. M. and B. R. Burmester (1982). "Resistance to Marek's disease at hatching in chickens 
vaccinated as embryos with the turkey herpesvirus." Avian Dis 26(1): 134-149. 
Shekhar, S. and X. Yang (2012). "The darker side of follicular helper T cells: from autoimmunity 
to immunodeficiency." Cell Mol Immunol 9(5): 380-385. 
Shimada, N., H. Matsudo, K. Osano, H. Arakawa, J. M. Buerstedde, Y. Matsumoto, K. Chayahara, 
A. Torihata and M. Ono (2006). "Activation of the chicken Ig-beta locus by the collaboration of 
scattered regulatory regions through changes in chromatin structure." Nucleic Acids Res 34(13): 
3794-3802. 
167 
 
 
 
Shuto, T., T. Furuta, M. Oba, H. Xu, J. D. Li, J. Cheung, D. C. Gruenert, A. Uehara, M. A. Suico, 
T. Okiyoneda and H. Kai (2006). "Promoter hypomethylation of Toll-like receptor-2 gene is 
associated with increased proinflammatory response toward bacterial peptidoglycan in cystic 
fibrosis bronchial epithelial cells." FASEB J 20(6): 782-784. 
Sierra, E. E., K. E. Brigle, M. J. Spinella and I. D. Goldman (1997). "pH dependence of 
methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia 
cells. Further evidence for a third route mediated at low pH." Biochem Pharmacol 53(2): 223-231. 
Simeoli, R., G. Mattace Raso, A. Lama, C. Pirozzi, A. Santoro, F. Di Guida, M. Sanges, E. Aksoy, 
A. Calignano, A. D'Arienzo and R. Meli (2015). "Preventive and therapeutic effects of 
Lactobacillus paracasei B21060-based synbiotic treatment on gut inflammation and barrier 
integrity in colitic mice." J Nutr 145(6): 1202-1210. 
Simonsen, M. (1957). "The impact on the developing embryo and newborn animal of adult 
homologous cells." Acta Pathol Microbiol Scand 40(6): 480-500. 
St Paul, M., S. Paolucci, L. R. Read and S. Sharif (2012a). "Characterization of responses elicited 
by Toll-like receptor agonists in cells of the bursa of Fabricius in chickens." Vet Immunol 
Immunopathol 149(3-4): 237-244. 
St Paul, M., S. Paolucci and S. Sharif (2012b). "Treatment with ligands for toll-like receptors 2 
and 5 induces a mixed T-helper 1- and 2-like response in chicken splenocytes." J Interferon 
Cytokine Res 32(12): 592-598. 
168 
 
 
 
Stahl, J. L., J. L. Greger and M. E. Cook (1989). "Zinc, copper and iron utilisation by chicks fed 
various concentrations of zinc." Br Poult Sci 30(1): 123-134. 
Stamper, C. C., Y. Zhang, J. F. Tobin, D. V. Erbe, S. Ikemizu, S. J. Davis, M. L. Stahl, J. Seehra, 
W. S. Somers and L. Mosyak (2001). "Crystal structure of the B7-1/CTLA-4 complex that inhibits 
human immune responses." Nature 410(6828): 608-611. 
Stetson, D. B. and R. Medzhitov (2006). "Recognition of cytosolic DNA activates an IRF3-
dependent innate immune response." Immunity 24(1): 93-103. 
Strozzi, G. P. and L. Mogna (2008). "Quantification of folic acid in human feces after 
administration of Bifidobacterium probiotic strains." J Clin Gastroenterol 42 Suppl 3 Pt 2: S179-
184. 
Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman and L. H. Glimcher (2000). "A 
novel transcription factor, T-bet, directs Th1 lineage commitment." Cell 100(6): 655-669. 
Tactacan, G. B., M. Jing, S. Thiessen, J. C. Rodriguez-Lecompte, D. L. O'Connor, W. Guenter and 
J. D. House (2010). "Characterization of folate-dependent enzymes and indices of folate status in 
laying hens supplemented with folic acid or 5-methyltetrahydrofolate." Poult Sci 89(4): 688-696. 
Tactacan, G. B., J. C. Rodriguez-Lecompte, K. O and J. D. House (2012). "The adaptive transport 
of folic acid in the intestine of laying hens with increased supplementation of dietary folic acid." 
Poult Sci 91(1): 121-128. 
169 
 
 
 
Takeuchi, O. and S. Akira (2001). "Toll-like receptors; their physiological role and signal 
transduction system." Int Immunopharmacol 1(4): 625-635. 
Tammen, S. A., S. Friso and S. W. Choi (2013). "Epigenetics: the link between nature and nurture." 
Mol Aspects Med 34(4): 753-764. 
Tate, P. H. and A. P. Bird (1993). "Effects of DNA methylation on DNA-binding proteins and 
gene expression." Curr Opin Genet Dev 3(2): 226-231. 
Taylor, P. R., G. D. Brown, D. M. Reid, J. A. Willment, L. Martinez-Pomares, S. Gordon and S. 
Y. Wong (2002). "The beta-glucan receptor, dectin-1, is predominantly expressed on the surface 
of cells of the monocyte/macrophage and neutrophil lineages." J Immunol 169(7): 3876-3882. 
Temperley, N. D., S. Berlin, I. R. Paton, D. K. Griffin and D. W. Burt (2008). "Evolution of the 
chicken Toll-like receptor gene family: a story of gene gain and gene loss." BMC Genomics 9: 62. 
ten Broeke, T., R. Wubbolts and W. Stoorvogel (2013). "MHC class II antigen presentation by 
dendritic cells regulated through endosomal sorting." Cold Spring Harb Perspect Biol 5(12): 
a016873. 
Thakur, S. and J. Kaur (2015). "Regulation at multiple levels control the expression of folate 
transporters in liver cells in conditions of ethanol exposure and folate deficiency." Biofactors 
41(4): 232-241. 
170 
 
 
 
Thapa, S., E. Nagy and M. F. Abdul-Careem (2015). "In ovo delivery of Toll-like receptor 2 ligand, 
lipoteichoic acid induces pro-inflammatory mediators reducing post-hatch infectious 
laryngotracheitis virus infection." Vet Immunol Immunopathol 164(3-4): 170-178. 
Thellin, O., B. Coumans, W. Zorzi, R. Barnard, G. Hennen, E. Heinen and A. Igout (1998). 
"Expression of growth hormone receptors by lymphocyte subpopulations in the human tonsil." 
Dev Immunol 6(3-4): 295-304. 
Thompson, C. B. (1992). "Creation of immunoglobulin diversity by intrachromosomal gene 
conversion." Trends Genet 8(12): 416-422. 
Topping, D. L. (1996). "Short-chain fatty acids produced by intestinal bacteria." Asia Pac J Clin 
Nutr 5(1): 15-19. 
van den Elsen, P. J., T. M. Holling, N. van der Stoep and J. M. Boss (2003). "DNA methylation 
and expression of major histocompatibility complex class I and class II transactivator genes in 
human developmental tumor cells and in T cell malignancies." Clin Immunol 109(1): 46-52. 
van den Elsen, P. J., N. van der Stoep, H. E. Vietor, L. Wilson, M. van Zutphen and S. J. Gobin 
(2000). "Lack of CIITA expression is central to the absence of antigen presentation functions of 
trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of 
CIITA." Hum Immunol 61(9): 850-862. 
171 
 
 
 
van der Burg, M., B. H. Barendregt, T. Szczepanski, E. R. van Wering, A. W. Langerak and J. J. 
van Dongen (2002). "Immunoglobulin light chain gene rearrangements display hierarchy in 
absence of selection for functionality in precursor-B-ALL." Leukemia 16(8): 1448-1453. 
Van Kooten, C., L. Galibert, B. K. Seon, P. Garrone, Y. J. Liu and J. Banchereau (1997). "Cross-
linking of antigen receptor via Ig-beta (B29, CD79b) can induce both positive and negative signals 
in CD40-activated human B cells." Clin Exp Immunol 110(3): 509-515. 
Visentin, M., N. Diop-Bove, R. Zhao and I. D. Goldman (2014). "The intestinal absorption of 
folates." Annu Rev Physiol 76: 251-274. 
Wald, D. S., E. Hennessy and M. Law (2001). "Do folate induced changes in serum homocysteine 
affect leukocyte concentrations in patients with ischaemic heart disease?" Thromb Res 104(5): 
343-345. 
Wan, Z., L. Rui and Z. Li (2014). "Expression patterns of prdm1 during chicken embryonic and 
germline development." Cell Tissue Res 356(2): 341-356. 
Wang, X., Z. Guan, Y. Chen, Y. Dong, Y. Niu, J. Wang, T. Zhang and B. Niu (2015). "Genomic 
DNA hypomethylation is associated with neural tube defects induced by methotrexate inhibition 
of folate metabolism." PLoS One 10(3): e0121869. 
Weng, N. P. (2006). "Aging of the immune system: how much can the adaptive immune system 
adapt?" Immunity 24(5): 495-499. 
172 
 
 
 
Whetstine, J. R., R. M. Flatley and L. H. Matherly (2002). "The human reduced folate carrier gene 
is ubiquitously and differentially expressed in normal human tissues: identification of seven non-
coding exons and characterization of a novel promoter." Biochem J 367(Pt 3): 629-640. 
Wienands, J. and N. Engels (2001). "Multitasking of Ig-alpha and Ig-beta to regulate B cell antigen 
receptor function." Int Rev Immunol 20(6): 679-696. 
Williams, P. J., J. N. Bulmer, B. A. Innes and F. Broughton Pipkin (2011). "Possible roles for folic 
acid in the regulation of trophoblast invasion and placental development in normal early human 
pregnancy." Biol Reprod 84(6): 1148-1153. 
Wintergerst, E. S., S. Maggini and D. H. Hornig (2007). "Contribution of selected vitamins and 
trace elements to immune function." Ann Nutr Metab 51(4): 301-323. 
Witte, W. (2000). "Selective pressure by antibiotic use in livestock." Int J Antimicrob Agents 16 
Suppl 1: S19-24. 
Wong-Baeza, I., M. Alcantara-Hernandez, I. Mancilla-Herrera, I. Ramirez-Saldivar, L. Arriaga-
Pizano, E. Ferat-Osorio, C. Lopez-Macias and A. Isibasi (2010). "The role of 
lipopeptidophosphoglycan in the immune response to Entamoeba histolytica." J Biomed 
Biotechnol 2010: 254521. 
Yasuda, M., Y. Taura, Y. Yokomizo and S. Ekino (1998). "A comparative study of germinal 
center: fowls and mammals." Comp Immunol Microbiol Infect Dis 21(3): 179-189. 
173 
 
 
 
Yitbarek, A., H. Echeverry, J. Brady, J. Hernandez-Doria, G. Camelo-Jaimes, S. Sharif, W. 
Guenter, J. D. House and J. C. Rodriguez-Lecompte (2012). "Innate immune response to yeast-
derived carbohydrates in broiler chickens fed organic diets and challenged with Clostridium 
perfringens." Poult Sci 91(5): 1105-1112. 
Yitbarek, A., J. C. Rodriguez-Lecompte, H. M. Echeverry, P. Munyaka, N. Barjesteh, S. Sharif 
and G. Camelo-Jaimes (2013). "Performance, histomorphology, and toll-like receptor, chemokine, 
and cytokine profile locally and systemically in broiler chickens fed diets supplemented with yeast-
derived macromolecules." Poult Sci 92(9): 2299-2310. 
Yuan, X. J., B. Dixon-McCarthy, H. W. Kunz and T. J. Gill, 3rd (1994). "Role of methylation in 
placental major histocompatibility complex antigen expression and fetal loss." Biol Reprod 51(5): 
831-842. 
Zarember, K. A. and P. J. Godowski (2002). "Tissue expression of human Toll-like receptors and 
differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their 
products, and cytokines." J Immunol 168(2): 554-561. 
Zhang, L., L. Zhang, X. Zhan, X. Zeng, L. Zhou, G. Cao, A. Chen and C. Yang (2016). "Effects 
of dietary supplementation of probiotic, Clostridium butyricum, on growth performance, immune 
response, intestinal barrier function, and digestive enzyme activity in broiler chickens challenged 
with Escherichia coli K88." J Anim Sci Biotechnol 7: 3. 
174 
 
 
 
Zhang, Y., F. Guo, Y. Ni and R. Zhao (2013). "LPS-induced inflammation in the chicken is 
associated with CCAAT/enhancer binding protein beta-mediated fat mass and obesity associated 
gene down-regulation in the liver but not hypothalamus." BMC Vet Res 9: 257. 
Zhao, R., G. Li, X. J. Kong, X. Y. Huang, W. Li, Y. Y. Zeng and X. P. Lai (2016). "The 
improvement effects of edible bird's nest on proliferation and activation of B lymphocyte and its 
antagonistic effects on immunosuppression induced by cyclophosphamide." Drug Des Devel Ther 
10: 371-381. 
Zhao, R., R. G. Russell, Y. Wang, L. Liu, F. Gao, B. Kneitz, W. Edelmann and I. D. Goldman 
(2001). "Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic 
acid supplementation reveals early neonatal failure of hematopoietic organs." J Biol Chem 
276(13): 10224-10228. 
Zynda, E. R., M. J. Grimm, M. Yuan, L. Zhong, T. A. Mace, M. Capitano, J. R. Ostberg, K. P. 
Lee, A. Pralle and E. A. Repasky (2015). "A role for the thermal environment in defining co-
stimulation requirements for CD4(+) T cell activation." Cell Cycle 14(14): 2340-2354. 
 
